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1. Molecular Recognition of Azamacrocycles1 
1.1 Introduction 
The field of coordination chemistry of polyazamacrocycles has undergone immense 
growth since the publication of seminal articles by Curtis [1] and Thompson and Curtin [2] 
in the early 1960s. Especially two cyclic tetraamines have played a key role in this field, 
namely 1,4,7,10-tetraaza-cyclododecane ([12]aneN4 or cyclen) and 1,4,8,11-tetraaza-
cyclotetradecane ([14]aneN4 or cyclam). 
 
1.1.1 General Properties of metal complexes of azamacrocycles 
The fit between the size of the metal ion and the cavity provided by the macrocycle is 
crucial for the design of metal complexes. On complexation with transition metals, the 
stereo-electronic requirements must also be taken into account.[3,4] As the cavity of the 
12-membered cyclen is smaller than that of 14-membered cyclam, the macrocycle tends to 
fold around metal ions with octahedral coordination geometry adopting a cis 
conformation.[4-6] 
 
In general, tetraazamacrocycles exhibit high basicity in the first two protonation steps and 
rather low basicity in the last two steps. The critical protonation constants (log KHi) for 
cyclen and cyclam and stability constants (log KMmHhLl) of their complexes with several 
metal ions are reported in Table 1. 
 
                                                 
1 The results of this chapter are in preparation for submission:  
Kruppa, M.; Walenzyk, T.; Koenig, B. Chem. Rev.  
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Table 1: Protonation constants (log KHi) for cyclen and cyclam and stability constants 
(log KMmHhLl) of their complexes with selected metal ions. T = 25 °C. 
Ion Equilibrium quotient Cyclam Cyclen 
H+ [HL]/[L] x [H] 11.58,a 11.3b 10.97h 
 [H2L]/[HL] x [H] 10.62,a 10.23b 9.87h 
 [H3L]/[H2L] x [H] 1.61,a 1.43b 1.6i 
 [H4L]/[H3L] x [H] 2.42,a 2.27b 0.8i 
 [H4L]/[L] x [H]4 26.23,a 25.23b 23.24h,i 
Ni2+ [ML]/[M] x [L] 22.2,c 20.1d 16.4j 
 [MHL]/[ML] x [H] 2.3d  
Cu2+ [ML]/[M] x [L] 26.5,b 27.2e 23.29,b 24.8e 
Zn2+ [ML]/[M] x [L] 15.0,e 15.5f 16.2f 
 [ML]/[MLOH] x [H] 3.99g 5.74g 
Cd2+ [ML]/[M] x [L] 11.23b 14.3f 
Pb2+ [ML]/[M] x [L] 10.83b 15.9f 
Co2+ [ML]/[M] x [L] 12.7i  
Hg2+ [ML]/[M] x [L] 23.0k 25.5k 
    
 
a I = 0.5 mol dm-3 KNO3 [7]; b I = 0.1 mol dm-3 NaNO3 [8]; c I = 0.1 mol dm-3 NaOH [9]; d I = 0.5 mol dm-3 
NaCl [10]; e I = 0.2 mol dm-3 KNO3 [11,12]; f I = 0.2 mol dm-3 NaClO4 [13]; g I = 0.2 mol dm-3 KNO3 [14]; 
h I = 0.5 mol dm-3 KNO3 [15]; i I = 0.2 mol dm-3 NaClO4 [16]; j I = 0.1 mol dm-3 NaNO3 [17]; k I = 0.2 mol dm-3 
KNO3 [18]  
 
1.1.2 Scope 
In this review the role of metal complexes of 1,4,7-triazonane ([9]aneN3), 
1,5,9-triaza-cyclododecane ([12]aneN3), 1,4,7,10-tetraaza-cyclododecane (cyclen or 
[12]aneN4) and 1,4,8,11-tetraaza-cyclotetradecane (cyclam or [14]aneN4) as molecular 
binding sites is discussed (Figure 1). Many metal complexes of azamacrocycles have in 
addition to the azamacrocycle ligand additional reversibly coordinated ligands. Their 
binding and exchange can be used in molecular recognition, if reversible and rapid. In the 
following review we discuss the current literature (up to early 2005) available for such 
binding situations. Reported X-ray structure analyses of [9]aneN3 cyclen and cyclam metal 
3 
complexes which coordinate additional ligands and the literature on solution studies 
involving reversible coordination to [9]aneN3, [12]aneN3, cyclen and cyclam complexes 
are summarised and discussed. 
N
N N
N N
N N
N
N
N
N N
N
N
1
[9]aneN3
2
[12]aneN3
3
[12]aneN4
4
[14]aneN4
Figure 1: The parent structures [9]aneN3, [12]aneN3, [12]aneN4 and [14]aneN4. 
 
In order to be considered, the parent structure needed to complex a metal, thereby 
coordinating to all nitrogens (3 in the case of [9]aneN3 and [9]aneN3 and 4 in the case of 
[12]aneN4 and [14]aneN4) in the azamacrocycle. Alkyl, phenyl and aryl substitution at any 
position (carbon or nitrogen substitution) was allowed provided such substitution did not 
affect the geometry of the parent structure nor introduce additional ligands which 
coordinate to the metal and thus induce a change in the coordination geometry.   
 
Such metal complexes needed to undergo an intermolecular coordination with another 
molecule. Only metal coordination with O, N and S atoms was examined. Metal complexes 
which only coordinated to halogens, sulfates, perchlorates, cyanides, isothiocyanides, 
azides, nitrates, nitrites, carbonates and solvent molecules (DMF, DMSO, H2O) were 
excluded. In general the guest molecule should be an organic entity which can coordinate 
to the host, ideally under physiological conditions.  
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1.2 Structures of 1,4,7,10-tetraaza-cyclododecane ([12]aneN4 or cyclen) 
complexes in solid state 
1.2.1 Co(III) complexes 
[Co(cyclen)-(X)Y]n+ species exhibit exclusive cis stereochemistry, but exist as various 
isomeric forms depending on the orientation (syn or anti) of the sec-NH protons at the two 
equatorial sites.[19] The X-ray structure analysis of [Co(cyclen)(O2C2O2)]+ (Figure 2) shows 
the oxalate coordinated with a cis stereochemistry with the Co(III) atom adopting a 
distorted octahedral geometry which is typical for Co(III) cyclen complexes.[20-23] Similar 
complexes such as [Co(cyclen)-(O2CCH2CO2)]+,[19] show the same geometry. 
 
 
 
Figure 2: Structure of syn,anti-[Co(cyclen)(O2C2O2)]+ in the crystal. Thermal ellipsoids 
are drawn at the 50 % probability level. 
 
On coordination with a monodentate ligand such as a phosphite anion, Co(III) cyclen 
maintains its octahedral geometry by also coordinating a water molecule (Figure 3).[24]  
5 
 
Figure 3: Structure of syn(OP(H)(O)2),anti(OH2)-[Co(cyclen)(OH2){OP(H)(O)2}]+ in the 
solid state. Thermal ellipsoids are drawn at the 50 % probability level. 
 
Co(III) complexes of cyclen also coordinate diamines, such as ethylenediamine, 
2-(aminomethyl)pyridine, (R)-1,2-propanediamine, (R,R)-1,2,-diaminocyclohexane, 
trimethylenediamine or 2-methyl-1,3-diaminopropane.[25,26]  
 
In addition the coordination of amino acids such as alanine to Co(III) complexes has been 
reported.[20,27] Figure 4 shows the cis octahedral geometry, with the macrocycle 
coordinated in a folded manner which leaves space available for the coordination of two 
other monodentate ligands or a bidentate one. 
 
Figure 4: The structure of the Co(III) complex of (2R,5R,8R,11R)-2,5,8,11-tetraethyl-
1,4,7,10-tetra-azacyclododecane. 
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Figure 5 shows the X-ray structure of the Co(III) complex of (2R,5R,8R,11R)-2,5,8,11-
tetraethyl-1,4,7,10-tetra-azacyclododecane bound to (S)-alanine. The stereochemistry of 
the amino acid is maintained upon coordination to Co(III) ion.[28]  
 
Figure 5: The crystal structure of the Co(III) complex of (2R,5R,8R,11R)-2,5,8,11-
tetraethyl-1,4,7,10-tetra-azacyclododecane bound to (S)-alanine. 
 
1.2.2 Cu(II) complexes 
Several structures of Cu(II) complexes of cyclen have been reported.[29,30] X-ray analyses 
show that copper is coordinated in a square planar geometry with the four nitrogens of 
cyclen.[31] However no solid state structures of complexes with additional ligands 
coordinated to copper have been reported. 
 
1.2.3 Ni(II) complexes 
Nickel(II) cyclen complexes have an octahedral coordination sphere by binding two water 
molecules in a cis orientation that only slowly exchange with other ligands.[32,33] Figure 6 
shows the structure of the [Ni(cyclen)(H2O)2]2+ cation in the solid state.[34] 
7 
 
Figure 6: Structure of the [Ni(cyclen)(H2O)2]2+ cation in the solid state. Hydrogen atoms 
are omitted for clarity. Probability ellipsoids are 30 %. 
 
An N-methylated Ni(II) cyclen derivative leads to the [Ni2(Me2-cyclen)2ox]2+ binuclear 
cation (where ox = oxalate anion).[34] The oxalate dianion acts a tetradentate bridging 
ligand between two Ni(II) cyclen complexes. 
 
The Ni(II) cyclen complex was also found to coordinate imidazole. The X-ray structure 
analysis shows the Ni(II) ion in a distorted octahedral coordination geometry consisting of 
four nitrogen atoms from cyclen as ligands, one nitrogen atom from the imidazole and one 
oxygen atom from one of the perchlorate ions.[35] The same distorted octahedral geometry 
is also illustrated in the following example where a Ni(II) cyclen complex binds an acetate 
anion (Figure 7).[36] 
 
8 
 
Figure 7: Structure of [Ni(cyclen)(η2-CH3CO2)]+ cation in the solid state. Hydrogen atoms 
are omitted for clarity. Probability ellipsoids are 30%. 
 
Ni(II) cyclen complexes coordinate phenanthroline (phen) (Figure 8) [37] and 
7,7,8,8-tetracyanoquinodimethane (TCNQ) [30] as additional ligands giving distorted 
octahedral coordination geometry consisting of four nitrogen atoms from cyclen and two 
nitrogens atoms from the heteroaromatic ligand.  
 
N
N
Ni
NH
N
HN
HN
 
2+
ClO42 
-
 
Figure 8: Molecular structure of [Ni(cyclen)(phen)](ClO4)2. 
 
1.2.4 Zn(II) complexes 
Zn(II) cyclen complexes interact with uridine (U) and thymidine (T) nucleotides by 
specific Zn2+-imide N- coordination (Figure 9).[38] Additional stabilisation of this structure 
9 
by hydrogen bonds between amine N-H of the cyclen ligand and the carbonyl groups of the 
heterocycle have been proposed, but solid evidence is missing. 
N
N
O
N3
OH
O
O
Me
Zn(II)
N
N
N
N
H
H
H
H
-
 
Figure 9: Zn(II) cyclen complexes selectively coordinate the imide group in nucleosides, 
such as 3’-azido-3’-deoxythymidine (AZT). 
 
The X-ray structure analysis of [Zn(cyclen)(AZT)](H2O)2(ClO4) reveals a distorted square 
pyramidal N5-coordination geometry for the Zn(II) ion (Figure 10).[38] 
 
  
Figure 10: Structure of [Zn(cyclen)(AZT)](H2O)2(ClO4) (AZT = 3’-azido-3’-
deoxythymidine) in the crystal. A perchlorate anion and two water molecules are omitted 
for clarity. Probability ellipsoids are 50%. 
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This distorted square pyramidal geometry is also present when Zn(II) cyclen coordinates to 
the important metabolite creatinine (Figure 11).[39] 
 
 
Figure 11: Structure of [Zn(cyclen)(creatinine)](ClO4)2. Two perchlorate anions are 
omitted for clarity. 
 
Zn(II) cyclen complexes coordinated with phosphate anions as additional ligands have 
been described and characterised by X-ray analysis. (Figure 12).[40] The para-nitro phenyl 
ester of phosphate (NPP2-) forms a complex with three Zn(II) cyclen complexes. The three 
oxygen atoms of the phosphate anion act as the fifth ligand for the Zn(II) ions coordinated 
by the cyclen ligand. 
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Figure 12: Structure of Zn(cyclen)]3-NPP2- in the solid state. All hydrogen atoms, 
perchlorate anions and water molecules are omitted for clarity. Probability ellipsoids are 
30%. 
 
An imidazolate anion can act as a bridging ligand for two Zn(II) cyclen complexes. The 
X-ray structure analysis (Figure 13) shows the two Zn(II) ions with distorted square 
pyramidal coordination geometry composed of four nitrogen atoms from cyclen ligand and 
one nitrogen atom from the bridging imidazolate ion.[35] 
 
 
Figure 13: Structure of [Zn(cyclen)]2-im (im = imidazolate) in the solid state.  
 
Structures of bis-Zn(II) cyclen complexes coordinate barbital (Figure 14) [41] as well as 
thymidine and uridine nucleosides, such as thymidine 5’-monophosphate (5’-dTMP).[42] 
The aggregates have a 2:2 stoichiometry and consist of a macrocyclic arrangement. 
12 
Tris-Zn(II) cyclen variations have also been reported to coordinate organic phosphate 
dianions.[40]  
 
Figure 14: Structure of bis-[Zn(cyclen)]-bar2- (bar = barbital) as a 2:2 complex in the 
crystal. All hydrogen atoms, perchlorate anions and water molecules are omitted for 
clarity. Probability ellipsoids are 30%. 
 
1.3 Structures of 1,4,7,10-tetraaza-cyclododecane ([12]aneN4 or cyclen) 
complexes in solid state (Tabulated) 
Table 2 summarises all X-ray structures registered at the Cambridge Crystallographic 
Database according to the selection criteria previously mentioned.  
 
 
 Table 2: Structurally characterised metal complexes of 1,4,7,10-tetraaza-cyclododecane with additional ligand coordinated to the metal ion in the 
solid state. 
Structure of the Metal ions 
additional ligand Zn2+ Ni2+ Co3+ Rh3+ Ru2+ 
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(18) See ref. 
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(19) See ref. 
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(20) See ref. 
[37,54] 
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(21) See ref. 
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M
NH2O
O
R6
R5
 
 
(22) See ref. 
[55] 
(23) See ref. 
[20,56-65] 
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(24) See ref. 
[66] 
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N S
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(25) See ref. 
[67] 
    
 M
NH2S
 
  
(26) See ref. 
[68] 
  
 
(1) Substitution - n-aryl; R1 = aryl; (2) a) Substitution - none; R2 = p-nitrophenolate; (2) b) Substitution - n-alkyl; R2 = O; (3) Substitution - none; (4) Substitution - none; (5) 
Substitution - n-alkyl (cage); R8 = CH3, R9 = H; (6) a) Substitution - none; R8 = CH3, R9 = H; (6) b) Substitution - none; R8 = CH3, R9 = Br; (7) Substitution - none; (8) Substitution 
- none; (9) Substitution - none; (10) Substitution - none; (11) Substitution - none; (12) Substitution - n-aryl; R2 = CH3; (13) Substitution - none; R2 = Metal; (14) Substitution - none; R2 = 
H; (15) Substitution - n-aryl; (16) Substitution - none; (17) Substitution - none; (18) Substitution - none; (19) Substitution - none; (20) Substitution - none; (21) Substitution - n-alkyl; (22) 
Substitution - n-alkyl; R5 = H, R6 = CH3 (alanine); (23) a) Substitution - c-alkyl; R5 = H, R6 = CH3 (alanine); (23) b) Substitution - c-alkyl; R5 = COOH, R6 = CH3; (23) c) 
Substitution - c-alkyl; R5 = H, R6 = CH2OH (serine); (23) d) Substitution - c-alkyl; R5 = CH3, R6 = CH2OH (methylserine); (23) e) Substitution - c-alkyl; R5 = H, R6 = H (glycine); 
(23) f) Substitution - c-alkyl; R5 = H, R6 = -CH2CH2-S-CH3; (23) g) Substitution - c-alkyl; R5 = H, R6 = CH(OH)CH3 (threonine); (23) h) Substitution - c-alkyl; R5 = CH3, R6 = 
CH2PhOH (methyltyrosine); (24) Substitution - none; (25) Substitution - none; (26) Substitution - none 
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1.4 Molecular recognition of 1,4,7,10-tetraaza-cyclododecane ([12]aneN4 
or cyclen) complexes in solution 
1.4.1 Co(III) complexes 
The optically active Co(III) complex of (2R,5R,8R,11R)-2,5,8,11-tetraethyl-1,4,7,10-tetra-
azacyclododecane was found to react with several neutral amino acids at pH 8 to form the 
corresponding amino acidato complexes.[56] The stereochemistry of the amino acid was 
retained on complexation with the macrocycle.  
 
1.4.2 Cd(II) complexes 
The Cd(II) complex of cyclen containing 7-amino-4-trifluoromethylcoumarin, 5 was 
designed as a fluorescent reporter.[69] Particular phosphate and citrate anions are bound by 
the metal complex, thus displacing the aromatic amino group of the coumarin and causing 
a change of the excitation spectrum (Figure 15). 
 
O
MN N
N N
HN
OF3C
H
H
H
n+
anion
H
H
H
anion
ONH
MN N
N N
CF3
O
n+
:
5 (M = Cd2+)  
Figure 15: Sensoric principle of phosphate ion sensing with 5.  
 
The metal complex detects pyrophosphate and citrate with high selectivity, whilst no 
response was shown for fluoride or perchlorate. Organic anions such as adenosine 
triphosphate (ATP) and adenosine diphosphate (ADP) also gave strong signals whilst 
cyclo-adonosine monophosphate (cAMP) showed little response (Table 3). The sensing 
mechanism was shown to be reversible.  
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Table 3: Apparent dissociation constants (Kd) of sensor 5 for anions in 100 mM HEPES 
Buffer (pH 7.4). 
Anion Kd (M) 
Pyrophosphate 7.5 x 10-5
Citrate 9.0 x 10-5 
Phosphate 1.5 x 10-2 
ATP 1.4 x 10-5 
ADP 2.6 x 10-5 
GMP 4.8 x 10-5  
AMP 4.4 x 10-4 
UMP 1.7 x 10-3 
UMP 1.7 x 10-3 
cAMP a 
a Kd is too large to be calculated. 
 
1.4.3 Zn(II) complexes 
The prevalence of Zn(II) ions in biological systems has lead to a large number of Zn(II) 
complexes as models for such systems. A comprehensive review on the molecular 
interactions of Zn(II) cyclen and its derivatives was recently published.[70] On 
complexation with cyclen, the acidity of the Zn(II) ion is reinforced, which results in a 
lowering of the pKa value of the Zn(II)-bound water from 9.0 to 7.9 at 25 °C.[38] Zn(II) 
cyclen forms 1:1 complexes with deprotonated sulfonamides at neutral pH, despite the 
weak acidity of sulfonamides with pKa values of 7-10 (Figure 16). [71,72]  
N N
N N
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H
H
H
N N
N N
X
H
H
H
H
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2+
RSO2NH2
- H+
6a (X = H2O)
6b (X = HO )-
7
 
Figure 16: Reversible coordination of sulphonamide anions to Zn(II) cyclen 
 
Following a similar principle, Zn(II) cyclen complexes have been applied to the molecular 
recognition of nucleobases, thymine (dT) and uracil (U), which possess similarly weak 
acidic (pKa around 10) protons at their ‘imide’ groups.[73] The centrosymmetric linear 
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arrangement of the three-point functional groups in 8 comprises the acidic Zn(II) acting to 
yield the ‘imide’ anion to form a stable Zn(II)-N(3)- bond and the two hydrogens attached 
to cyclen nitrogens to form two complementary hydrogen bonds with each of the ‘imide’ 
carbonyls. This specific Zn2+-imide N- coordination allows the reversible coordination of 
flavin derivates, which are important cofactors of flavoproteins [74-76] and photolyases.[77] 
These electronic and structural fittings also permit formation of extremely strong 1:1 
complexes of 8 with dT, AZT, U, Ff (5-fulorouracil) and riboflavin (Figure 17). Zn(II) 
cyclen complexes appended with polyaromatic rings were shown to selectively bind to T- 
or U-rich sequences in double stranded DNA (or RNA) to denature them.[50,78] It does not 
interact with the other DNA nucleosides (i.e. dG, dA and dC) making the reversible 
coordination selective. 
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Figure 17: Zn(II) cyclen complex coordination to molecules bearing slightly acidic imide 
groups. 
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Zn(II) cyclen complexes reversibly coordinate phosphate dianions such as HPO42-, phenyl 
phosphate (PP2-) and 4-nitrophenyl phosphate (NPP2-) as monodentate ligands to yield 1:1 
complexes 9 in solution (Figure 18).[79] The observed binding affinities in neutral aqueous 
solution are in the millimolar range. 
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9b : R1 = H, R2 =
 
Figure 18: Zn(II) cyclen coordinating monodentate phosphate dianions. 
 
The dianions of phosphate monoesters, RPO32- are potential bidentate donors and bridge 
two Zn(II) ions (Figure 19). A bis-Zn(II) cyclen complex linked with a meta-xylene spacer 
forms a stable complex with NPP2- with log Ks of 4.0 in aqueous solution (I = 0.1 NaClO4 
at 25 °C).[41]  
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Figure 19: Bis-Zn(II) cyclen complexes bind phosphate monoesters in a bidentate fashion. 
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Figure 20: The C3-symmetric tris-Zn(II) cyclen complex 12. 
 
A yet higher binding constant could be achieved for tris-Zn(II) cyclen complexes 
(Figure 20).[40] Table 4 summarises the phosphate affinity constants of Zn(II) cyclen, 
bis-Zn(II) cyclen and tris-Zn(II) cyclen. 
 
Table 4: Phosphate (phosphonate) affinity constants (log Ks)2 of Zn(II) cyclen 9, 
m-bis(Zn(II) cyclen) 10 and tris(Zn(II) cyclen) 12, for NPP-, PP2-, phenyl phosphonate 
(PhP2-), and α -D-glucose 1-phosphate (α-Glu-P2-) at 25 °C and I = 0.10 (NaNO3).[80] 
Phosphate (pK2’b)  Log Ksa  
 (phosphonate)  9 10 12 
NPP2- (5.2) 3.1 4.0 5.8 
PP2- (5.9) 3.5 4.6 6.6 
α-Glu-P2- (6.1) - - 7.0 
PhP2- (7.0) - - 7.9 
aKs = [ZnL1-RPO32- complex] / [ZnL1][RPO32-] (M-1) for 9, [Zn2L3-RPO32- complex] / [Zn2L3][RPO32-] (M-1) 
for 10, or [Zn3L5-RPO32- complex] / [Zn3L5][RPO32-] (M-1) for 12. 
bK2’ = - log ([RPO32-]aH + / [RPO3H-]) obtained by pH titration at 25 °C with I = 0.10 (NaNO3). 
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Figure 21: Zn(II) benzylcyclen, m-xylyl-bis-[Zn(II) cyclen] and p-xylyl-bis-[Zn(II) 
cyclen]. 
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Figure 22: The binding of p-bis-[Zn(II) cyclen] to 5’-dTMP and 5’-dTDP respectively, 
showing the NOE interactions. 
 
The bis-[Zn(II) cyclen] complexes 10 and 14 (Figure 21 and 22) can bind imide-containing 
nucleotides. Table 5 compares the apparent complexation constants of 13, 10 and 14.[80] 
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Table 5: Apparent complexation constants (log Kapp) for imide-containing nucleotides with 
Zn(II) cyclen complexes at pH 7.6 and 25 °C. 
 13 10 14 
dT 3.2a (5.7)d 3.2, 3.2b  
 3.4c (10:dT = 1:2)  
c-dTMP 3.3c 3.5, 3.5b  
  (10:c-dTMP = 1:2)  
5’-CMP 3.3a (3.7)d 3.2a (4.3)d  
 3.3b 3.4b  
3’-dTMP  5.2a (8.6)d 5.9a (8.9)d 
  5.3b 5.8b,e 
  5.4c,f 5.8c,f 
5’-dTMP 3.4, 3.4b 5.5a (9.3)d 6.4a (9.6)d 
 (27:5’-dTMP = 2:1) 5.5b > 6b,e 
  5.7c,f > 6c,f 
2’-UMP  5.7b  
3’-UMP  4.8a (7.8)d 5.5a (8.5)d 
  5.2c,f 5.7c,f 
5’-UMP  5.4a (8.3)d 6.2a (8.8)d 
  5.5c,f > 6b 
   > 6c,f 
5’-dTDP  5.6b > 6b 
  5.5c,f > 6c,f 
5’-dTTP  5.0b 5.6b 
5’-AZTMP  5.5b > 6b,e 
  5.7c,f > 6c,f 
5’-AZTDP  5.3b 5.9b 
  5.5c > 6c,f 
 
a Determined by potentiometric pH titration. 
b Determined by isothermal titration calorimetry (50 mM HEPES buffer). 
c Determined by UV titration in 50 mM HEPES buffer with I = 0.1 (NaNO3). 
d For the intrinsic complexation constants Ks, see reference. 
e Titrations were carried out at [5’-dTMP] = 0.2 mM and 0.1 mM and the average values were listed. 
f Titrations were carried out at [nucleotide] = 0.1 mM and 50 µM and the average values were listed. 
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The search for small molecules that interact with RNA is currently attracting great interest 
for drug discovery in AIDS thrapeutics.[81] The transcription of HIV-1 genome is 
facilitated by a HIV-1 regulatory protein Tat which activates the synthesis of full-length 
HIV-1 mRNA by its binding to a TAR (trans-activation responsive) element RNA.[82] The 
TAR element comprising the first 59 nucleotides of the HIV-1 primary transcript adopts a 
hairpin structure with a uracil (U)-rich bulge (UUU or UCU), which is the Tat binding site. 
Linear tris-[Zn(II) cyclen] complexes inhibit HIV-1 TAR RNA-Tat peptide binding due to 
its strong binding to the UUU bulge.[81,83] Figure 23 shows the coordination of dT-pdT-pdT- 
with a linear tris-[Zn(II) cyclen] complex. 
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Figure 23: The binding of tris-[Zn(cyclen)] to dT-pdT-pdT-. 
 
1.5 Immobilised 1,4,7,10-tetraaza-cyclododecane ([12]aneN4 or cyclen) 
complexes 
1.5.1 Zn(II) complexes 
Zn(II) cyclen complexes have been bound to polymers and used to extract riboflavin from 
aqueous solutions. The reversible recognition of Zn(II) cyclen complexes to flavin imide 
moieties allowed the quantitative and selective extraction (and release from the polymer) 
of Vitamin B2 (riboflavin) from a mixture of compounds at physiological pH 
(Figure 24).[84]  
 
26 
Zn
2+
N
NN
N
H
H
OH
H
ClO42        - 
N
O
O
H N
N
R
ClO4          - 
Zn
2+
N
NN
N
H
H H
OH
N
O
O
N
N
R
pH = 7.4
pH = 5.4
HClO4
 
Figure 24: Binding equilibrium of Zn(II) cyclen polymer with riboflavin (R = ribityl) or its 
tetraacetate [R = CH2CH(OAc)CH(OAc)CH(OAc)CH2OAc]. 
 
A molecular imprinted polymer (MIP) from polymerisable Zn(II) cyclen complexes and 
ethylene glycol dimethyl acrylate has been prepared.[39] Creatinine, 8 was used as the 
template molecule which was reversibly coordinated to the zinc atom (Figure 25). The 
imprinted polymer reverses the binding selectivity of Zn(II) cyclen for creatinine and 
thymine from 1:34 in homogenous solution to 3.5:1 in the MIP.  
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Figure 25: Preparation of a stoichiometric template Zn(II) cyclen-creatinine monomer salt 
and copolymerisation of 16-Zn-8 with ethylene glycol dimethyl acrylate (EDGMA). 
 
A similar MIP polymer was prepared for the selective recognition and separation of 
phosphates.[85] Here again a polymerisable Zn(II) cyclen complex (ZnL2) was 
copolymerised with ethylene glycol dimethyl acrylate. The polymer interacts selectively 
with phosphomonoester dianions such as deoxyadenosine 5’-monophosphate (5’-dAMP) 
and 4-nitrophenyl phosphate (4-NPP) over deoxyadenosine (dA) and adenosine 
3’,5’-cyclic-monophosphate (3’,5’-cAMP). The apparent complexation constants for the 
1:1 complex of ZnL2 on the MIP and 5’dAMP and 4-NPP, log Kapp(ZnL-S2-) (S2- = 
phosphomonoester dianion), at pH 7.0 and 25 °C were determined as 4.1.  
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1.6 Structures of 1,4,8,11-tetraaza-cyclotetradecane ([14]aneN4 or 
cyclam) complexes in solid state 
1.6.1 Zn(II) complexes 
Zn(II) cyclam complexes can coordinate carboxylates as additional ligand. The X-ray 
structure of a Zn2-xylyl-bicyclam with an acetate anion is shown (Figure 26).[86] Both 
cyclam units adopt the cis-V configuration (according to the nomenclature of Bosnich [87]) 
with chelation by acetate on one cyclam face and twofold H-bonding on the other.  
 
 
Figure 26: X-ray crystal structure of [Zn2-xylyl-bicyclam(OAc)2](OAc)2·2CH3OH. 
CH3OH is not shown for clarity.  
 
The Zn(II) complex of 1,4,8,11-tetraazacyclotridecane-5-one can coordinate glycine by 
glycine amine-Zn(II) coordination.[88] The X-ray structure (Figure 27) shows a distorted 
square pyramidal geometry. The Zn atom has an irregular five-coordinate geometry, with 
the donors being three nitrogen atoms and one oxygen atom from the azamacrocycle and 
one coordinated chloride. 
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Figure 27: Structure of Zn(II) complex of 1,4,8,11-tetraazacyclotridecane-5-one in the 
solid state. 
 
1.6.2 Ni(II) complexes 
Cyclam forms thermodynamically and kinetically more stable complexes with copper and 
nickel, where the cyclic amine is arranged in a strain-free conformation with the metal 
atom located in the plane defined by the four nitrogen atoms of the cyclam.[4-6] There is 
some evidence that Ni(II) cyclam can bind benzoates and that the metal free cyclams 
preorganise the ligands. The X-ray structure (Figure 28) of Ni(O-benzoato)2(cyclam) quite 
closely parallels that of nickel free (4-t-butylbenzoato)2(cyclamH2). The X-ray structure of 
the Ni(II) cyclam distinctly shows that a Ni-O bond is formed in the case of 
Ni(O-benzoato)2(cyclam). 
 
30 
 
Figure 28: Structure of (4-t-butylbenzoato)2(cyclamH2) and Ni(O-benzoato)2(cyclam) 
respectively, in the solid state. 
 
Similar geometries were found for the corresponding Cu(II) complexes. However in the 
case of copper, the two carboxylate anions remain hydrogen bound to the (coordinated) 
cyclam ligand, and do not take part in the metal’s inner coordination sphere and no Cu-O 
bond is formed.[89]  
 
The Ni(II) complex of 1,4,7,10-tetraazacyclododecane-2,9-dione coordinates the dipeptide 
glycine-glycine.[90] The X-ray structure (Figure 29) shows a octahedral coordination 
geometry. The Ni atom has an has a regular six-coordinate geometry, with the donors 
being four nitrogen atoms and two oxygen atoms from two macrocyclic ligands.  
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Figure 29: Structure of Ni(II) complex of 1,4,7,10-tetraazacyclododecane-2,9-dione) in 
the crystal. 
 
1.7 Structures of 1,4,8,11-tetraaza-cyclotetradecane ([14]aneN4 or 
cyclam) complexes in solid state (tabulated) 
Table 6 summarises all X-ray structures registered at the Cambridge Crystallographic 
Database according to the selection criteria previously mentioned.  
 
 
 Table 6: Structurally characterised metal complexes of 1,4,8,11-tetraaza-cyclotetradecane with additional ligand coordinated to the metal ion in the 
solid state. 
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(1) Substitution - n-alkyl; R1 = CH3; (2) Substitution - none; R2 = Ga3+; (3) Substitution - none; R2 = Ga3+; (4) Substitution - c-alkyl; R3 = Al3+; (5) a) Substitution - none; R3 = Ar; (5) 
b) Substitution - none; R3 = OMe; (6) a ) Substitution - none; R3 = Ar; (6) b) Substitution - none; R3 = OMe; (7) a) Substitution - none; R3 = Ar; (7) b) Substitution - none; R3 = 
cyclohexane; (8) Substitution - none; R3 = pyridine; (9) Substitution - none; R4 = H; (10) Substitution - none; (11) Substitution - none; (12) Substitution - none; (13) Substitution - c-
 alkyl; (14) Substitution - none; (15) a) Substitution - c-alkyl; R3 = aryl; (15) b) Substitution - c-alkyl; R3 = pyridine; (16) Substitution - c-alkyl; R3 = aryl; (17) Substitution - c-alkyl; R7 
= alkyl or aryl; (18) Substitution - c-alkyl; (19) a) Substitution - none; (19) b) Substitution - c-alkyl; (20) Substitution - c-alkyl; (21) Substitution - c-alkyl; (22) a) Substitution - n-alkyl 
(caged); R8 = CH3; (22) b) Substitution - c-phenyl; R8 = CH3; (23) Substitution - none; R8 = CH3; (24) Substitution - n-alkyl; R6 = R7 = CH3; (25) a) Substitution - c-alkyl; R6 = R7 = 
H; (25) b) Substitution - n-alkyl; R6 = H, R7 = CH3; (25) c) Substitution - c-alkyl; R6 = R7 = CH2CH3; (26) Substitution - none; R1 = quinonedi-imine; (27) Substitution - n-alkyl; R1 
= 2-cyanoethene-1,2-dithiolate; (28) Substitution - none; (29) Substitution - none; (30) Substitution - none; (31) Substitution - none; (32) Substitution - none; (33) Substitution - none; (34) 
Substitution - none; (35) Substitution - c-alkyl; R9 = O, R10 = NH-alkyl; (36) a) Substitution - c-alkyl; R11 = Ar; (36) b) Substitution - c-alkyl; R11 = -SCH2COO-; (36) c) Substitution 
- c-alkyl; R11 = -CH2CH2COO-; (37) Substitution - c-alkyl; (38) Substitution - c-alkyl; R12 = R13 = CH2CH2-Ph; 39) Substitution - c-alkyl; R12 = R13 = CH2CH2-Ph 
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1.8 Molecular recognition of 1,4,8,11-tetraaza-cyclotetradecane 
([14]aneN4 or cyclam) complexes in solution 
1.8.1 Zn(II) complexes 
The bicyclam 18 (Figure 30) is a very potent anti-HIV agent.[143] Entry of T-lymphotropic 
HIV-1 and HIV-2 strains is blocked by specific binding to the CXCR4 coreceptor.[144] 
Since the level of free Zn(II) in plasma is ca. 1 nM and cyclam and its alkylated derivates 
strongly bind Zn(II), it is reasonable to expect that the active compound in vivo is the 
Zn(II) complex.[86]  
NH NH
N NH
NHNH
NNH
1
23
4
1'
2' 3'
4'
18  
Figure 30: Molecular structure of xylyl-bis-cyclam, 1,1'-[1,4-phenylenebis(methylene)]-
bis(1,4,8,11-tetraazacyclotetradecane) 18. The octa-HCl salt of the compound is registered 
as the anti-HIV drug AMD3100. 
 
The interaction of the Zn(II) complex of xylyl-bis-cyclam, which is 10 times more active 
than 18 in its interaction with the CXCR4 receptor,[145] with acetate was studied. In 
solution, acetate binds [146] to the Zn(II) bis-cyclam complex with a binding constant of 
log K = 2.75 ± 0.15, assuming the formation of 1:1 complexes of acetate with Zn(II) 
cyclam units and that the two Zn(II) cyclam units are independent.[86]  
 
Both in solution and in the solid state the complex adopts a cis-V configuration (according 
to the nomenclature of Bosnich [87]) via chelation and second coordination sphere double 
H-bonding.[86] It was shown that only Zn(II) cyclams could bind acetates. Pd(II) cyclams 
do not coordinate acetates, as the acetate does not induce configurational changes of Pd(II) 
cyclam nor Pd(II)2-xylyl-bis-cyclam, and Pd(II) cyclams cannot readily adopt a cis-V 
configuration.[86,145]  
 
Although Co(III) cyclams are known to bind strongly to carboxylates, and are capable of 
undergoing isomerisations from cis to trans configurations,[147] Co(III)2-xylyl-bis-cyclam 
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has a very low activity towards CXCR4.[145] This is most likely attributable to the kinetic 
inertness of Co(III) cyclams.[148] 
 
The Zn(II) complex of 1,4,8,11-tetraazacyclotridecane-5-one was found to be extremely 
efficient in the recognition of glycine in aqueous solution (Figure 31).[88]  
NN O
N N
O NH
O
Zn
H
H H
H
-
19  
Figure 31: Zn(II) complex of 1,4,8,11-tetraazacyclotridecane-5-one can bind glycine. 
 
The carboxylate group is capable of forming a coordinative bond to the Zn(II) ion, while 
the H-atom of the amide on the macrocycle may also favour aggregate formation. Table 7 
shows the stability constants for the Zn(II) 1,4,8,11-tetraazacyclotridecane-5-one glycine 
complex 19. 
 
Table 7: Stability constants for the Zn(II) 1,4,8,11-tetraazacyclotridecane-5-one (L) 
glycine complex 19 (µ = 0.10 M KCl, 25 °C). 
Stoichiometry    Quotient K log K 
 (L) Zn Glycine H   
1 1 0 0 [LZn] / [L][Zn] 9.33 
1 1 0 1 [LZnH] / [LZn][H] 6.44 
1 1 0 2 [LZnH2] / [LZn][H]2 6.65 
1 1 1 0 [LZnGly-] / [LZn][Gly-] 12.25 
1 1 1 1 [LZnGlyH] / [LZnH][Gly] 2.58 
1 1 1 -1 [LZnGlyOH] / [LZnOH][Gly] 1.00 
1 1 1 -2 [LZnGlyOH2] / [LZnOH2][Gly] 0.88 
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1.8.2 Ni(II) complexes 
The Ni(II) complex of 1,4,7,10-tetraazacyclododecane-2,9-dione was found to be efficient 
in the recognition of the dipeptide glycine-glycine in aqueous solution (Figure 32).[90]  
NiN
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H
H
-
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Figure 32: Ni(II) complex of 1,4,7,10-tetraazacyclododecane-2,9-dione can coordinate the 
dipeptide glycine-glycine. 
 
Table 8: Stability constants for the Ni(II) 1,4,7,10-tetraazacyclododecane-2,9-dione (L) 
glycine-glycine (G) complex 20 (µ = 0.10 M KCl, 25 °C). 
Stoichiometry    Quotient K log K 
(L) Ni G H   
1 1 0 0 [LNi] / [L][Ni] 15.51 
1 1 0 1 [LHNi] / [LNi][H] 4.50 
1 1 0 2 [LH2Ni] / [LHNi][H] 4.11 
1 1 0 -1 [LNiOH] / [LNi][H] 6.31 
1 1 0 -2 [LNiOH2] / [LNiOH][OH] -9.64 
1 1 1 0 [LNiG] / [LNi][G] 19.20 
1 1 1 -1 [LNiGOH] / [LNiG][OH] 10.07 
1 1 1 -2 [LNiGOH2] / [LNiGOH][OH2] 0.29 
 
The formation of a stable ternary complex, L-Ni(II)-Gly-Gly- leads to a very high binding 
constant of log K = 19.20 (Table 8). The strong recognition may also be partially attributed 
to the formation of an H-bond between the macrocycle and the dipeptide. 
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1.8.3 Hg(II) complexes 
Mallik et al. have shown that the Hg(II)-xylyl-biscyclam 21 (Figure 33) could bind 
imidazole in DMSO (binding constants >> 100 M-1).[149,150] 
N
N
N
NN
N
Hg
N
N
N
N N
N
Hg
21  
Figure 33: The Hg(II)-xylyl-bis-cyclam 21 bound to two imidazole units. 
 
An improvement in imidazole binding was shown with the tris-cyclam ligand 22 which 
when complexed with Hg2+ recognised a model histidine peptide 23 with a K > 105 M-1 in 
DMSO solution (Figure 34).[151]  
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Figure 34: A tris-cyclam 22 when complexed with Hg(II) recognises the model 
tris-histidine peptide 23, which is complementary in geometry. 
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1.9 Immobilised 1,4,8,11-tetraaza-cyclotetradecane ([14]aneN4 or 
cyclam) complexes 
1.9.1 Ni(II) complexes 
A linear polymer containing Ni(II) cyclam and 2,2’-bipyridyl-5,5’-dicarboxylate (bpydc2-) 
was synthesised (Figure 35). The polymer binds guests in the order of ethanol ≈ phenol 
(formation constant, Kf = 42 M-1) > pyridine (Kf = 13 M-1) > benzene (Kf = 3 M-1) in 
isooctane solution.[152]  
 
Ni
2+
N
N
N
N
H H
H H
N N O
OO
O
[Ni(cyclam)]2+ bpydc2-  
 
 
Figure 35: Structure of the linear polymer containing Ni(II) cyclam and bpydc2-. 
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1.10 Structures of 1,5,9-triaza-cyclododecane ([12]aneN3) complexes in 
solid state 
1.10.1 Zn(II) complexes 
Although the coordination of Zn(II) [12]aneN3 to acetazolamide and sulfonamides has 
been reported in solution,[14,71] no X-ray structures were found for their coordination in the 
solid state. The X-ray structure of Zn(II) [12]aneN3 shows a zinc atom with slightly 
distorted tetrahedral coordination environment, with a bound water molecule (Figure 36).  
 
Figure 36: Structure of Zn(II) [12]aneN3 in the crystal. Perchlorate anions and hydrogen 
atoms are omitted for clarity. Probability ellipsoids are 30%. 
 
1.11 Molecular recognition of 1,5,9-triaza-cyclododecane ([12]aneN3) 
complexes in solution 
1.11.1 Zn(II) complexes 
The Zn(II) complex of the 12-membered triamine, [12]aneN3 forms 1:1 complexes with 
acetazolamide and sulfonamides.[14,71] The intermolecular affinities of aromatic 
sulfonamides to Zn(II) [12]aneN3 (ZnL) are summarised in the Table 9. 
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Table 9: Comparison of critical affinity constants, Ki (M-1) and K [Zn(II) 
[12]aneN3-I-] (M-1).[71]  
 log Ki log K[Zn(II) [12]aneN3-I-] 
acetazolamide 3.6 4.9 
4-nitrobenzenesulfonamide 2.6 4.8 
p-toluenesulfonamide 2.4 5.7 
Determined by inhibition kinetics at pH 8.4 (50 mM TAPS buffer), I = 0.10 and 25 °C. 
 
Due to the poor solubility of the sulfonamides, the potentiometric pH titration method 
could not be used to determine the binding constants. The binding constants were 
measured by a kinetic inhibition method of the Zn(II) [12]aneN3 promoted 4-nitrophenyl 
acetate hydrolysis, which is analogous to the procedure used to determine sulphonamide 
binding to carbonic anhydrase (CA).[153] The apparent binding constants are consistent with 
previous biochemical data reported for CA models which makes such Zn(II) [12]aneN3 
complexes good models for CA. 
 
1.12 Immobilised 1,5,9-triaza-cyclododecane ([12]aneN3) complexes 
No reports on immobilised [12]aneN3 complexes have appeared in the literature so far. 
  
1.13 Structures of 1,4,7-triazonane ([9]aneN3 or TACN) complexes in 
solid state 
1.13.1 Cu(II) complexes 
The smallest azamacrocycles which forms metal complexes is [9]aneN3. Its Cu(II) 
complex binds to the amino acid histidine, forming a square pyramidal Cu(II) coordination 
geometry.[154] The X-ray structure analysis confirms that the distorted square-pyramidal 
Cu(II) coordination sphere is comprised of three nitrogen donors from the [9]aneN3 plus 
one carboxylate atom and the primary nitrogen from L-histidine (Figure 37). 
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Figure 37: The structure of [Cu(TACN)(histidine)]2+(PF6)- in the solid state. 
 
1.14 Structures of 1,4,7-triazonane ([9]aneN3 or TACN) complexes in 
solid state (Tabulated) 
Table 10 summarises all X-ray structures registered at the Cambridge Crystallographic 
Database according to the selection criteria previously mentioned.  
 
 
 Table 10: Structurally characterised metal complexes of 1,4,7-triazonane with additional ligand coordinated to the metal ion in the solid state. 
Structure of the  Metal ions 
additional ligand Zn2+ Cu2+ Ni2+ Co3+ Rh3+ Fe3+ Fe2+ Ru2+ Mn3+ Cr3+ V3+ Zr4+ 
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(1) a) Substitution - none; R1 = aryl; (1) b) Substitution - n-alkyl; R1 = aryl; (2) Substitution - n-alkyl; R4 = Ph; (3) a) Substitution - n-alkyl; R2 = aryl; (3) b) Substitution - none; R2 = 
aryl; (4) Substitution - n-alkyl; R4 = CH2Ph; (5) Substitution - n-alkyl; R4 = Ph; (6) Substitution - none; (7) Substitution - none; (8) a) Substitution - n-CH2Ph; (8) b) Substitution - n-
alkyl; (9) Substitution - n-alkyl; (10) Substitution - n-alkyl; (11) Substitution - n-alkyl; (12) Substitution - n-alkyl; R8 = CH3; (13) Substitution - n-alkyl; R8 = Ph; (14) Substitution - n-
alkyl; R8 = Ph; (15) Substitution - n-alkyl; R8 = CH3; (16) Substitution - n-alkyl; R8 = CH3; (17) Substitution - n-alkyl; R8 = CH3; (18) Substitution - n-alkyl; R8 = CH3; (19) 
Substitution - none; R8 = CH3; (20) Substitution - n-alkyl; (21) Substitution - n-alkyl; (22) Substitution - none; R5 = pyridine; (23) Substitution - n-alkyl; (24) a) Substitution - none; (24) 
b) Substitution - n-alkyl; (25) Substitution - none; (26) Substitution - none; (27) Substitution - none; (28) Substitution - n-alkyl; (29) a) Substitution - n-alkyl; R5 = CH3; (29) b) 
Substitution - n-alkyl; R5 = O-alkyl; (30) a) Substitution - n-alkyl; R7 = H; (30) b) Substitution - none; R7 = CH3; (31) Substitution - none; (32) Substitution - n-alkyl; R7 = Ph, R8 = 
tert-butyl 
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1.15 Molecular recognition of 1,4,7-triazonane ([9]aneN3 or TACN) 
complexes in solution 
1.15.1 Cu(II) complexes 
TACN strongly chelates Cu(II) (log K = 15.5 at 25 °C).[193] Above pH 8 one of the two 
equatorial coordination sites available on the copper atom is occupied by an hydroxide 
ion.[194] Above pH 9 glucose readily displaces water and hydroxide to form a ternary 
TACN-Cu(II)-glucose complex, which results in the net release of protons (Figure 38). The 
measurement of this proton release by pH titration gives apparent binding constants of 
35 M-1 at pH 10.25 to 1200 M-1 at pH 11.5 for the complexation of Cu(II) TACN with 
glucose.[195] The Cu(II) TACN complex 24 exhibits considerable selectivity depending on 
the diol. At alkaline pH it can bind cis-diols 1,4-anhydroerythritol and glucose, while 
trans-diol sugar analogue and 1,4-anhydro-L-threitol cannot be coordinated. 
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Figure 38: The Cu(II) TACN complex coordinates glucose at alkaline pH. 
 
1.16 Immobilised 1,4,7-triazonane ([9]aneN3 or TACN) complexes 
1.16.1 Cu(II) complexes 
A polymerisable Cu(II) TACN glucopyranoside complex 25 has been copolymerised with 
a cross linking monomer to form a porous polymer.[195] After washing to remove the 
template, a polymer which rebinds glucose and thereby releasing protons into the 
surrounding solution was created (Figure 39). The change in pH provides a convenient 
measure of glucose concentration over a clinically relevant range (0-25 mM) (Figure 40). 
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Figure 39: Preparation of a glucose sensing Cu(II) TACN containing polymer. 
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Figure 40: Titration of methyl-ß-D-glucopyranoside-imprinted polymer (0.034 mmol 
Cu(II)) with D-glucose in 0.15 M NaCl, 25 °C at pH 10.25, 10.75 and 11.25 at constant 
pH. 
 
The high ratio of cross-linker in the polymer generates a microporous polymer which 
allows the small glucose molecules to bind, but hinders larger molecules such as 
glycosylated proteins which may otherwise also bind to the metal complex. The polymers 
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ability to sense glucose is not impeded by the many potential competing species present in 
a complex biological sample such as porcine plasma (adjusted to pH 11.25).[196] 
 
1.17 Conclusion 
A variety of transition metal complexes of [9]aneN3, [12]aneN4 and [14]aneN4 reversibly 
coordinate additional donor molecules in the solid state, in solution or immobilised on 
polymer support. In many cases this coordination of an additional ligand is selective for a 
particular functional group. In solution binding affinities in the milli or micromolar range 
are observed, even at physiological conditions. This allows the selective molecular 
recognition of target molecules with high binding strength in biological media, a process 
which is difficult to achive using synthetic receptors based on hydrogen bonding. 
Therefore many transition metal complexes of azamacrocyclic ligands are ideally suited as 
molecular binding sites for analytes, and many applications in diagnostics, bioanalytics, 
biotechnology or material sciences may be envisaged. 
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2. Immobilised Zn (II) cyclen complexes as catalytic reagents 
for phosphodiester hydrolysis2 
Abstract:  
 
Many hydrolases found in nature have Zn(II) ions at their active site. Artificial hydrolases 
as alternatives for non-enzymatic hydrolysis were prepared by attaching Zn(II) cyclen 
complexes with an alcohol pendant to a polymeric support. These modified polymers 
showed a 104 fold enhanced intrinsic reactivity for the hydrolysis of phosphodiesters over 
the non-catalysed reaction in solution.  
 
 
 
                                                 
2 The results of this chapter have been published:  
Walenzyk, T.; Koenig, B. Chim. Inorg. Acta 2005, 358, 2269 
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2.1 Introduction 
2.1.1 Metalloenzymes 
Phosphate esters exist ubiquitously in nature [1] in the form of nucleoside phosphates 
(nucleotides) as components of RNA (or DNA), sugar nucleotides for glycosylation of 
oligosaccharides or proteins, activated form of proteins responding to extracellular signals, 
and chemical mediators playing central roles in intracellular signals.[2] Most nucleases 
contain in their active site metal ions, typically Zn(II), Ca(II), Mg(II) and Fe(II), which can 
play fundamental catalytic roles.[3] Phosphodiester linkages of DNA are very stable to 
hydrolysis, with a half-life for spontaneous hydrolysis estimated at 1011 years at pH 7 and 
25 °C.[4]  
 
Zn(II) is used by hydrolases over other metals due to its specific properties. Zn(II) does not 
have any redox activity (no generation of radical sites), is a strong Lewis acid and binds 
strongly to oxyanions. Zinc has intermediate polarisability (hard-soft character) and 
flexible coordination geometry (coordination number between four and six), which is 
essential for hydrolytic processes involving expansion of the coordination sphere.[5]  
 
Typical hydrolases which have Zn(II) at their active centre include carboxypeptidase 
(CPD), thermolysin, β-lactamase, phosphomonoesterase [such as alkaline phosphatase 
(AP)], phosphodiesterase, phosphotriesterase, matrix metalloproteinase (MMP) and 
carbonic anhydrase (CA).[1,5,6,7,8,9] There are three primary types of zinc binding sites: 
structural, catalytic and cocatalytic. In catalytic sites zinc forms complexes, which are 
tetrahedral or trigonal-bipyramidal, with water and four or five amino acid residues, with 
His, Glu, Asp and Cys being the most common.[9] The coordinated water may be polarised 
and activated by the Zn(II) alone, or together with a base of an active-site amino acid at 
neutral pH. This generates OH- ions and displacement of water or expansion of the 
coordination spheres results in Lewis acid catalysis by the catalytic zinc atom.[8,9,10,11,12,13] 
This is generally done by strong ligands or inhibitors such as iodide, sulphonamide, 
alcohol, thiol, phosphates or phenol.[6] 
65 
2.1.2 Models 
In order to gain a better understanding of the chemistry of the Zn(II) ion in zinc hydrolases, 
simple models have been designed, generally featuring tridentate or tetradentate ligands 
with free binding sites.[11,12,14,15,16]  
 
Scheme 1. Acceleration of phosphate ester hydrolysis by azamacrocycles. 
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The macrocyclic complex 1b was found to mimic the pH dependant CO2 hydration and 
HCO3- dehydration of CA, suggesting that the Zn(II)-OH-/Zn(II)-OH2 equilibrium at the 
active centre controlled the catalysis.[17,18,19,20] The acceleration of hydrolysis of phosphate 
esters by metal complexes has in particular lead to a large number of simple artificial 
nucleases.[11,15,16,21] The 12-membered macrocyclic tetraamine, 1,4,7,10-
tetracyclododecane (cyclen or Cyc) 3 was also shown to be a useful biomimetic model for 
CA [17,20,22] and AP.[19] Kimura and co-workers found that 1 and 3 (with 1b and 3b being 
the active species) hydrolysed bis(4-nitrophenyl) phosphate (BNPP) with second order rate 
constants of 8.5 x 10-5 M-1s-1 and 2.1 x 10-5 M-1s-1 respectively, at 35 °C.[23]  
 
A Zn(II)Cyc complex with an alcohol-pendant 5 mimicked the Zn(II) activated serine of 
AP and gave a second-order rate constant for the 4-nitrophenolate release reaction from 
BNPP of 6.5 x 10-4 M-1s-1 in aqueous solution at 35 °C.[23] In the proposed mechanism the 
alcohol group is deprotonated by the proximate Zn(II) to an alkoxide (5b). This alkoxide is 
125 times a better nucleophile to the phosphate substrate than the Zn(II)-bound hydroxide 
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of 3, and attacks BNPP to give a phosphoryl intermediate 6. This intermediate is 
susceptible to further hydrolysis by the intramolecular Zn(II)-bound hydroxide to give 7. 
The studies of Kimura showed that phosphomonoesters are not substrates for mononuclear 
Zn(II) phosphatase models, but rather inhibitors as shown by the isolation of the stable 
complexes 2, 4 and 7.[6] 
 
Scheme 2. Proposed hydrolytic mechanism of Zn(II)Cyc with an alcohol-pendant. 
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Since dianions of phosphate monoesters are potentially bidentate donors, RPO32- may 
bridge two Zn(II) ions.[24] A number of various bis-Zn(II)Cyc [25] and tris-Zn(II)Cyc [26] 
complexes were synthesised in an attempt to improve the binding affinity to phosphate 
monoesters. It was found that tris-Zn(II)Cyc complexes bind NPP2- 300 times better than 
bis-Zn(II)Cyc and 60 times better than Zn(II)Cyc.[24]  
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2.1.3 Synzymes - Synthetic polymers with enzyme like activities 
In enzyme-substrate complexes, polar interactions such as hydrogen bonding and 
dipole-dipole interactions as well as electrostatic interactions between the enzyme and 
substrate contribute significantly to the stabilisation of the transition states.[27] These polar 
interactions are enhanced in the hydrophobic microenvironment provided by the enzyme. 
Construction and control of such an environment of a catalyst-substrate complex is not 
easy with a small molecular framework.[28] The easiest way to obtain a hydrophobic 
environment in water is to attach the catalytic centre to a synthetic polymer.[29] Metal 
complexes as active sites for polymeric artificial enzymes have been constructed and their 
enhanced intrinsic reactivity for the hydrolysis of peptide or phosphodiester bonds 
shown.[30,31,32] The most common technique employed so far for creating such active sites 
has been molecular imprinting.[33] The disadvantage of molecular imprinted polymers 
(MIPs) is that a large number of the catalytic sites are embedded within the polymeric 
body and substrates have limited access to these cavities.[31,34]  
 
Cu(II)Cyc complexes which were attached to poly(chloromethylstyrene-co-
divinylbenzene) (PCD) beads were found to enhance the proteolytic activity up to 104 
times when compared to Cu(II)Cyc complex.[31] The Co(III)Cyc complex is one of the 
most effective synthetic catalysts for the hydrolysis of supercoiled DNA.[35] Suh and 
co-workers attached the Co(III)Cyc complex to PCD derivatives and showed that the 
reactivity of the resulting polymer is enhanced 200 times toward super coiled DNA [36] and 
150 times toward linear DNA [32] when compared to the Co(III)Cyc complex. To further 
increase the catalytic activity of artificial active sites, Suh increased the catalytic group 
density by synthesising polymers with dinuclear and tetranuclear sites containing 
Cu(II)Cyc.[37]  
 
By attaching a preassembled catalytic module to a synthetic polymer, all sites are on the 
surface and thus have access to the substrate (unlike in MIPs) and it is easier to interpret 
the catalytic outcome on a molecular basis as the structure is already known. The catalytic 
module chosen was Zn(II)Cyc with an alcohol pendant, due to the strong binding of Zn(II) 
to Cyc,[38] the hydrolytic abilities of such complexes [24] and their known mechanisms.[6] 
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2.2 Results and discussion 
2.2.1 Synthesis of mono-Zn(II)Cyc polymer 
The solid support chosen for the synthesis was a 40-90 µm Fractogel Epoxy bead 8.[39] The 
presence of the epoxide groups on the surface allowed for an efficient way to incorporate 
an alcohol pendant into the catalytic module. The epoxide ring opening can form two 
regiomers, however only one is shown in the structures for simplicity.  
 
In order to determine the maximum amount of epoxide groups available on the surface for 
nucleophilic attack, diethylaminoethylamine was coupled to the polymer. Standard 
conditions [40] gave polymer 9, with an amine loading of 0.26 mmolg-1, which was taken to 
be the maximum loading for the polymer.  
 
Scheme 3. Determination of maximum loading of the epoxide polymer. 
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A blank polymer was also generated in order to quantify the hydrolytic effect of the 
polymer itself. The epoxide polymer 8, with 0.394 mmol epoxide/g polymer, was heated 
with dilute H2SO4 to generate the diol 10. This diol was then complexed with zinc 
perchlorate to yield polymer 11. The corresponding diol loading of polymer 11 was 
calculated to be 0.37 mmol/g.  
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Scheme 4. Synthesis of the Zn(II) diol polymer 11. 
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To generate a Zn(II)Cyc with an alcohol pendant (analogous to 5) on a solid support, 
1,4,7,10-tetraazacyclododecane (Cyc) was coupled to the epoxide polymer under standard 
conditions. After deactivation of the remaining epoxide groups with dilute H2SO4, the 
corresponding Zn(II) complex 13 was generated by reacting the polymer with aqueous 
zinc(II) perchlorate hexahydrate solution at pH 10. The Zn(II)Cyc loading of the polymer 
can be calculated from the N content via elemental analysis, giving a value of 
0.25 mmol Cyc / g polymer. This corresponds to a yield of 96 % when the loading of 
polymer 9 is taken to be the maximum loading. A Zn content of 8.9 % in the polymer was 
determined by ICP-OES analysis. This large value suggests that in addition to quantitative 
zinc complexation of the Cyc, amphorteric Zn(OH)2 formation occurred. The precipitation 
of polymeric zinc hydroxide above neutral pH is known in the development of zinc-based 
hydrolytic agents.[41,42,43] 
 
Although the Zn(II)Cyc loading is very high, it is not certain if the Cyc modules are 
present as schematically drawn. The Cyc has 4 possible amines which could attack an 
epoxide thus causing cross-linked structures.  
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Scheme 5. Synthesis of a polymer bearing a Zn(II)Cyc complex with an alcohol 
pendant 11. 
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Another polymer was generated using 1,4,7,-tris-tert-butyloxycarbonyl-
1,4,7,10-tetraazacyclododecane 14 [44] instead of Cyc. After deactivation of the remaining 
epoxide groups with dilute H2SO4, the boc-protecting groups were removed quantitatively 
with TFA. Generation of the corresponding Zn(II) complex 16 occurred by reacting the 
polymer with aqueous zinc(II) perchlorate hexahydrate solution at pH 10. The loading of 
the polymer was determined to be 0.07 mmol Cyc / g polymer (27 % when compared to 
polymer 9) which is much lower than the loading of polymer 13. Possible reasons for the 
lower loading could include steric hindrance through the protecting groups and decreased 
reactivity of the free amine. The strategy has however the great advantage that only one of 
the amines of the Cyc can react with the epoxide, thereby only allowing the generation of 
the desired hydrolytic module.  
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Scheme 6. Synthesis of a polymer bearing a Zn(II)Cyc complex with an alcohol 
pendant 16. 
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2.2.2 Kinetic measurements for the phosphodiester cleavage reaction with mono-
Zn(II)Cyc complexes bound to a solid support 
2.2.2.1 Calculation of the molar extinction coefficient for para-nitrophenolate 
The hydrolysis of bis-p-nitrophenylphosphate (BNPP) releases p-nitrophenolate as a 
product which can be detected spectroscopically. Due to the protonation equilibrium of the 
nitrophenolate ion, its molar extinction coefficient depends on the pH and the used buffer 
system. The molar extinction coefficient of p-nitrophenolate was determined 
experimentally for the pH range 7 to 9 in the buffer system Tris/HCl (20 - 80 mM). 
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For the protonation equilibrium and the corresponding equilibrium constant (Ka) applies:  
OH
NO2
O
NO2
H
+
+
( HNP )
(1) Ka = [HNP]
(2)
[NP  ] [H  ]- +
Ka
-( NP   )  
According to the Lambert-Beer Law the absorption in dilute solutions is:  
(3)Abs = εobs d [HNP] total = εNP d [NP  ]
-
 
 
εobs is the measured extinction coefficient of HNP, εNP the extinction coefficient of the 
p-nitrophenolate ion and d the thickness of the cell. Equations (2) and (3) give Equation (4) 
which correlates the molar extinction coefficient with the pH value.  
(4)εobs = 
εNP Ka
Ka + [H  ]
+
 
 
By plotting 1/εobs against [H+] the molar extinction coefficient for the p-nitrophenolate can 
be determined for various pH values and various buffer systems. In the pH range of 7 to 9 
for the buffer system Tris/HCl the respective εobs values were obtained with a regression 
coefficient of R2 > 0.999 using a dilution series (c = 1 x 10-4 to 5 x 10-7 molL-1 
p-nitrophenol). The εobs values for 408 nm are summarised in Table 1. 
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Table 1. εobs values for p-nitrophenolate at 408 nm (25 °C, 50 mM Tris/HCl). 
pH Value[a] 
εobs for 408 nm 
[mol-1cm-1] 
7.01 7274 
7.04 7717 
7.21 9421 
7.28 10097 
7.50 12082 
7.81 14436 
8.11 15835 
8.53 16824 
8.75 17123 
9.01 17310 
[a] ∆ pH = ± 0.005 
0.0 2.0x10-8 4.0x10-8 6.0x10-8 8.0x10-8 1.0x10-7
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Figure 1. Calculation of εobs for p-nitrophenolate at 408 nm (25 °C, 50 mM Tris/HCl). 
 
The [H+] concentration was plotted against the 1/εobs, with a linear regression of 
R2 > 0.9999 (See Figure 1). With the help of the reciprocal of Equation (4), and the 
gradient and y-intercept from Figure 1, the equilibrium constant (pKa = 7.14 ± 0.01) and 
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molar extinction coefficient (εNP, 408nm = 17565 mol-1cm-1) could be calculated respectively. 
This calculated equilibrium constant agrees sufficiently well with the literature values.[45] 
 
Variations in the buffer concentration (Tris/HCl 20 and 80 mM) or in the ionic strength 
show no significant changes in the molar extinction coefficient. Changes in the region of 
∆εNP ≈ ± 70 mol-1cm-1 were detected. 
 
2.2.2.2 Non-catalysed hydrolysis of bis-(4-nitrophenyl)phosphate (BNPP) 
In addition to the metal catalysed hydrolysis of BNPP, the nucleophilic attack of OH- from 
the used solvent mixtures is a parallel reaction which contributes (although only to a small 
extent) to the overall hydrolysis and must also be considered (base hydrolysis). The base 
hydrolysis is a bimolecular reaction which can be expressed as the general Equation (5):  
(5)v = kx+y [OH  ]   [BNPP]
x y-
 
 
Under the used reaction conditions, the rate of reaction of the base hydrolysis vbase is 
directly proportional to the concentration of the ester and the hydroxide ions. Here the 
reaction rate of the base hydrolysis follows 2nd order kinetics, with 1st order for each of the 
reactants. At constant pH, Equation (5) gives Equation (6) which can be simplified to 
Equation (7). 
    
(6)vbase = 
d(Abs)
d(t)  εobs
= kobs [BNPP]  = kOH [OH  ] [BNPP]
-
 
 (7)kobs = kOH [OH  ]
-
 
 
The hydrolysis reaction is monitored spectroscopically, following the increase in 
absorptivity at 408 nm due to released p-nitrophenolate. The processing of the 
corresponding Absorption vs Time curves can be carried out using two different methods, 
whereby both generate pseudo-first-order kinetics due to the presence of an excess 
reactant. The ‘initial slope’ method is used for reactions with small turnovers (< 5 %).[46] 
With this method the rate of reaction is calculated from the gradient of the absorption vs 
time curves which is plotted against concentration of the varying reactant, giving a kobs (s-1) 
value. For reactions with larger turnovers, the ‘log-plot’ method is used which allows for a 
linearisation of the absorption vs time curve.[46] With this method the kobs value is the 
gradient from a plot of ln(Abs*/ε) vs time (for more detailed information to Abs* see 
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literature). Both methodologies give within the range of the experimental error the same 
kobs values for the base hydrolysis of BNPP.  
 
2.2.2.3 Hydrolysis of BNPP with immobilised mononuclear Zn(II)Cyc complexes 
(batch reaction) 
The rate of reaction (vobs) for a metal catalysed hydrolysis of BNPP is comprised of two 
terms, namely the base hydrolysis (vbase) and the metal catalysed hydrolysis (vcat).  
(8)vobs = vcat + vbase  
 
The phosphodiester cleavage reaction (i.e. p-nitrophenolate release reaction) rates of 
bis-(4-nitrophenyl) phosphate (BNPP) in the presence of immobilised metal catalyst were 
measured by following the time-dependant release of 4-nitrophenolate (at 408 nm) in 
buffered solutions at 25 °C. The kinetic data were collected under the conditions of [Zn-L] 
(concentration of the Zn(II)Cyc complex when the polymer is assumed to be 
dissolved) >> [BNPP]0 (the initially added concentration of BNPP). As [Zn-L] is constant 
pseudo-first-order kinetics can be assumed. 
        vcat = kcat [Zn-L]total [BNPP]  (9) 
 
By monitoring a sample containing no immobilised metal catalyst parallel to each reaction, 
the rate of reaction for the base hydrolysis could be determined. Substituting Equations (6) 
and (9) into Equation (8) gives Equation (10).  
     vobs = (kOH [OH-] + kcat [Zn-L]total)  [BNPP] (10) 
[Zn-L]total = [Zn-L-OH ] + [Zn-L-OH2] (11)
-
 
 
By subtracting vbase from the observed metal catalysed reaction rate (vobs), vcat and kcat can 
be determined according to Equation (10). 
 
The various immobilised catalysts were added to BNPP in buffered solutions at varying pH 
and allowed to shake in the dark at 25 °C for 24 hours. Polymer 11, a polymer containing 
no Zn(II)Cyc complex was taken as a reference. Polymer 13 has Cyc on the surface (free 
Cyc strategy), where all four nitrogen atoms of the cyclen were free to react with the 
epoxide groups on the surface. In polymer 16 only one nitrogen atom could react thus 
generating solely a cyclen moiety analogous to 5.  
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Figure 2. Proposed structure of polymer 11, 13 and 16. 
 
The kcat values for polymers 13 and 16 are shown in Table 2. The kcat values for 
polymer 13 are approximately half than those of polymer 16. This can be attributed to the 
fact that polymer 13 has catalytic sites cross-linked on the surface and thus not all can 
contribute effectively to the hydrolysis. Polymer 16, with a catalytic module analogous to 
5, showed the highest kcat values at pH 9.00, where 97 % of the catalytic site was present as 
Zn-L-OH-(see Equation (11)).[47] From this value a kBNPP value of 3.8 x 10-3 M-1s-1 at 25 °C 
was calculated. Kimura reported a kBNPP value of 6.5 x 10-4 M-1s-1 at 35 °C for 5b.[23]  
 
Table 2. The kcat values (M-1s-1) for the hydrolysis of BNPP by polymer 13, polymer 16 at 
25 °C. 
 pH 7.00 pH 8.00 pH 9.00 
Polymer 13 (5.2 ± 0.5) x 10-4 (8.6 ± 0.9) x 10-4 (1.2 ± 0.1) x 10-3 
Polymer 16 (8.9 ± 0.9) x 10-4 (1.9 ± 0.2) x 10-3 (3.7 ± 0.4) x 10-3 
 
Table 3 summarises the intrinsic rate of reaction enhancements for 5 and the 
polymer-catalysed hydrolysis of BNPP. The uncatalysed hydrolysis reaction of BNPP is 
taken as a reference and is assigned a value of 1. 
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Table 3. Rate of reaction enhancements for the hydrolysis of BNPP by polymer 11, 5, 
polymer 13 and polymer 16 and at 25 °C (Base hydrolysis has a rate enhancement of 1). 
 pH 7.00 pH 8.00 pH 9.00 
Polymer 11 23 5 1 
5[48] 186 56 9 
Polymer 13 1169 195 34 
Polymer 16 2001 430 98 
 
All three polymers showed decreasing rate enhancements with increasing pH. For 
polymer 11, where no catalytic module was present to enhance the rate of hydrolysis, the 
intrinsic reaction rate enhancement was most likely due to the polymer surface. The 
hydroxide concentration in the system at pH 9.00 is high and thus the polymer surface has 
little influence accelerating the hydrolysis (supported by a reaction rate enhancement factor 
of 1 at pH 9.00). At pH 7.00 however the hydroxide concentration on the surface of the 
polymer has an influence on the base hydrolysis as the concentration of hydroxide ions in 
solution is much lower. Similar observations are noted for polymer 13 and polymer 16, 
however here the enhancements effect is much larger as the catalytic site plays the central 
role.  
 
By comparing the rate enhancement of polymer 13 and 16 and taking polymer 11 as a 
reference, the rate enhancement effects of the polymer and its surface are removed. Table 4 
shows that the rate enhancement of both polymers is much more stable to changes in pH.  
 
Table 4. Rate of reaction enhancements for the hydrolysis of BNPP by polymer 13 and 
polymer 16 at 25 °C (polymer 11 has a rate enhancement of 1). 
 pH 7.00 pH 8.00 pH 9.00 
Polymer 13 51 37 26 
Polymer 16 87 82 77 
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2.2.2.4 Hydrolysis of BNPP with immobilised mononuclear Zn(II)Cyc complexes 
(PBR Reactor) 
The advantages of immobilised hydrolytic agents are most marked in continuous flow 
reactors. In these reactors the average residence time of the substrate molecules within the 
reactor is far shorter than that of the immobilised catalyst. This results in a far greater 
productivity from a fixed amount of catalyst than is achieved in batch processes. In a 
packed bed reactor (PBR) the substrate flows through the reactor as a plug. Ideally all of 
the substrate flows at the same velocity, in a parallel fashion with no back-mixing. In a 
PBR the conditions for pseudo-first-order kinetics, namely C0 (concentration of the 
Zn(II)Cyc complex when the polymer is assumed to be dissolved) >> S0 (the initial 
concentration of BNPP) are met. 
 
The volume of substrate (VolS) which has contact with the catalyst is an important 
parameter as it effectively determines the concentration of the system where reaction is 
taking place. The volume at any one time can be determined by comparing the mass of a 
packed reactor containing pre-swelled catalyst with a packed reactor containing pre-
swelled catalyst with the minimum amount of solvent needed to completely wet it. The 
calculated volume varies according to the characteristics (swelling ability, hydrophilicity, 
etc) of the polymer.  
 
The flow rate (F) of the reactor can be determined by measuring the time taken for each 
fraction to pass through the reactor. 
(12)F = 
Volfrac
tfrac  
 
As each fraction consists of numerous plugs (each with a volume of VolS) passing through 
the reactor, the average contact time (CT) of one plug can be calculated from 
Equation (13). Combining Equations (10) and (13) gives Equation (14), from which kcat 
can be calculated. 
(13)CT = 
VolS
F  
      
(14)vobs = 
d(Abs)
CT εobs
= (kOH [OH-] + kcat [Zn-L]total)  [BNPP]
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A PBR with polymer 11 containing Zn(II) ions but no Cyc complex (3.7 x 10-4 mol/g diol 
on the surface, with a contact volume of 0.15 ml) was eluated with BNPP (8.75 x 10-4 M in 
Tris/HCl buffer, pH 9.00). Once a steady state was achieved, a pseudo-first-order rate 
constant (kcat) of (4.5 ± 1.6) x 10-6 LMol-1s-1 was calculated from Equation (14), with the 
catalytic site taken as the diols generated from the epoxide opening. Polymer 11 showed an 
average rate enhancement of 51 ± 18 relative to the base hydrolysis (with a value of 1). 
 
A column with polymer 16 containing Zn(II)Cyc complex (7.1 x 10-5 mol/g binding sites, 
with a contact volume of 0.1 ml) was eluated with BNPP (8.75 x 10-4 M in Tris/HCl buffer, 
pH 9.00) and the UV absorption increase followed generally for 100 ml of BNPP solution. 
After a brief adsorption of the phosphodiester onto the polymer a steady state was achieved 
(see Figure 3).  
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Figure 3. Concentration of 4-NP- in each fraction after contact with polymer 16. 
 
During this steady state the entire reactor was an intense yellow. The pseudo-first-order 
rate constant (kcat) of (7.1 ± 0.6) x 10-3 LMol-1s-1 was calculated from Equation (14). 
Polymer 16 showed an average rate enhancement of (4.3 ± 0.3) x 104 relative to the base 
hydrolysis (with a value of 1).  
 
Once all the BNPP had been eluated the column was washed with Tris/HCl buffer, pH 9.00 
until 4-nitrophenolate could no longer be detected. Through this washing with buffer, the 
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reactor returned to its original colour, namely off white. The eluated samples were 
combined and allowed to pass over the same column again. This procedure was repeated 5 
times. With each cycle the rate of reaction decreased (Table 5).  
 
Table 5. Rate of reaction at steady state for the hydrolysis of BNPP by a PBR containing 
polymer 16 over 5 cycles. 
Cycle No. vcat (MolL-1s-1) 
1 2.27 ± 0.02 x 10-6 
2 1.03 ± 0.02 x 10-6 
3 0.72 ± 0.03 x 10-6 
4 0.31 ± 0.02 x 10-6 
5 0.27 ± 0.02 x 10-6 
 
As the turnover rate for the 1st cycle was only 6% (5.5 x 10-6 mol NP were produced from 
8.70 x 10-5 mol BNPP available), this decrease in vcat cannot be attributed a limited amount 
of BNPP available. Rather, the decreasing vcat values suggest catalyst inhibition through 
the phosphate monoester.  
 
2.2.3 Synthesis of bis-Zn(II)Cyc Polymer 
In order to obtain a bis-Zn(II)Cyc complex on a solid support, a suitable catalytic module 
which could be coupled to the epoxide polymer had to be synthesised. Compound 19, was 
synthesised from the chloride 18 [49]. After removal of the boc-protecting groups with TFA 
and resulting complexation with aqueous zinc(II) perchlorate hexahydrate solution at 
pH 10, compound 21 was generated. Here the Zn(II) is already complexed before coupling 
to the polymer.  
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Scheme 7. Synthesis of bis-Zn(II)Cyc 21 
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This amine could now be coupled with the epoxide polymer to yield the polymer bound 
bis-Zn(II)Cyc 22. Only the primary amine in 21 is available as a nucleophile for the 
coupling reaction. The amines in the Cyc are deactivated due to the coordinated Zn(II) and 
the secondary amine in the linker is aniline like and thus has a low reactivity. 
 
Scheme 8. Synthesis of the polymer bound bis-Zn(II)Cyc 22 
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40 °C, 5 days
0.08 mmol bis-Cyc / g polymer (30 %)
(from N content)
21 22  
The loading of the bis-Zn(II)Cyc complex on the polymer is quite low. The data from 
13C NMR for compound 21 shows a differentiation between the two Caryl-N bonds (two 
signals at 170.8 and 171.3 ppm). This suggests that the primary amine can coordinate to 
one of the zinc atoms and thus not always be free to attack the epoxide. The fact that a high 
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resolution MS could also be obtained from this highly charged molecule further supports 
this assumption. 
 
2.2.4 Kinetic measurements for the phosphodiester cleavage reaction with 
bis-Zn(II)Cyc complexes bound to a solid support 
A column with polymer 22 containing bis-Zn(II)Cyc complex was eluated with BNPP. The 
flow rate however was so small (< 1 ml / hour) that the conditions for a PBR (back mixing 
and diffusion) could not be met. The reasons for the low flow rate lie most likely in the 
surface characteristics, such as high hydrophobicity of the polymer.  
 
A stirred reactor (STR) in batch mode was set up in which the polymer is suspended in a 
defined amount of substrate over a membrane (in this case a glass frit) and stirred 
vigorously. This has the advantage that there is very little resistance to the flow of the 
substrate stream through the membrane.  
 
The polymer 22 containing bis-Zn(II)Cyc complex (7.7 x 10-5 molg-1 binding sites) was 
placed into a vessel with frit and eluated with aliquots of BNPP (8.75 x 10-4 M in Tris/HCl 
buffer, pH 9.00). Initial samples were allowed to drop through the frit where physical 
absorption of the phosphodiester onto the polymer occurred and until a steady state was 
achieved. 10 ml aliquots were now added to the polymer and mechanically stirred. After a 
defined time the BNPP solution was separated from the polymer and fresh BNPP was 
added.  
 
In addition to the hydrophobic nature of the polymer, the physical handling of the STR was 
very difficult and factors such as substrate evaporation and membrane seepage generated 
large errors. Unfortunately no reliable rate constant could be generated. The observed 
reaction rates (vobs) varied between 3 x 10-10 and 8 x 10-9 MolL-1s-1. 
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2.3 Conclusion 
Artificial hydrolases as alternatives for non-enzymatic hydrolysis were prepared by 
attaching Zn(II) cyclen complexes with an alcohol pendant to a polymeric support. These 
modified polymers showed a 104 fold enhanced intrinsic reactivity for the hydrolysis of 
bis-p-nitrophenylphosphate over the non-catalysed reaction in solution (pH 9.0, 25 °C) 
when a packed bed reactor (PBR) was used. A batch process showed lower intrinsic 
reactivities.    
 
84 
2.4 Experimental 
2.4.1 General 
2.4.1.1 Spectroscopy 
UV-VIS Spectra 
Varian Cary BIO 50 UV/VIS/NIR Spectrometer. Use of a 1 cm quartz cell (Hellma) and 
Uvasol solvents (Merck). Reported as: λmax in nm (ε). 
 
NMR-Spectra 
- Bruker AC-250 (1H: 250.1 MHz, 13C: 62.9 MHz), Measurement temperature: 24 °C. 
- Bruker Avance 300 (1H: 300.1 MHz, 13C: 75.5 MHz), Measurement temperature: 27 °C. 
- Bruker ARX-400 (1H: 400.1 MHz, 13C: 100.6 MHz), Measurement temperature: 21 °C. 
- Bruker Avance 400 (1H: 400.1 MHz, 13C: 100.6 MHz), Measurement temperature: 27 °C. 
- Bruker Avance 600 (1H: 600.1 MHz, 13C: 150.1 MHz), Measurement temperature: 27 °C. 
The chemical shifts are in δ-values (ppm) relative to the internal (or external) standard 
TMS. Reported as: Chemical shift (multiplicity, coupling constant, number of protons, 
assignment). Reported assignments were determined with the help of COSY, HMQC, 
HSQC, and NOESY 2D-Spectra. Abbreviations: s = singlet, bs = broad singlet, d = 
doublet, bd = broad doublet, dd = doublet of doublets, t = triplet, q = quartet, m = 
multiplet, bm = broad multiplet, sept = septet. Error of reported values: chemical shift: 
0.01 ppm for 1H-NMR, 0.1 ppm for 13C -NMR; Coupling constants: 0.1 Hz. The used 
solvent is reported for each spectrum. 
 
Mass spectra 
- Varian CH-5 (EI) 
- Finnigan MAT 95 (CI; FAB and FD) 
- Finnigan MAT TSQ 7000 (ESI) 
Xenon serves as the ionisation gas for FAB.  
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2.4.1.2 Analysis 
Melting Points 
Melting points are uncorrected and were determined according to Tottoli using 
instrumentation from Büchi. 
 
Elemental Analysis 
Elemental analyses were carried out by the central analytical department of Merck KGaA, 
Darmstadt. 
 
2.4.1.3 Synthesis 
Column Chromatography 
Silica gel Merck Geduran SI 60. 
 
Thin Layer Chromatography 
Aluminium sheets Merck 60 F254 Silica gel, thickness 0.2 mm. 
Detection via UV light at 254 nm or through discolouration with ninhydrin in ethanol. 
 
Solvents 
Purification and drying according to accepted general procedures.
[50,51]
  
If not otherwise stated, commercially available solvent of the highest purity were used.  
 
2.4.2 Synthesis of New Compounds 
Fractogel-diethylaminoethylamine (9) 
N
H
N
OH
 
 
2-diethylaminoethylamine (700 mg, 6.02 mmol) and Fractogel® EMD Epoxy (M) (1.50 g) 
were added to carbonate buffer (60 ml, pH 10.0) and allowed to stir (KPG stirrer) at 40 °C 
for five days. The polymer was filtered and washed with 3 x 50 ml dichloromethane, 
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2 x 50 ml THF and 1 x 50 ml dichloromethane. After drying under high vacuum, a white 
polymer was obtained (1.60 g). 
Elemental Analysis: C: 50.73, H: 6.94, N: 0.73 
This corresponds to an approximate polymer loading of 0.26 mmol diamine / g polymer.  
 
Fractogel (epoxy opening with H2SO4) (10) 
OHOH
 
 
Fractogel® EMD Epoxy (M) (1.20 g), with an epoxide loading of 394 mmol/g polymer,[52] 
was suspended in H2SO4 (40 ml, 0.5 M) and allowed to stir (KPG stirrer) at 40 °C for 2 h. 
The polymer was filtered and washed with 5 x 50 ml water, 2 x 50 ml methanol and 
1 x 50 ml dichloromethane. After drying under high vacuum, a white polymer was 
obtained (1.22 g).  
Elemental Analysis: C: 52.3, H: 7.1, N: 0.0 
 
Fractogel-zinc(II) diperchlorate (epoxy opening with H2SO4) (11) 
OHOH Zn
2+
ClO4-2
 
 
Polymer 10 (1.00 g) was suspended in carbonate buffer (20 ml, pH 10.0) to which zinc(II) 
perchlorate (1.12 g, 7.50 mmol) was added and allowed to stir (KPG stirrer) at 85 °C for 
18 h. The polymer was filtered and washed with 3 x 50 ml water, 2 x 50 ml methanol and 
1 x 50 ml dichloromethane. After drying under high vacuum, a white polymer was 
obtained (960 mg).  
ICP-OES: Zn: 1.6 % 
Elemental Analysis: C: 51.40, H: 6.86, N: 0.0 
This corresponds to an approximate polymer loading of 0.366 mmol diol / g polymer.  
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Fractogel-1,4,7,10-tetraazacyclododecane (cross-linked) (12) 
N
N
N
N
RR
R
OH
R = H or
OH*
 
 
1,4,7,10-tetraazacyclododecane (0.413 g, 2.40 mmol) and Fractogel® EMD Epoxy (M) 
(3.00 g) were added to carbonate buffer (80 ml, pH 10) and allowed to stir (KPG stirrer) at 
40 °C for five days. The polymer was filtered and washed with 3 x 50 ml dichloromethane, 
2 x 50 ml THF and 1 x 50 ml dichloromethane. The polymer was resuspended in H2SO4 
(60 ml, 0.5 M) and allowed to stir (KPG stirrer) at 40 °C for 2 h. The polymer was filtered 
and washed with 3 x 50 ml water, 2 x 50 ml THF and 1 x 50 ml dichloromethane. After 
drying under high vacuum, a white polymer was obtained (3.05 g). 
Elemental Analysis: C: 50.2, H: 7.4, N: 1.7 
 
Fractogel-1,4,7,10-tetraazacyclododecane-zinc(II) diperchlorate (cross-linked) (13) 
Zn
2+ ClO4-2
N
N
N
N
RR
R
OH
R = H or
OH*
 
 
Polymer 12 (1.73 g) was suspended in carbonate buffer (35 ml, pH 10) to which zinc(II) 
perchlorate (1.86 g, 5.0 mmol) was added and allowed to stir (KPG stirrer) at 85 °C for 
18 h. The polymer was filtered and washed with 3 x 50 ml water and then resuspended in 
100 ml water and allowed to stir (KPG stirrer) at 40 °C for a further 3 hours. The polymer 
was filtered and washed with 3 x 100 ml water, 2 x 50 ml methanol and 1 x 50 ml 
dichloromethane. After drying under high vacuum, a white polymer was obtained (1.83 g).  
ICP-OES: Zn: 8.9% 
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Elemental Analysis: C: 45.8, H: 6.8, N: 1.4 
This corresponds to an approximate polymer loading of 0.25 mmol Zn-Cyc / g polymer, 
which is a yield of 96 % assuming the loading of diethylaminoethylamine is the maximum 
loading possible 
 
Fractogel-1,4,7,10-tetraazacyclododecane (15) 
N
N
N
N
HH
H
OH
  
 
1,4,7-Tris-tert-butyloxycarbonyl-1,4,7,10-tetraazacyclododecane 14 [44] (1.134 g, 
2.40 mmol) and 3.00 g Fractogel® EMD Epoxy (M) were added to carbonate buffer (80 ml, 
pH 10) and allowed to stir (KPG stirrer) at 40 °C for five days. The polymer was filtered 
and washed with 3 x 50 ml dichloromethane, 2 x 50 ml THF and 1 x 50 ml 
dichloromethane. The polymer was resuspended in H2SO4 (60 ml, 0.5 M) and allowed to 
stir at 40 °C for 2 h. The polymer was filtered and washed with 3 x 50 ml water, 2 x 50 ml 
THF and 1 x 50 ml dichloromethane. The polymer was resuspended in TFA (20 ml) and 
allowed to stir at RT for 10 min. The polymer was filtered and then washed 2 x 50 ml with 
NaOH (2 M), 2 x 50 ml water, 2 x 50 ml THF and 1 x 50 ml dichloromethane. After drying 
under high vacuum, a white polymer was obtained (3.10 g).  
Elemental Analysis: C: 51.8, H: 7.3, N: 0.6 
 
Fractogel-1,4,7,10-tetraazacyclododecane-zinc(II) diperchlorate (16) 
N
N
N
N
HH
H
OH
Zn
2+ ClO4-2
 
 
Polymer 15 (1.72 g) was suspended in carbonate buffer (35 ml, pH 10.0) to which zinc(II) 
perchlorate (1.86 g, 5.0 mmol) was added and allowed to stir (KPG stirrer) at 85 °C for 
18 h. The polymer was filtered and washed with 3 x 50 ml water and then resuspended in 
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100 ml water and allowed to stir (KPG stirrer) at 40 °C for a further 3 hours. The polymer 
was filtered and washed with 3 x 100 ml water, 2 x 50 ml methanol and 1 x 50 ml 
dichloromethane. After drying under high vacuum, a white polymer was obtained (1.86 g).  
ICP-OES: Zn: 11.7% 
Elemental Analysis: C: 44.2, H: 6.6, N: 0.4 
This corresponds to an approximate polymer loading of 0.07 mmol Zn-Cyc / g polymer, 
which is a yield of 27 % assuming the loading of diethylaminoethylamine is the maximum 
loading possible. 
 
N*1*-[4,6-Bis-(4,7,10-triboc-1,4,7,10tetraaza-cyclododec-1-yl)-[1,3,5]triazin-2-yl]-
ethane-1,2-diamine (19) 
N
N
N
N
boc
boc
boc
N N
N
N
N
N
N
boc
boc
boc
N
N
H
boc
H  
1-N-boc-2-aminoethane (180 mg, 1.12 mmol) was dissolved in dioxane (15 ml). 
Compound 18 (300 mg, 0.28 mmol) and potassium carbonate (310 mg, 2.24 mmol) were 
then added allowed to stir under nitrogen at 95 °C for 36 hours. The potassium carbonate 
was filtered off and the solution evaporated to dryness. The crude product was 
chromatographed on silica gel with 1:1 petroleum ether:ethyl acetate as eluent yielding 
product 9 (325 mg, 0.27 mmol, 96 %) as a white solid.  
 
MP: 131 °C; IR (KBr): ν~  (cm-1) = 2976, 2930, 1678, 1569, 1365, 1167; 1H-NMR 
(300 MHz, CDCl6): δ [ppm] = 1.41 (s, 9 H, boc-CH3), 1.42 (s, 18 H, boc-CH3), 1.44 (s, 36 
H, boc-CH3), 1.97-2.05 (m, 2 H, CH2), 3.00-3.90 (m, 34 H, Cyc-CH2, CH2), 4.89 (s, 1 H, 
N-H), 6.13 (bs, 1 H, N-H); 13C-NMR (75 MHz, CDCl6): δ [ppm] = 28.5 (+, boc-CH3), 
41.0 (–, CH2), 50.2 (–, Cyc-CH2), 78.8 (Cquat, boc-C), 79.8 (Cquat, boc-C), 80.2 (Cquat, 
boc-C), 156.5 (Cquat, boc-CO), 166.0 (Cquat, Caryl-N); MS (ESI-MS, CH2Cl2/MeOH + 
10 mmol/l NH4OAc) m/z (%): 1181 (100) [MH]+; C56H101N13O14 + C4H8O2 (1268.60) 
Found: C 57.14, H. 8.11, N. 14.57; Calculated: C 56.81, H 8.66, N 14.35. 
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N*1*-[4,6-Bis-(1,4,7,10tetraaza-cyclododec-1-yl)-[1,3,5]triazin-2-yl]-ethane-1,2-
diamine (20) 
N
N
N
N
H
H
H
N N
N
N
N
N
N
H
H
H
N
N
H
H
H  
Compound 19 (1.18 g, 1.0 mmol) was dissolved in dichloromethane (40 ml), added to TFA 
(6.5 ml) and allowed to stir at RT for 36 h. The crude product was evaporated to dryness, 
passed over a strong basic ionic exchange column and washed with water. The solution 
was freeze dried yielding a white solid (479 mg, 1.0 mmol, 100 %).  
 
MP: 155 °C ; IR (KBr): ν~  (cm-1) = 3412, 3245, 2936, 1567, 1355, 1103, 635; 1H-NMR 
(300 MHz, CD3OD): δ [ppm] 2.61 - 2.81 (m, 18 H, 16 H CH2-Cyc, 2 H CH2), 2.92 (bs, 
8 H, 4 CH2-Cyc), 3.41 (t, 3J = 6.3 Hz, 2 H, CH2), 3.69 - 3.80 (m, 8 H, CH2-Cyc); 
13C-NMR (75 MHz, CD3OD): δ [ppm] = 42.7 (–, CH2), 44.2 (–, CH2), 46.8 (–, Cyc-CH2), 
49.4 (–, Cyc-CH2), 49.7 (–, Cyc-CH2), 167.4 (Cquat, Caryl-N), 168.2 (Cquat, Caryl-N); MS 
(ESI-MS, CH3CN/MeOH) m/z (%): 241 (100) [M+2H]+, 480 (53) [MH]+; HRMS 
(PI-LSI-MS, NBA) calculated for C21H46N13: 480.3999, found: 480.3998 ± 0.56 ppm); 
 
Bis-Zn(II)Cyc amine (21) 
N
N
N
N
H
H
H
N N
N
N
N
N
N
H
H
H
N
N
H
H
H
Zn
2+
Zn
2+
 
Compound 20 (247 mg, 0.52 mmol) was dissolved in methanol to which zinc(II) 
perchlorate (384 mg, 1.03 mmol) was added and allowed to stir under nitrogen at RT for 
36 hours. The reaction was then allowed to reflux for 2 hours. The product was evaporated 
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to dryness, recrystalised from water/methanol and dried yielding the Zn(II) complex 21 
(520 mg, 0.52 mmol, 100 %) as a white solid. 
 
MP: 245 °C; IR (KBr): ν~  (cm-1) = 3407, 3265, 2939, 1563, 1346, 1089, 627; UV/Vis 
(CH3CN): λmax (log ε) = 222 nm (4.561); 1H-NMR (400 MHz, CD3CN): δ [ppm] 2.67 - 
2.97 (m, 12 H, CH2-Cyc), 2.98 - 3.27 (m, 14 H, CH2-Cyc), 3.31 - 3.64 (m, 9 H, 2 CH2-Cyc, 
5 N-H), 3.65 - 3.80 (m, 1 H, N-H), 3.71 (dt, 3J = 6.0 Hz, 2 H, CH2), 4.15 - 4.50 (m, 4 H, 
CH2-Cyc), 6.10 - 6.80 (m, 3 H, N-H); 13C-NMR (100 MHz, CD3CN): δ [ppm] = 38.8 (–, 
CH2), 41.5 (–, CH2), 44.5 (–, Cyc-CH2), 46.2 (–, Cyc-CH2), 46.2 (–, Cyc-CH2), 46.8 (–, 
Cyc-CH2), 47.6 (–, Cyc-CH2), 47.8 (–, Cyc-CH2), 49.1 (–, Cyc-CH2), 167.5 (Cquat, Caryl-N), 
170.8 (Cquat, Caryl-N), 171.3 (Cquat, Caryl-N); MS (ESI) m/z (%): 236 (100) 
[(L+2Zn2++ClO4-)]3+; HRMS (LSI-MS, CH2Cl2/NBA) calculated for C21H45N13O12Zn2 
[(L+2Zn2+)4++3(ClO4-)]+: 904.0959, found: 904.0960 ± 0.96 ppm); 
 
Fractogel- bis-Zn(II)Cyclen (glycine ring opening) (22) 
N
N
N
N
H
H
H
N N
N
N
N
N
N
H
H
H
N
N
H
H
OH
Zn
2+
Zn
2+
 
 
The Zn(II) complex 21 (438 g, 0.43 mmol) and Fractogel® EMD Epoxy (M) (700 mg) 
were added to carbonate buffer (30 ml, pH 10) and allowed to stir (KPG stirrer) at 40 °C 
for five days. The polymer was filtered and washed with 3 x 50 ml water, 2 x 50 ml 
methanol and 1 x 50 ml dichloromethane. After drying under high vacuum, a white 
polymer was obtained (722 mg).  
Elemental Analysis: C: 51.31, H: 7.06, N: 1.41 
This corresponds to an approximate polymer loading of 0.08 mmol bis-Zn-Cyc / g 
polymer, which is a yield of 30 % assuming the loading of diethylaminoethylamine is the 
maximum loading possible. 
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The polymer (700 mg) was resuspended in tris-HCl buffer (25 ml, pH 8.00) containing 
glycine (0.2 M) and allowed to stir at 40 °C overnight. The polymer was filtered and 
washed with 3 x 50 ml water, 2 x 50 ml methanol and 1 x 50 ml dichloromethane. After 
drying under high vacuum a white polymer was obtained (655 mg).  
Elemental Analysis: C: 52.25, H: 6.70, N: 1.41 
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3. Synthesis of mono-dispersed spherical silica particles 
containing covalently bonded chromophores3 
Abstract:  
 
Organic-inorganic UV active hybrid materials have been prepared by a sol-gel process 
from benzophenone derivatives and tetraethylorthosilicate. The silica particles are 
spherical in shape and have a narrow size distribution which remains unchanged up to 
organic chromophore concentrations of 0.2 mmol/g. At higher concentrations the spheres 
become less regular and fuse. A dependence of the materials absorption properties on the 
particle size (at the same organic chromophore concentration) and on the concentration of 
surface grafted chromophores was noted. The most effective UV filter materials were 
found in a combination of silica incorporated chromophores and surface grafted 
chromophores at low overall chromophore concentration. A comparison of the 
chromophores photostability at standardised UV irradiation revealed an increase in 
stability for silica incorporated and surface immobilised benzophenone compared to 
benzophenone in homogeneous solution. 
 
 
                                                 
3 The results of this chapter have been patented :  
Walenzyk, T.; Carola, C.; Buchholz, H.; Synthesis of colloidal silica containing covalently bonded 
chromophores. Eur. Pat. Appl. 2004, EP 04013515.4 
The results of this chapter have been published:  
Walenzyk, T.; Carola, C.; Buchholz, H.; Koenig, B. Int. J. Cos. Sci. 2005, 27, 1-14 
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3.1 Introduction 
3.1.1 Background 
The evolution of modern ultraviolet (UV) filters or sunscreen chemicals have come along 
way from the first reported emulsions containing benzyl salicylate and benzyl cinnamate in 
1928.[1,2] In 1943, with the patent of p-aminobenzoic acid (PABA) as a sunscreen 
chemical, the stage was set for a whole family of p-aminobenzoate derivatives to be 
incorporated into sunscreen formulations.[3] PABA was a popular sunscreen in the 1950s 
and 1960s however its worldwide decline was due to reports questioning its dermatological 
safety and stability.[4] During the next 50 years various classes of organic compounds 
including p-aminobenzoates, salicylates, cinnamates, benzophenones, anthranilates, 
dibenzoylmethanes and camphor derivatives were approved in Europe and the United 
States as UV filters.[5,6] The majority of these filters protect against wavelengths in the 
UVB range (290-320 nm) which are known to cause erythema (sunburn),[7] immuno-
suppression [8] as well as skin cancer.[9] The benzophenones, dibenzoylmethanes and 
terephthalydenedicamphor sulfonic acid [10,11] also absorb in the UVA range (315-380 nm) 
which promotes skin ageing, chronic photopathy and denaturation of cellular protein 
structures.[12,13] Today’s UV filters are expected to protect not only against sun burn but 
also against the long term damaging effects [14,15] such as actinic aging or cutaneous 
cancer [16] which UV radiation can inflict on the skin.[17,18,19] UV filters are added to 
sunscreen products up to 10% for skin protection and more recently they are also present in 
many different cosmetic preparations for product stability.[20] With such large amounts of 
UV filters being applied to the skin, the percutaneous absorption and consequent systemic 
distribution and effects of these chemicals must be considered.[21,22]  
 
3.1.2 Bioaccumulation and degradation of UV filters in humans 
Evidence of bioaccumulation of UV filters in humans was shown in a study where 5 from 
6 samples of human milk contained benzophenone-3 and/or octylmethoxycinnamate.[23] In 
another study Hayden found that in humans up to 2% of an applied dose of 
benzophenone-3 and its metabolites were excreted in urine following topical 
application.[24] The possible adverse effects of bioaccumulation was demonstrated by two 
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studies in which six frequently used UVA and UVB filters (benzophenone-3, 
butyl-methoxydibenzoylmethane, homosalate, 4-methylbenzylidene camphor, 
octyldimethyl-p-aminobenzoic acid and octylmethoxycinnamate) were analysed for their 
endocrine activities in vitro using MCF-7 breast cancer cells [25] and in vivo in immature 
rats with the uterotrophic assay.[26] Estrogenic activity was demonstrated for five 
compounds in vitro and for three in vivo, with EC50 and ED50 values in the range of other 
known xenogens.  
 
3.1.3 Non-penetrating inorganic UV filters 
Recently, micropigments such as microfine titanium dioxide (TiO2) and zinc oxide (ZnO) 
have become a well known physical UV filter used in sunscreen formulations.[27,28,29] 
These inorganic particles cover the skin and block the UV radiation from reaching the skin 
through reflection, light scattering and absorption (TiO2 and ZnO are semiconductors).[30] 
TiO2 designed to optimally attenuate UV radiation has a mean particle size below 
20 nm.[31,32] In contrast to formulations containing macropigmented TiO2 particles, 
formulations containing microfine TiO2 are transparent on the skin and show a high 
cosmetic acceptance.[33] Due to their high surface activity, such particles have the tendency 
to form agglomerates which cause them to lose their efficiency in the UV and increasing 
interaction in the visible range of the electromagnetic spectrum, hence appearing white 
when applied onto the skin.[30,34] Various technologies such as coatings, dispersion 
techniques and formulation methods are employed to reduce this problem.[30] Due to the 
large number of various techniques employed and contributing factors such as vehicle and 
analysis method, the dermal uptake properties of microfine TiO2 has been controversially 
discussed in recent years.[35] Two different studies confirmed that TiO2 with a mean 
diameter of 20 nm does not penetrate the outer layer of the skin.[36,37]  
 
By combining the advantages of sunscreen chemicals, namely specific UV absorbance 
ranges, and those of physical UV blockers, namely non-skin penetrating, a new generation 
of sunscreen agents can be created. In the design of UV filters a good UV absorption in the 
range of 290–400 nm, photostability and dermatological compatibility are very 
important.[38]  
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3.1.4 New advances in non-penetrating UV filters 
In the year 2000 the first organic microparticles of diameter of less than 200 nm combining 
the absorption properties of organic UV filters with the scattering and reflection properties 
of inorganic UV filters such as TiO2, were approved as cosmetic filters by EU 
authorities.[14,39] UV filters based on organic chromophores which were grafted on 
organosiloxane polymers or encapsulated in silica capsules soon followed.[40,41,42] The 
amount of organic UV filter incorporated in such silica capsules is between 0.5 and 20 % 
by weight and the size of the particles varies between 10 nm and 10 µm. SiO2 is used today 
in the cosmetic industry as a formulation filler.[43,44] The SiO2 is in the form of nanometre 
sized spheres of equal size, called Microspheres (MS).[45] These MS do not penetrate the 
skin and are like tiny ball bearings, giving the skin a silky smooth feeling. 
 
The following project aims to improve the properties of the functionalised silica particles. 
Instead of just encapsulating organic UV filters within silica capsules or post-
functionalising silica with UV filters, a spherical polymer containing UV filters in its core 
and surface was synthesised. The dependence of the particle shape on the concentration 
and distribution of the organic chromophore and the photostability of the chromophore was 
examined. 
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3.2 Results and Discussion 
3.2.1 Synthesis of Microspheres 
Microspheres (MS) are synthesised from tetraethylorthosilicate (TEOS) 1 in a solution of 
ethanol, water and ammonia (Scheme 1). The size of the MS is influenced by the 
concentration of ammonia in solution and the temperature at which the polycondensation 
reaction takes place, and range from 25 to 500 nm in diameter. The general synthesis of 
equal sized spherical silica particles is outlined in Scheme 1.  
 
Scheme 1. General synthesis of neat microspheres (MSN) 
Si(OEt)4
Polymerisation
MS
Ethanol, H2O, 25 % NH3
2 h, ∆
1  
By introducing small amounts of a chromophore linked to triethoxysilyl functionality into 
the polymerisation, it is still possible to generate spherical hybrid silica particles even 
though the symmetry of the polymerisation is reduced.  
 
3.2.2 Choice of UV filter 
The class of UV filter used in the synthesis of the various microspheres were 
benzophenones, in particular (2-hydroxy-4-methoxyphenyl)-phenyl-methanone 
(benzophenone-3).  
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Figure 1. UV absorption spectra of (2-hydroxy-4-methoxy-phenyl)-phenyl-methanone in 
2-propanol 
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Benzophenone-3 has a strong absorption in both the UVA (320 - 400 nm) and 
UVB (290 - 320 nm) region of the electromagnetic spectrum (Figure 1). In 2-propanol, 
benzophenone-3 has 3 peaks, at 242 nm (log ε = 4.033), 287 nm (log ε = 4.173) and 
325 nm (log ε= 3.988). The UV characteristics were analysed at different concentrations in 
2-propanol and it was found that the Beer-Lambert Law is obeyed up to a chromophore 
concentration of 2 x 10-4 molL-1.  
 
3.2.3 Synthesis of monomer 
In order to incorporate the UV filter with covalent bonds into the inorganic matrix, a 
triethoxysilyl functionality was added via a spacer to benzophenone-3.  
 
103 
Scheme 2. Synthesis of a silyloxy monomer 
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O
H
2 3 4  
Benzophenone-3, 2 was reacted with allyl bromide (potassium carbonate acted as the base) 
in acetone to yield the allyl ether in quantitative yields. The addition reaction of 
triethoxysilane and the allyl ether 3 in the presence of a Pt (0) catalyst yielded the desired 
silylated product 4 (Scheme 2). The silyl ether 4 would then be added as the UV active 
monomer to the polycondensation reaction. Destruction of the hydrogen bond in 3 was 
however responsible for loss of the UVA (325 nm) absorption peak (Figure 2) and an 
alternative site for allylation needed to be found.  
 
Figure 2. Comparison of (2-hydroxy-4-methoxyphenyl)-phenyl-methanone and 
(2-allyloxy-4-methoxyphenyl)-phenyl-methanone 
O
OHO
O
O O
2 3
UV (CH3CN) λmax (log ε) 281 nm (3.869)UV (CH3CN) λmax (log ε) 287 nm (4.172)
UV (CH3CN) λmax (log ε) 325 nm (3.983)
 
 
Commercially available 2-hydroxy-(4-allyloxyphenyl)-methanone, 5 allowed the further 
functionalisation to the silyl ether, whilst still retaining the phenol. Silylation was first 
attempted using hexachloroplatinic (IV) acid hexahydrate as the catalyst.[46] Although the 
product was recovered, poor yields and purification difficulties due to instability of the 
product and high boiling point required that a new catalyst be sought. When 
platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane complex was used as the catalyst [47] 
the reaction was much cleaner, however purification was still an issue (Scheme 3). 
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Scheme 3. Synthesis of 2-hydroxy-4-(3-triethoxysilylpropoxy)diphenylketone 
Si
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O
H
5 6  
Purification of 2-hydroxy-4-(3-triethoxysilylpropoxy)diphenylketone, 6 was attempted 
with high vacuum distillation (230 °C at 0.5 mbar). The harsh conditions caused 
decomposition of the product and only small amounts (< 30 %) of 6 could be recovered. 
Before trying to improve the purification of the reaction, the product 6 was purchased 
directly. It was decided to only use commercially available 6 for the synthesis of the 
monospheres, thus reducing the time taken to synthesise the various MS and all MS were 
synthesised with the same purity of 6. The reaction model can however be used for other 
molecules bearing a hydroxyl group which may be of interest in the future. 
 
3.2.4 Microspheres containing a chromophore (MSI) 
Commercially available 2-hydroxy-4-(3-triethoxysilylpropoxy)diphenylketone 6 was 
added in various proportions to tetraethylorthosilicate (TEOS) 1 in the presence of ethanol, 
water and ammonia solution (Scheme 4). By varying the ammonia concentration and 
temperature, three sizes (100 nm, 250 nm and 500 nm diameter) of MS were prepared each 
with the maximum chromophore loading whilst still remaining spherical. 
(MSI = MicroSpheres with chromophores Inside) MS with a comparable diameter were 
functionalised with the same chromophore on the surface and taken as a reference.  
 
Scheme 4. General synthesis of Microspheres containing a chromophore (MSI) 
OHO
Si(OEt)3O
Si(OEt)4 Polymerisation
+
1 6
MSI  
Once the polymerisation was complete, the ammonia was removed via evaporation, and 
the MS were washed to remove any unreacted chromophore starting material. The washing 
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method varied according to the size of the particles. MS sized 250 nm and 500 nm 
sedimented well and were washed using centrifugation (Washing Method B). The smaller 
100 nm monospheres did not sediment fully in the centrifuge vial, and an alternative 
method in washing the MS was found in soxhlet extraction with dichloromethane 
(Washing Method A). All MS were washed until all physically bonded starting material 
was removed from the MS. Once the MS were washed, the mass of the residual oil 
containing only 6 (verified by GC-MS) was then subtracted from the initially added 
amount of the starting material 6, from which the chromophore loading could be 
calculated. No residual 1 was found in the oil suggesting that it was completely 
incorporated into the MS. On average 75 % of the added chromophore took part in the 
polymerisation, regardless of the size of the MS. 
 
A linear increase in carbon content was noted with increased loading of chromophore in 
the MS (Table 1). In MS containing only Si and O (MSN = Neat MicroSpheres), the small 
amount of carbon found can be attributed to ethoxy groups of the TEOS which did not 
react in the polymerisation.[48]  
 
Table 1. Carbon content of 100 nm, 250 nm and 500 nm MS with various chromophore 
loadings 
MS loading %C MS loading %C MS loading %C 
(mmol/g)  (mmol/g)  (mmol/g)  
MSI-100 MSI-250 MSI-500 
0 1.3 0 3.2 0 4.3 
0.118 3.2 0.208 6.9 0.106 5.5 
0.216 5.3 0.313 8.1 0.213 7.2 
0.316 6.8 0.428 10.5 0.306 7.9 
0.409 8.4 0.524 11.9 0.391 9.6 
0.511 10.5 0.897 17.2 0.506 11.0 
 
The concentration of chromophore added during the polymerisation determines whether 
the resulting MS retain their spherical shape and size distribution when compared to the 
pure SiO2 reference MS. The chromophore 6 is not symmetrical and introduces an impurity 
into the ordered polymerisation of a monosphere. When this impurity reaches a certain 
concentration it interferes so much with the polymerisation that equal sized spherical 
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particles can no longer form. The size of the MS did not affect the chromophore loading 
capacity.  
 
Figure 3. SEM images of 100 nm MS containing various amounts of chromophore 
 
 
Figure 4. SEM images of 250 nm MS containing various amounts of chromophore 
 
 
Figure 5. SEM images of 500 nm MS containing various amounts of chromophore 
 
 
Figures 3, 4 and 5 show the effect of chromophore concentration on the shape for MS of 
diameter 100 nm, 250 nm and 500 nm respectively. When the loading is low 
(≤ 0.2 mmol/g) the MS are of equal size and spherical. As good as no aggregation occurs 
and the chromophores are evenly distributed throughout the suspension. As the 
chromophore loading increases more and more aggregation occurs, the MS become less 
spherical and have a larger size distribution, resulting in that the chromophores are no 
Chromophore loading: 0 mmol/g                0.21 mmol/g                                  0.51 mmol/g 
Chromophore loading: 0 mmol/g               0.21 mmol/g                                  0.54 mmol/g 
Chromophore loading: 0 mmol/g              0.22 mmol/g                                 0.51 mmol/g 
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longer evenly distributed in the suspension. Although the size of the MS does not affect the 
loading of the chromophore, it does affect the UV properties of the MS. Table 2 
summarises the UV properties of MS containing the maximum loading of chromophore 
whilst still remaining spherical and with a narrow size distribution. The extinction 
coefficient κ describes the UV properties of the entire polymer. The molar extinction 
coefficient ε describes the UV properties with respect to the amount of chromophore in the 
MS. The fact that both κ and ε decrease with increasing diameter suggests that the 
chromophores located within the core of the larger MS cannot absorb UV light.  
 
Table 2. UV data for MS containing the maximum loading of chromophores 
MS diameter 
MS loading 
(maximum) 
Extinction 
Coefficient, κ 
Molar Extinction 
Coefficient, ε 
(nm) (mmol/g) (Lg-1cm-1) (Lmol-1cm-1) 
100 0.22 2.221 10269 
250 0.21 2.003 9628 
500 0.21 1.864 8751 
 
3.2.5 Microspheres with chromophores on the surface (MSS) 
Microspheres with a functionalised surface (MSS = MicroSpheres with chromophore on 
the Surface) have previously been reported.[45] Their synthesis is a two step process in 
which first MSN are synthesised and transferred into ethanol, where they are stored as a 
suspension. In the second step a chromophore similar to 6 is slowly added to the ethanol 
suspension. The final washing step is replaced by a high vacuum distillation to remove any 
unreacted chromophore. This tedious procedure was simplified to a one pot reaction with 
milder washing method using a centrifuge.  
 
Firstly, TEOS was added to a mixture of ammonia, ethanol and water and MSN of a set 
size (250 and 500 nm diameter) were synthesised. Once the polymerisation was complete, 
the chromophore 6 (up to a maximum to 10 mol%) dissolved in ethanol was added directly 
and the reaction allowed to stir for 2 hours at the set temperature (see Scheme 5). The 
functionalised microspheres were then separated from the remaining reactants in the same 
way as for MSI (Washing Method B).  
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Scheme 5. General synthesis of Microspheres with a functionalised surface (MSS) 
OHO
Si(OEt)3OSi(OEt)4
Polymerisation Surface functionalisation (in situ)
MSS  
 
Figures 6 and 7 show MS of fixed diameter 250 nm and 500 nm respectively, with various 
amounts of chromophore on the surface (MSS-250 and MSS-500 respectively). When the 
chromophore loading is low, only parts of the surface have been functionalised. As the 
loading increases the entire surface becomes covered with chromophore and individual 
spheres adhere together. A linear increase in carbon content was noted with increased 
loading of chromophore in the MS. 
 
Figure 6. SEM images of 250 nm MS with various amounts of chromophore on the 
surface 
 
 
Figure 7. SEM images of 500 nm MS with various amounts of chromophore on the 
surface 
 
 
Chromophore loading: 0.05 mmol/g     0.41 mmol/g                0.74 mmol/g 
Chromophore loading: 0.07 mmol/g     0.24 mmol/g                      0.51 mmol/g 
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Table 3 summarises the UV properties of MSS (of diameter 250 and 500 nm) with the 
minimum and maximum loading of chromophore on the surface whilst still remaining 
spherical. The extinction coefficient, κ describes the UV properties of the entire polymer. 
The molar extinction coefficient, ε describes the UV properties with respect to the amount 
of chromophore in the MS.  
 
Table 3. UV data for MSI with the minimum and maximum loading chromophore on the 
surface 
MS diameter MS loading 
Extinction 
Coefficient, κ 
Molar Extinction 
Coefficient, ε 
(nm) (mmol/g) (Lg-1cm-1) (Lmol-1cm-1) 
250 0.05 [a] 0.610 13224 
250 0.41 [b] 1.725 4240 
500 0.07 [a] 0.602 8538 
500 0.24 [b] 1.429 6020 
[a] The loading at which the highest ε values was observed. 
[b] The maximum loading whilst still forming spherical MS of narrow size distribution.  
 
MSS exhibit the highest ε values when only the minimal amount of chromophore is on the 
surface. This suggests that with an increase in the chromophore concentration on the 
surface, the molecules interact causing a decrease in UV absorption ability. MS with a 
smaller diameter have a larger surface area and thus with the same polymer and 
chromophore amount, the distribution on the surface is more homogeneous for small MS. 
This is supported by the fact that MS with a smaller surface area show a sharper decline in 
ε (with increasing chromophore loading) than MS with a larger diameter.  
 
For MSI, the chromophores are evenly spaced throughout the matrix. The interactions 
between chromophore molecules are not as frequent, as the chromophore molecules are 
much further apart within the matrix, than the chromophore molecules of MSS. For MSI, 
increasing the chromophore concentration simply increases the UV absorption properties. 
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3.2.6 Microspheres containing chromophores in the core and on the surface (MSIG) 
In an attempt to further improve the UV activity, MS containing chromophores in the core 
as well as on the surface were synthesised. This was achieved by post-functionalising the 
surface of MSI in situ with either the unreacted chromophore 6 (MSIG = MicroSpheres 
with chromophores Inside and Grafted on surface) or additional chromophore 6 (MSIGC = 
MicroSpheres with chromophores Inside and Grafted on surface with additional 
Chromophore). The top synthesis route in Scheme 6 describes the MSIG while the bottom 
route describes MSIGC. 
 
Scheme 6. General synthesis of chromophore containing MS and with a functionalised 
surface 
OHO
Si(OEt)3O
OHO
Si(OEt)3O
OHO
Si(OEt)3O
Si
OEt
OEtEtO
OEt
Polymerisation
(Polymerisation with additional starting material)
+
MSIGC
(unreacted starting material)
+
MSI MSIG
 
 
Figure 8 compares the ε values of chromophore containing MS (MSI, square), MS with 
chromophore on the surface (MSS, triangle), chromophore containing MS and with a 
grafted surface (MSIG, circle) and MS containing chromophore and with a grafted surface 
with additional chromophores (MSIGC, diamond).  
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Figure 8. UV data for MSI-250, MSS-250, MSIG-250 and MSIGC-250 
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
0
10000
20000
30000
40000
50000
ε 
(L
m
ol
-1
cm
-1
)
MS loading (mmol/g)
 MSI-250
 MSS-250
 MSIG-250
 MSIGC-250
 
Of all the MS of 250 nm diameter the best ε value was generated by MSIG-250-1. Here 
the MS contains chromophore and the minimal amount of chromophore was functionalised 
on the surface. This polymer thus combines the advantages of utilising the volume of the 
sphere as well as optimising the concentration of chromophores on the surface.  
 
3.2.7 Photostability  
The reduction of UV-induced decomposition of UV filters is an active field of research in 
the cosmetic industry.[6] In order to test if incorporation of a chromophore into a matrix 
increases its photostability, studies were carried out on two polymers with similar 
chromophore loadings. The photo-degradation of MSI-250-2 (0.31 mmol/g) and 
MSS-250-4 (0.30 mmol/g) were compared to that of benzophenone-3 (2) and 6.  
 
The Minimal Erythemal Dose (MED) is used to describe the erythemal potential of UV 
radiation and 1 MED is defined as the effective UV dose that causes a perceptible 
reddening of previously unexposed human skin. An MED of 1 for an individual with skin 
type II (light to medium hair, eyes and skin) is 20 minutes in the midday sun in 
midsummer. An exposure of 5 MED produces a painful sunburn, whilst 10 MED can cause 
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oedema, vesiculation and bullae formation.[49,50] The method for measuring photostability 
is based on an established method.[51] Samples were irradiated for 130.5 min at 89.6 W/m2 
(corresponds to 5 MED) using a Suntest CPS with xenon radiator (radiation filter limited to 
≥ 290 nm). The UV spectrum after irradiation was compared to samples which were not 
irradiated. Table 4 summarises the percentage of UV absorption activity remaining after 
irradiation at 5 MED.  
 
Table 4. Photostability (%) of selected MSI-250-2 and MSS-250-4 at 5 MED 
Integrated region Benzophenone-3 6 MSI-250-2 MSS-250-4 
UV 
(290-400 nm) 
79 ± 3 80 ± 3 93 ± 1 89 ± 1 
UVA 
(320-400 nm) 
80 ± 3 78 ± 3 95 ± 1 88 ± 1 
UVB 
(290-320 nm) 
77 ± 2 86 ± 2 89 ± 1 89 ± 2 
 
Samples with benzophenone-3 and its silyloxy derivative 6 retain 79 and 80 % of their UV 
absorption ability after irradiation over the entire UV spectrum respectively. When 6 is 
immobilised onto the surface of a MS as in MSS-250-4, its photostability increases to 
89 %. A further improvement in photostability is noted when the chromophore is 
incorporated into the matrix as in MSI-250-2, where 93 % of the UV absorption ability 
retains after irradiation.  
 
The increased photostability of a chromophore embedded in a matrix over a chromophore 
in solution might be explained by a higher degree of caging of the silylated 
chromophore [52] and a more facile energy dissipation onto the silica bulk around it.[53,54] 
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3.3 Conclusion 
Spherical, sub-micron sized organic-inorganic hybrid polymers with a narrow size 
distribution were synthesised. A loading of up to approximately 0.2 mmol organic 
chromophore per gram of material gave a regular spherical particle shape for different 
particle sizes. Increasing amounts of organic chromophore incorporation lead to non-
regular shape and particle fusion. The UV absorption properties of the material depend on 
chromophore concentration and particle size. At the same incorporated chromophore 
concentration, the extinction coefficient of regular shaped particles decreases with 
increasing size, due to the poorer accessibility of inner chromophores. The UV absorption 
ability of material with surface grafted chromophores strongly depends on concentration. 
At higher loadings a decrease in UV absorption ability is noted, which corresponds to a 
non linear Beer Lambert behaviour at high concentrations. The highest effective UV 
absorption of functionalised silica particles was found in a combination of incorporated 
and grafted organic chromophores at low concentration. Incorporation of the 
benzophenone chromophore into a silica matrix or the immobilisation on a silica surface 
increased the photostability of the compounds as compared with its properties in solution. 
  
The study leads to the conclusion that organic-inorganic hybrid materials from silica and 
benzophenone chromophores have interesting UV filter properties. To gain the optimal 
performance from the complementing properties of the inorganic and the organic 
component, the dependence of particle shape and UV absorption properties on the 
chromophore concentration and the mode of immobilisation must be considered. 
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3.4 Experimental 
3.4.1 General 
3.4.1.1 Spectroscopy 
UV-VIS Spectra 
Varian Cary BIO 50 UV/VIS/NIR Spectrometer. Use of a 1 cm quartz cell (Hellma) and 
Uvasol solvents (Merck). Reported as: λmax in nm (ε). 
 
The colloidal silica (50 mg) was placed into a 100 ml volumetric flask containing 50 ml 
2-propanol. The flask was placed into an ultrasound bath until a homogenous suspension 
was achieved. The volumetric flask was then made up to the mark and homogenised again. 
A sample was directly taken and measured using an Integrating (Ulbricht) Sphere (taking 
absorption, transmission and scattering into account). 
 
Photostability 
The colloidal silica (500 mg) was placed into a 50 ml volumetric flask containing a 70:30 
ethanol:isopropylmyristate solvent mixture. 20 µl of the suspension was spread over a 
glass slide with a surface area of 10 cm2. For each sample four glass slides were irradiated 
at 5 MED with a Suntest CPS with xenon radiator (radiation filter limited to ≥ 290 nm) 
equipped with a Solar-Standard filter 310-400 nm, whilst a further four glass slides were 
kept in the dark. After irradiation, the colloidal silica particles were washed from the glass 
slides into a 10 ml volumetric flask containing methanol. UV absorptions were measured 
using a Varian Cary 300 Bio with Integrating (Ulbricht) Sphere. 
 
3.4.1.2 Analysis 
Elemental Analysis 
Elemental analyses were carried out by the central analytical department of Merck KGaA, 
Darmstadt. 
 
Scanning Electron Microscopy (SEM) 
SEM analyses were carried out by the central analytical department of Merck KGaA, 
Darmstadt.  
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The colloidal silica was submitted as a fine powder for analysis. No difference was noted 
in aggregation of particles whether the samples were submitted as a dry solid or in an 
ethanol suspension. When the MS were suspended in ethanol, they could simply be 
evaporated to dryness without them losing their spherical properties. This was not the case 
when ammonia or water was present in the suspension. 
 
3.4.1.3 Synthesis 
Solvents 
Purification and drying according to accepted general procedures.
 [55,56]
  
If not otherwise stated, commercially available solvent of the highest purity were used. 
 
Washing Method A – Soxhlet solid extraction 
The reaction mixture was evaporated under reduced pressure to 50% of its volume. An 
azeotropic distillation was carried out leaving the product in ethanol. The suspension was 
evaporated slowly under reduced pressure yielding a fine solid. The crude MS were placed 
in a 100 ml soxhlet and extracted with 30 ml of DCM for 24 hours. The soxhlet sleeve was 
washed with DCM to remove any remaining educt. Filtration of the DCM using a pressure 
filter with a 0.45 µm filter, recovered residual MS which had seeped through the soxhlet 
sleeve. The filtrate was washed three times with DCM and then added to the bulk washed 
MS. The clear mother liquor was evaporated to dryness leaving a yellow-brown oil.  
 
Washing Method B – Centrifuge 
The reaction mixture was evaporated under reduced pressure to 50% of its volume and 
then centrifuged using PC cone centrifuge vials at 3500 rpm for 20 minutes. The clear 
mother liquor was decanted and the sedimented colloidal silica resuspended using an 
ultrasound bath and a spatula in fresh ethanol. This procedure was repeated a further four 
times. The mother liquor was concentrated and centrifuged again (two ethanol washes) to 
remove any colloidal silica which may have been decanted into the mother liquor. The 
clear mother liquor was evaporated to dryness leaving a yellow-brown oil.  
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3.4.2 Synthesis of New Compounds 
MS100 
 
Ethanol (160 ml, 2.7 mol) and deionised water (82 ml, 4.6 mol) were placed into a 500 ml 
4 neck round and stirred using a mechanical stirrer (Teflon stirrer, 160 rpm) and heated to 
58 °C in a water bath. Tetraethylorthosilicate (TEOS) (21.15 g, 101.5 mmol) 1, was also 
heated to 58 °C (no stirring) in the same water bath (water bath temperature of 60 °C). 
Once the temperature of the ethanol-water azeotrope had reached a stable 58 °C, 25% 
ammonia solution (9.4 ml, 0.13 mol) was injected into the azeotrope (at the edge of the 
vessel) via a syringe. The stirring was increased (470 rpm) to ensure good mixing. Once 
the temperature of the mixture had reached 58 °C again, 1 was poured positively via a 
funnel into the azeotrope and allowed to stir for exactly 15 seconds. After 15 seconds the 
stirring was stopped and the reaction was allowed to stand at 58 °C (the reaction was 
slightly exothermic but the water bath temperature was kept at 60 °C) for 2 hours. The 
product was washed using Washing Method A, yielding a white solid of 6.80 g. No starting 
material was recovered.  
Elemental Analysis of solid found: C 1.3, H 1.4, Si 42.3.  
SEM image of MS-100 
 
 
 
MSI-100-1 to MSI-100-5 
 
The procedure is identical to the synthesis of MS100, except that varying reactant 
proportions of 1 and 2-hydroxy-4-(3-triethoxysilylpropoxy) diphenylketone 6 were added 
instead of just 1 alone: MSI-100-1 (100.5 mmol 1 and 1.0 mmol 6), MSI-100-2 
(99.5 mmol 1 and 2.0 mmol 6), MSI-100-3 (98.4 mmol 1 and 3.1 mmol 6), MSI-100-4 
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(97.4 mmol 1 and 4.1 mmol 6) and MSI-100-5 (91.4 mmol 1 and 10.2 mmol 6). The 
products were washed using Washing Method A. The yields of the reactions a tabulated 
below:  
Reaction 
Number 
MS 
recovered 
MS 
loading 
Extinction 
coefficient 
Molar extinction 
coefficient 
C [a] H Si 
 (g) (mmol/g) κ (Lg-1cm-1) ε (Lmol-1cm-1) (%) (%) (%) 
MSI-100-1 6.08 0.118 1.128 9588 3.2 1.6 40.5
MSI-100-2 7.31 0.216 2.221 10269 5.3 1.9 38.4
MSI-100-3 7.36 0.316 2.872 9086 6.8 2.0 37.7
MSI-100-4 7.49 0.409 3.651 8933 8.4 1.9 37.1
MSI-100-5 7.60 0.511 2.788 5452 10.5 2.3 36.3
[a] Nitrogen content was not detectable. Oxygen content could not be reported due to SiO2 
formation. 
 
SEM image of MS-100-1   SEM image of MS-100-2 
  
 
SEM image of MS-100-3   SEM image of MS-100-4  
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SEM image of MS-100-5 
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MS250 
 
Ethanol (150 ml, 2.6 mol) and deionised water (56 ml, 3.1 mol) were placed into a 500 ml 
4 neck round and stirred using a mechanical stirrer (Teflon stirrer, 160 rpm) and heated to 
60 °C in a water bath. Compound 1 (21.15 g, 101.5 mmol) was also heated to 60 °C (no 
stirring) in the same water bath (water bath temperature of 62 °C). Once the temperature of 
the ethanol-water azeotrope had reached a stable 60 °C, 25% ammonia solution (35 ml, 
0.47 mol) was injected into the azeotrope (at the edge of the vessel) via a syringe. The 
stirring was increased (470 rpm) to ensure good mixing. Once the temperature of the 
mixture had reached 60 °C again, 1 was poured positively via a funnel into the azeotrope 
and allowed to stir for exactly 15 seconds. After 15 seconds the stirring was stopped and 
the reaction was allowed to stand at 60 °C (the reaction was slightly exothermic but the 
water bath temperature was kept at 62 °C) for 2 hours. The product was washed using 
Washing Method B, yielding a white solid of 6.8 g. No starting material was recovered.  
Elemental Analysis of solid found: C 3.2, H 1.9, Si 40.0.  
 
SEM image of MS-250 
 
 
 
MSI-250-1 to MSI-250-5 
 
The procedure is identical to the synthesis of MS250, except that varying reactant 
proportions of 1 and 2-hydroxy-4-(3-triethoxysilylpropoxy) diphenylketone 6 were added 
instead of just 1 alone: MSI-250-1 (100.5 mmol 1 and 1.0 mmol 6), MSI-250-2 
(99.5 mmol 1 and 2.0 mmol 6), MSI-250-3 (98.4 mmol 1 and 3.1 mmol 6), MSI-250-4 
(97.4 mmol 1 and 4.1 mmol 6) and MSI-250-5 (91.4 mmol 1 and 10.2 mmol 6). The 
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products were washed using Washing Method B. The yields of the reactions a tabulated 
below:  
Reaction 
Number 
MS 
recovered 
MS 
loading 
Extinction 
coefficient 
Molar extinction 
coefficient 
C [a] H Si 
 (g) (mmol/g) κ (Lg-1cm-1) ε (Lmol-1cm-1) (%) (%) (%) 
MSI-250-1 7.09 0.208 2.003 9628 6.9 2.1 34.0
MSI-250-2 7.42 0.313 2.789 8907 8.1 2.2 37.4
MSI-250-3 7.58 0.428 3.108 7255 10.5 2.3 36.4
MSI-250-4 7.77 0.524 3.430 6551 11.9 2.4 35.4
MSI-250-5 8.37 0.897 2.062 2299 17.2 2.7 32.6
[a] Nitrogen content was not detectable. Oxygen content could not be reported due to SiO2 
formation. 
 
SEM image of MS-250-1   SEM image of MS-250-2 
  
 
SEM image of MS-250-3   SEM image of MS-250-4 
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SEM image of MS-250-5 
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MS500 
 
The procedure is identical to the synthesis of MS250, except that the reaction is heated to 
30 °C instead of 60 °C. The product was washed using Washing Method B, yielding a 
white solid of 7.4 g. No starting material was recovered.  
Elemental Analysis of solid found: C 4.3, H 2.2, Si 32.2.  
 
SEM image of MS-500 
 
 
 
MSI-500-1 to MSI-500-5 
 
The procedure is identical to the synthesis of MSI-250-1 to MSI-250-5, except that the 
reactions are heated to 30 °C instead of 60 °C. The products were washed using Washing 
Method B. The yields of the reactions a tabulated below:  
Reaction 
Number 
MS 
recovered 
MS 
loading 
Extinction 
coefficient 
Molar extinction 
coefficient 
C [a] H Si 
 (g) (mmol/g) κ (Lg-1cm-1) ε (Lmol-1cm-1) (%) (%) (%) 
MSI-500-1 7.18 0.104 0.850 7989 5.5 2.2 38.6 
MSI-500-2 7.35 0.213 1.864 8751 7.2 2.3 37.1 
MSI-500-3 7.37 0.306 2.109 6881 7.9 2.3 37.0 
MSI-500-4 7.56 0.391 1.810 4628 9.6 2.4 35.7 
MSI-500-5 7.60 0.506 0.758 1499 11.0 2.5 35.6 
[a] Nitrogen content was not detectable. Oxygen content could not be reported due to SiO2 
formation. 
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SEM image of MS-500-1   SEM image of MS-500-2 
  
 
SEM image of MS-500-3   SEM image of MS-500-4 
  
 
SEM image of MS-500-5 
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MSS-250-1 to MSS-250-6 
 
Ethanol (150 ml, 2.6 mol) and deionised water (56 ml, 3.1 mol) were placed into a 500 ml 
4 neck round and stirred using a mechanical stirrer (Teflon stirrer, 160 rpm) and heated to 
60 °C in a water bath. Compound 1 (21.15 g, 101.5 mmol) was also heated to 60 °C (no 
stirring) in the same water bath (water bath temperature of 62 °C). Once the temperature of 
the ethanol-water azeotrope had reached a stable 60 °C, 25% ammonia solution (35 ml, 
0.47 mol) was injected into the azeotrope (at the edge of the vessel) via a syringe. The 
stirring was increased (470 rpm) to ensure good mixing. Once the temperature of the 
mixture had reached 60 °C again, 1 was poured positively via a funnel into the azeotrope 
and allowed to stir for exactly 15 seconds. After 15 seconds the stirring was stopped and 
the reaction was allowed to stand at 60 °C (the reaction was slightly exothermic but the 
water bath temperature was kept at 62 °C) for 2 hours. After 2 hours the stirring (470 rpm) 
was restarted and the suspension was allowed to stir for 30 minutes. 
2-hydroxy-4-(3-triethoxysilylpropoxy) diphenylketone 6 [0.425 g (1.0 mmol), 0.850 g 
(2.0 mmol), 1.275 g (3.1 mmol), 1.700 g (4.1 mmol), 2.125 g (5.1 mmol) and 4.249 g 
(10.2 mmol) for MSS-250-1, MSS-250-2, MSS-250-3, MSS-250-4, MSS-250-5 and 
MSS-250-6 respectively] was dissolved in 100 ml ethanol in a 100 ml pressure equalising 
funnel. The solution was added drop-wise into the stirring suspension over one hour. The 
suspension was allowed to stir for a further two hours at 60 °C. The product was washed 
using Washing Method B. A yield of 7.05 g of a fine solid was obtained for MSS-250-1. 
The yields of the remaining reactions a tabulated below:  
Reaction 
Number 
MS 
recovered 
MS 
loading 
Extinction 
coefficient 
Molar extinction 
coefficient 
C [a] H Si 
 (g) (mmol/g) κ (Lg-1cm-1) ε (Lmol-1cm-1) (%) (%) (%) 
MSS-250-1 7.05 0.046 0.610 13224 5.2 2.1 40.7
MSS-250-2 7.19 0.119 0.808 6795 6.6 2.2 40.3
MSS-250-3 7.33 0.216 0.764 3541 6.6 2.2 39.5
MSS-250-4 7.54 0.298 1.095 3676 8.1 2.3 39.4
MSS-250-5 7.70 0.407 1.725 4240 9.6 2.4 38.0
MSS-250-6 8.88 0.744 2.855 3835 13.7 2.7 35.9
[a] Nitrogen content was not detectable. Oxygen content could not be reported due to SiO2 
formation. 
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SEM image of MSS-250-1   SEM image of MSS-250-2 
  
 
SEM image of MSS-250-3   SEM image of MSS-250-4 
  
 
SEM image of MSS-250-5   SEM image of MSS-250-6 
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MSS-500-1 to MSS-500-6 
 
The procedure is identical to the synthesis of MSS-250-1 to MSS-250-6, except that the 
reactions are heated to 30 °C instead of 60 °C. The product was washed using Washing 
Method B. A yield of 7.35 g of a fine solid was obtained. The yields of the remaining 
reactions a tabulated below:  
Reaction 
Number 
MS 
recovered 
MS 
loading 
Extinction 
coefficient 
Molar extinction 
coefficient 
C [a] H Si 
 (g) (mmol/g) κ (Lg-1cm-1) ε (Lmol-1cm-1) (%) (%) (%) 
MSS-500-1 7.35 0.071 0.602 8538 6.0 2.4 39.3 
MSS-500-2 7.45 0.141 1.009 7163 6.9 2.4 39.2 
MSS-500-3 7.52 0.183 1.160 6349 7.3 2.4 38.9 
MSS-500-4 7.68 0.237 1.429 6020 8.1 2.5 38.9 
MSS-500-5 7.76 0.275 1.665 6062 9.1 2.6 38.3 
MSS-500-6 8.38 0.512 2.425 4740 12.3 2.8 37.2 
[a] Nitrogen content was not detectable. Oxygen content could not be reported due to SiO2 
formation. 
 
SEM image of MSS-500-1   SEM image of MSS-500-2 
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SEM image of MSS-500-3   SEM image of MSS-500-4 
  
 
SEM image of MSS-500-5   SEM image of MSS-500-6 
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MSIG-250-1 to MSIG-250-4 
 
Ethanol (150 ml, 2.6 mol) and deionised water (56 ml, 3.1 mol) were placed into a 500 ml 
4 neck round and stirred using a mechanical stirrer (Teflon stirrer, 160 rpm) and heated to 
60 °C in a water bath. A mixture of 1 and 6 [for MSIG-250-1 (100.5 mmol 1 and 
1.0 mmol 6), MSIG-250-2 (99.5 mmol 1 and 2.0 mmol 6), MSIG-250-3 (98.4 mmol 1 and 
3.1 mmol 6) and MSIG-250-4 (97.4 mmol 1 and 4.1 mmol 6) respectively] was also 
heated to 60 °C (no stirring) in the same water bath (water bath temperature of 62 °C). 
Once the temperature of the ethanol-water azeotrope had reached a 60 °C, 25 % ammonia 
solution (35 ml, 0.47 mol) was injected into the azeotrope (at the edge of the vessel) via a 
syringe. The stirring was increased (470 rpm) to ensure good mixing. Once the temperature 
of the mixture had reached 60 °C again the mixture of 1 and 6 was poured positively via a 
funnel into the azeotrope and allowed to stir for exactly 15 seconds. After 15 seconds the 
stirring was stopped and the reaction was allowed to stand at 60 °C (the reaction was 
slightly exothermic but the water bath temperature was kept at 62 °C) for 2 hours. After 2 
hours the stirring (470 rpm) was restarted. The suspension was allowed to stir for 2.5 hours 
at 60 °C. The product was washed using Washing Method B. A yield of 7.08 g of a fine 
solid was obtained for MSIG-250-1. The yields of the remaining reactions a tabulated 
below:  
Reaction 
Number 
MS 
recovered
MS 
loading 
Extinction 
coefficient 
Molar extinction 
coefficient 
C [a] H Si 
 (g) (mmol/g) κ (Lg-1cm-1) ε (Lmol-1cm-1) (%) (%) (%) 
MSIG-250-1 7.08 0.020 0.909 46456 5.1 2.1 40.0
MSIG-250-2 7.23 0.184 1.847 10037 6.7 2.2 38.7
MSIG-250-3 7.47 0.294 2.376 8081 8.5 2.4 37.6
MSIG-250-4 7.63 0.389 3.014 7758 9.8 2.5 36.8
[a] Nitrogen content was not detectable. Oxygen content could not be reported due to SiO2 
formation. 
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SEM image of MSIG-250-1   SEM image of MSIG-250-2 
  
 
SEM image of MSIG-250-3   SEM image of MSIG-250-4 
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MSIGC-250-1 to MSIGC-250-4 
 
The procedure is identical to the synthesis of MSIG-250-1 to MSIG-250-4, except that on 
restarting the stirring for the second time, additional 6 (850 mg, 2 mmol) dissolved in 
100 ml ethanol was added drop-wise into the stirring suspension over one hour. The 
suspension was allowed to stir for a further two hours at 60 °C. The product was washed 
using Washing Method B. A yield of 7.43 g of a fine solid was obtained for 
MSIGC-250-1. The yields of the remaining reactions a tabulated below:  
Reaction 
Number 
MS 
recovered 
MS 
loading 
Extinction 
coefficient 
Molar extinction 
coefficient 
C [a] H Si 
 (g) (mmol/g) κ (Lg-1cm-1) ε (Lmol-1cm-1) (%) (%) (%) 
MSIGC-250-1 7.43 0.269 2.102 7804 7.8 2.3 38.4
MSIGC-250-2 7.60 0.368 2.543 6912 8.5 2.4 37.2
MSIGC-250-3 7.82 0.456 2.619 5748 10.5 2.5 36.2
MSIGC-250-4 8.01 0.545 2.978 5469 11.0 2.6 35.6
[a] Nitrogen content was not detectable. Oxygen content could not be reported due to SiO2 
formation. 
 
SEM image of MSIGC-250-1  SEM image of MSIGC-250-2 
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SEM image of MSIGC-250-3  SEM image of MSIGC-250-4 
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4. Chromone derivatives which bind to human hair4 
Abstract:  
 
Chromone derivatives bearing a quaternary ammonium functionality which bind to human 
hair were synthesised. The radical scavenging activity, according to the DPPH assay, of the 
chromone derivatives is considerably lower compared with flavonoids. The compounds 
show interesting UV absorption properties that depend on the position of a methoxy 
substituent. A bathochromic shift of 29 nm was observed when the methoxy group on the 
ammonium salts were shifted from position 7 to position 6. 
 
 
 
                                                 
4 The results of this chapter have been patented :  
Walenzyk, T.; Carola, C.; Rosskopf, R.; Buchholz, H. Chromone derivatives which bind to hair. Germ. Pat. 
Appl. 2005, DE 102005011534.9 
The results of this chapter are submitted for publication :  
Walenzyk, T.; Carola, C.; Buchholz, B.; Koenig, B. Tetrahedron 2005, submitted 
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4.1 Introduction 
4.1.1 Chromones 
Chromones are a group of naturally occurring compounds that are ubiquitous in nature 
especially in plants.[1] They are oxygen-containing heterocyclic compounds with a 
benzoannelated γ-pyrone ring, with the parent compound being chromone 
(4H-chromen-4-one, 4H-1-benzopyran-4-one).[2,3] Molecules containing the chromone 
structure (for example chromones and flavonoids) have a wide range of biological 
activities including tyrosine and protein kinase C inhibitors, antifungal, antiallergenic, 
antiviral, antitublin, antihypertensive and anticancer agents, as well being active at 
benzoazepine receptors, lipoxygenase, cyclooxygenase and modulating 
P-glycoprotein-mediated multidrug resistance (MDR).[2-6] Due to their abundance in plants 
and their low mammalian toxicity, chromone derivatives are present in large amounts in 
the diet of humans.[7,8]  
 
Figure 1. Basic structure of flavonoids, flavones and chromones 
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4.1.2 Biological Activity of Flavonoids 
Many of these biological actions are attributed to the ability of flavonoids to transfer 
electrons, chelate metal catalysts,[9] activate antioxidant enzymes,[10] reduce α-tocopherol 
radicals,[11] inhibit oxidases [12] as well as through their possible influences on the 
intracellular redox status, however the precise mechanisms remain unclear.[13] Recent 
studies have speculated that the classical hydrogen-donating antioxidant activity of 
flavonoids [14-16] is unlikely to be the sole explanation for cellular effects.[17-19] The 
bioactive forms of flavonoids in vivo are not those found in plants but rather conjugates 
and metabolites arising from these on intestinal absorption.[20-24]  
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4.1.3 Structure Activity Relationships 
The relationship between the radical scavenging activity of flavonoid derivatives and their 
structure has been studied in depth.[5,25-28] In general, the radical scavenging activity 
depends on the number and location of hydroxyl groups. This determines the availability of 
phenolic hydrogens and the possibility of stabilisation of the resulting phenoxyl radicals 
via electron delocalisation or hydrogen bonding.[15,28,29]  
 
4.1.4 Reactive Oxygen Species 
By definition a free radical is any atom with at least one unpaired electron in the outermost 
shell.[30] Oxygen acts as the terminal electron acceptor within the electron transport system 
that produces energy in the form of adenosine triphosphate (ATP).[31] Oxygen-centred free 
radicals or reactive oxygen species (ROS) are formed when the electron flow becomes 
uncoupled (transfer of unpaired single electrons).[26] ROS are capable of oxidising cellular 
proteins, nucleic acids and lipids, and contribute to cellular aging,[32] mutagenesis,[33] 
carcinogenesis,[34] coronary heart disease,[35] inflammation [36] and brain dysfunction.[37] 
Such oxidations can be terminated by enzymatic means or by free radical scavenging of 
antioxidants.[38] 
 
4.1.5 Multifunctional Chromones 
The antioxidant characteristics of flavonoids in combination with their favourable UV 
absorption properties are also exploited by plants to protect them from the suns UV 
radiation and scavenge UV-generated ROS.[39] For example, there is evidence that 
flavonoids in leaves, deposited in either the epidermal cells or in the waxy upper leaf 
surface provide protection from the potential damage of UVB radiation.[40] This use could 
also be utilised in the protection of human hair from UV-radiation. It is well known that 
exposure to UV-radiation can damage hair fibres. UVB radiation is the principal radiation 
responsible for hair protein loss (causing dryness, reduced strength, rough surface texture, 
decreased luster, stiffness and brittleness). UVA radiation is responsible for colour changes 
regardless of hair type.[41] Hair melanins provide some photochemical protection to hair 
proteins, especially at lower wavelengths where both the hair pigments and proteins absorb 
radiation.[42] These melanins also immobilise many of the free radicals generated by 
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UV-radiation, however in the process they are often degraded or bleached.[43] The aim of 
this project is to synthesise a chromone derivative, bearing a cationic functionality which 
binds to human hair. 
 
4.2 Results and discussion 
4.2.1 Background 
As the structural features of chromones largely influence their biological activity, the 
position of further functionalisation is critical. The B-ring of flavanone is not present in 
chromone and thus is an ideal position to further functionalise without influencing the 
structural effects of the other groups the chromone skeleton. 
 
Quaternary ammonium compounds (cationic surfactants, cationic polyelectrolytes and 
cationic quaternary derivatives of hydrolyzed proteins) have been widely used as hair 
conditioning agents.[44] The deposition (substantivity) of such compounds can effect the 
hair fibre friction, stiffness, gloss, anti-static qualities and strength of hair.[42] By 
synthesising a chromone derivative with a quaternary ammonium functionality it was 
hoped that this compound would show not only biological activity but also hair 
substantivity. 
 
4.2.2 Synthesis of Chromone Derivatives with Hair Substantivity 
The synthetic strategy chosen for the preparation of the 2-amido-chromone required the 
preparation of 2-ethylester-chromone 2. Condensation of 1 with diethyl oxalate in the 
presence of sodium ethanoxide in ethanol and followed by acidic cyclisation afforded the 
ester 2.[6,45] By reacting different amines with 2, a variety of chromone amides were 
synthesised (Scheme 1).  
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Scheme 1. General synthesis of unsubstituted 2-amido chromones 
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Reacting the ester 2 with either an n-alkyl amine (butylamine, octylamine, dodecylamine) 
or 3-dimethylaminopropylamine gave the amides 3 and 4, respectively. Treatment of the 
latter with methyl iodide gave the trimethyl ammonium salt 5.  
 
Although numerous other methods exist for introducing a new functionality at the C-2 
position of chromone,[4,5,46-49] the chosen synthetic route is short, has two possibilities for 
introducing diversity needed to generate a small library and utilises cheap reagents which 
is an important factor for industrial applications.  
 
4.2.3 Synthesis of substituted chromone derivatives 
In order to increase the biological activity of 3 and 5, the 7-hydroxy-4-oxo-4H-chromene-
2-carboxylic acid ethyl ester was synthesised. Due to the formation of a zwitterion in 
compound 9 this synthetic route was not expanded for other hydroxy-4-oxo-4H-chromene-
2-carboxylic acid ethyl esters with other substitution patterns. The zwitterion was stable 
over a wide pH range and could not be extracted from aqueous media. By protecting the 
phenol with a suitable protecting group, the amine could then be extracted in acid media. 
The protecting group chosen was methoxy as methoxy acetophenones are cheap and 
commercially available.  
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Scheme 2. General synthesis of hydroxyl substituted 2-amido chromones 
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Thus, the methoxy derivatives 12 were synthesised (Scheme 3). Although in general 
hydroxyl groups give a better radical scavenging activity,[26] there are some examples 
where a hydroxyl group is deleterious and methoxy group beneficial to biological 
activity.[5,50] Compound 12 was prepared from the commercially available 11. The 
methoxy derivatives 14 could now be easily synthesised and purified without fear of 
zwitterion formation.  
 
Scheme 3. General synthesis of methoxy substituted 2-amido chromones 
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Numerous attempts with various conditions at O-demethylating 14a-c failed.[51,52,53,54] 
Alternative protecting groups that can withstand the reaction conditions and are 
industrially feasible need to be examined in order to readily synthesise hydroxyl 
derivatives.  
 
4.2.4 Hair Substantivity 
Compounds 2, 3, and 5 served as models for hair binding assay. Although there are various 
methods to measure the substantivity of cationic species to hair,[44,55] many are 
complicated, require specialised instrumentation and are time-consuming. As many 
compounds contained in cosmetic products including cationic surfactants [56] and dyes [57] 
can penetrate into hair fibres, it is important to choose an analytical method which can 
quantitatively recover the analyte.  
 
Although a number of methods for hair substantivity were tested,[58] only two 
(MALDI-MS [59] and hair digestion followed by HPLC analysis) could confirm the 
presence of compound bound to hair. The practicality of HPLC analysis and the large 
number of samples made the HPLC method very feasible. The compound was dissolved in 
a 70:30 ethanol:water mixture, to which then sterile, washed hair was added and allowed to 
stir for one hour. The hair was then thoroughly washed with water and air dried. A sample 
of this ‘treated’ hair was dissolved in sodium hydroxide solution at 60 °C and then 
analysed via HPLC. This method [60] which was adapted from an analytical procedure used 
for the detection of anabolic steroids in livestock has the advantage that even small 
amounts of compounds can be quantitatively recovered.  
 
Figure 2 shows the chromatogram of 2 after having been subjected to the same conditions 
used in the hair substantivity test but without coming in contact with any hair. The main 
peak at 5.47 min corresponds to the carboxylic acid, 4-Oxo-4H-chromene-2-carboxylic 
acid which is generated under the strong basic conditions. In the absence of such harsh 
conditions 2 has a retention time of 2.04 min (a residual peak is still visible). 
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Figure 2. Chromatogram of 2 after being subjected to strong basic conditions (digestion) 
 
 
Digested blonde human hair was taken as a reference showing characteristic peaks at 
1.54 min, 1.77 min, 2.05 min and 4.79 min (see Figure 3). The reference does not contain, 
nor is contaminated with, any 4-Oxo-4H-chromene-2-carboxylic acid (no peak is visible 
between 5 min and 6 min).  
 
Figure 3. Chromatogram of digested blonde hair 
 
Digested hair which had previously been stirred with 2 and then washed thoroughly, 
showed a peak at 5.47 min in addition to the characteristic peaks of digested hair 
(Figure 4). On spiking this sample with a small amount of the digested product of 2, the 
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peak at 5.47 min increased in intensity (and no new peaks are visible) confirming that 2 
binds to human hair (Figure 5).  
 
Figure 4. Chromatogram of digested blonde hair after being treated with 2 
 
 
Figure 5. Chromatogram of digested blonde hair after being treated with 2 (spiked with 
digested 2)  
 
 
In addition to 2, a number of other compounds were tested for their hair substantivity 
(Table 1). Tests were carried out on both bleached human hair and on brown human hair. 
The hair substantivity effect of all tested compounds was independent of hair type.  
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Table 1. Hair substantivity of chromones 
Compound Hair Substantivity
2 None 
3a None 
3b Possible 
3c -a 
8b Possible 
5 Yes 
15a Yes 
15b Yes 
15c Yes 
  a) could not be tested to due solubility problems 
 
The results show that compounds bearing a quaternary ammonium salt bind well to hair. 
An ester or butyl amide failed to show any binding. There is some evidence to show that an 
octyl amide functionality may bind to hair, however due to their poor solubility in 
ethanol/water mixtures, definite binding could not be confirmed. However the use of long 
alkyl chains in hair care products suggests that some interactions must take place.  
 
4.2.4.1 SEM Images of treated and untreated hair 
Scanning electron microscopy (SEM) images of treated and untreated hair were compared 
to assess if the treatment of hair with such compounds causes a visible change in the hair 
surface. Figure 6 and 7 shows SEM images of untreated hair and hair treated with 2 
respectively. As to be expected no differences could be seen.  
 
Figure 6. SEM images of brown European hair 
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Figure 7. SEM images of brown European hair treated with 2 
 
 
4.2.5 Antioxidant activities 
The DPPH (2,2-diphenyl-1-picrylhydrazyl) assay was used to screen the radical 
scavenging potential of the compounds. The DPPH radical, DPPH• is a relatively stable 
paramagnetic free radical which accepts a hydrogen radical to become a stable diamagnetic 
molecule. The DPPH• hydrate is violet in colour, and in the presence of a free radical 
quencher forms 2,2-diphenyl-1-picrylhydrazine, which is yellow (Figure 8). By monitoring 
the decrease in intensity of DPPH• at 515 nm, the radical scavenger abilities of the 
antioxidant molecule can be determined. This is commonly expressed as the amount of 
antioxidant required to decreased the initial DPPH• concentration to 50 % (EC50). 
 
Figure 8. DPPH• hydrate and its reduced form, DPPH-H 
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As chromones lack the B-ring of flavonoids, which is responsible for much of their 
antioxidant power, the radical scavenging ability of chromones remain modest. However, 
as the objective of this project is not to generate a powerful antioxidant, but rather to 
synthesise a molecule which could bind to hair and protect it from UV-radiation and its 
effects, such as being able to scavenge UV-generated ROS, the observed activities suffice. 
Table 2 shows the EC50 values of selected chromone derivatives.  
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Table 2. Radical Scavenging Activity  
Compound EC50 
2 >200 
7 40 
Acid of 7a >80 
8a 7.7 
8b 7.8 
10 16b 
15a 19.3 
15b -c 
15c -c 
a) The acid of 7 is has previously been synthesised.[61] 
b) Estimate as sample was contaminated through inorganic salts. Measured value (24.1). 
c) Samples polymerised during assay.  
 
Although no clear relationship is shown, it is evident that hydroxyl or methoxy substitution 
on the A ring and an amide (instead of an acid or ester) functionality improve the radical 
scavenging abilities of the compounds.  
 
4.2.6 Cyclic Voltammetry 
In flavonoids the reduction potential is strongly dependant on the electron donating 
properties of the B-ring as this is generally more electron rich as the A-ring.[62] As 
chromones do not possess the B-ring, the A-ring should influence the electronic chemical 
properties of the chromone. The electrochemical properties of compounds 15a, 15b and 
15c were measured by cyclic voltammetry [63,64] in acetonitrile. All three samples showed 
an electrochemical irreversible behaviour. Relative to the half wave reduction potential of 
Fc/Fc+, a shift of +30 mV, +60 mV and +50 mV was observed for 15a, 15b and 15c 
respectively. Although these shifts are small and close to the experimental error (± 20 mV) 
the general trend of increased reduction potential with increased electron donating 
properties of the substitutent is indicated.  
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4.2.7 UV absorption of substituted chromones 
The UV absorption properties of three different chromone derivatives (ester, alkyl amide 
and ammonium salt) with varying substitution patterns (methoxy substitution at position 
7-, 6- or 5-) were measured. Tables 3, 4 and 5 summarise the results.  
 
Table 3. Molar extinction coefficients for ethyl ester derivatives 
Compound R1 R2 R3 Wavelength, λmax [nm], Molar extinction coefficient (ε)a) 
12a OCH3 H H 212 (4.44) 238 (4.29)  310 (4.01) 
12b H OCH3 H 206 (4.45) 238 (4.22) 253 (4.31) 343 (3.77) 
12c H H OCH3  238 (4.22) 271 (4.00) 327 (3.64) 
a) Methanol was used as solvent 
 
Table 4. Molar extinction coefficients for alkyl amide derivatives 
Compound R1 R2 R3 Wavelength, λmax [nm], Molar extinction coefficient (ε)a) 
13a OCH3 H H 212 (4.42) 236 (4.35) 255 (4.10)b) 304 (4.04) 
13b H OCH3 H 205 (4.43) 230 (4.25) 252 (4.36) 338 (3.75) 
13c H H OCH3  238 (4.29) 260 (4.16) 323 (3.71) 
a) Methanol was used as solvent 
b) Present as a shoulder 
 
Table 5. Molar extinction coefficients for quaternary ammonium derivatives 
Compound R1 R2 R3 Wavelength, λmax [nm], Molar extinction coefficient (ε)a) 
5 H H H 204 (4.62) 246 (4.43)  304 (3.83) 
15a OCH3 H H 210 (4.47) 242 (4.32)  304 (3.80) 
15b H OCH3 H 205 (4.42) 248 (4.34)  333 (3.54) 
15c H H OCH3  242 (4.25)  319 (3.53) 
a) CH3CN was used as solvent 
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A bathochromic shift was observed for the chromone -esters, -alkyl amides and 
-ammonium salts upon substitution of a methoxy group at either position 5, 6 or 7. As 
expected the alkyl chain length has no effect on the UV absorption. When compared to 5, a 
red shift of 29 nm and 15 nm was observed for the 15b and 15c respectively, whilst 15a 
had the same λmax. Thus, by altering the chromone substitution pattern, the UV absorption 
properties can be tailored to individual needs. For example 15a would protect better 
against UVB radiation and thus hair protein loss, whilst 15b would protect better against 
UVA radiation and hair colour changes.  
 
4.3 Conclusion 
Chromone derivatives containing a quaternary ammonium functionality which bound to 
human hair were synthesised. The substitution pattern of the methoxy group was 
systematically changed to probe its effect on the redox potential and the UV absorption 
properties. The general radical scavenger activity of all derivatives is lower if compared to 
flavonoids. The UV absorption of the derivatives depends on the position of the methoxy 
groups. If the substitutent is shifted from the 7 to 6 position, a bathochromic shift of the 
UV absorption of 29 nm results.  
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4.4 Experimental 
4.4.1 General 
4.4.1.1 Spectroscopy 
IR-Spectra 
Bio-Rad FT-IR-Spectrometer FTS 155. 
 
UV-VIS Spectra 
Varian Cary BIO 50 UV/VIS/NIR Spectrometer. Use of a 1 cm quartz cell (Hellma) and 
Uvasol solvents (Merck). Reported as: λmax in nm (ε). 
 
NMR-Spectra 
- Bruker AC-250 (1H: 250.1 MHz, 13C: 62.9 MHz), Measurement temperature: 24 °C. 
- Bruker Avance 300 (1H: 300.1 MHz, 13C: 75.5 MHz), Measurement temperature: 27 °C. 
- Bruker ARX-400 (1H: 400.1 MHz, 13C: 100.6 MHz), Measurement temperature: 21 °C. 
- Bruker Avance 400 (1H: 400.1 MHz, 13C: 100.6 MHz), Measurement temperature: 27 °C. 
- Bruker Avance 600 (1H: 600.1 MHz, 13C: 150.1 MHz), Measurement temperature: 27 °C. 
The chemical shifts are in δ-values (ppm) relative to the internal (or external) standard 
TMS. Reported as: Chemical shift (multiplicity, coupling constant, number of protons, 
assignment). Reported assignments were determined with the help of COSY, HMQC, 
HSQC, and NOESY 2D-Spectra. Abbreviations: s = singlet, bs = broad singlet, d = 
doublet, bd = broad doublet, dd = doublet of doublets, t = triplet, q = quartet, m = 
multiplet, bm = broad multiplet, sept = septet. Error of reported values: chemical shift: 
0.01 ppm for 1H-NMR, 0.1 ppm for 13C -NMR; Coupling constants: 0.1 Hz. The used 
solvent is reported for each spectrum. 
 
Mass spectra 
- Varian CH-5 (EI) 
- Finnigan MAT 95 (CI; FAB and FD) 
- Finnigan MAT TSQ 7000 (ESI) 
Xenon serves as the ionisation gas for FAB.  
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4.4.1.2 Analysis 
Melting Point 
Melting points are uncorrected and were determined according to Tottoli using 
instrumentation from Büchi. 
 
Elemental Analysis 
Elemental analyses were carried out by the microanalytical laboratory of the School of 
Chemistry and Pharmacy, University of Regensburg. 
 
Scanning Electron Microscopy (SEM) 
SEM analyses were carried out by the central analytical department of Merck KGaA, 
Darmstadt.  
 
HPLC 
HPLC analyses were carried out by Ralf Rosskopf, Pigments R&D Cosmetic, Merck 
KGaA in Darmstadt: 
 
A Merck Hitachi LaChrom (Interface L-7000, UV detector L-7400, Column Oven L-7350, 
Autosampler L-7200, Pump L-7100) with a Chromolith RP-18e 100-4.6 column was used. 
Wavelength 220 - 400 nm; Column temperature 30 °C; Injection Volume 50 µl; Solvent A: 
acetonitrile, Solvent B: water buffered at pH 2.6. 
Pump Method: 0.0 min, 20 % A, 80 % B, 0.75 ml/min 
   7.5 min, 80 % A, 20 % B, 1.00 ml/min 
   9.0 min, 20 % A, 80 % B, 1.00 ml/min 
   10.0 min, 20 % A, 80 % B, 0.75 ml/min 
 
Cyclic Voltammetry 
The cyclic voltammetry measurements were conducted in dry acetonitrile with 0.1 molL-1 
NBu4+ BF4- as electrolyte and under argon. The working electrode was a graphite 
electrode, the counter electrode a platinum wire and the reference electrode Ag/AgCl in 
LiCl saturated ethanol. The PGSTAT 20 is from the company Eco Chemie and is 
controlled by the program GPES V 3.0. 
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4.4.1.3 Synthesis 
Column Chromatography 
Silica gel Merck Geduran SI 60. 
 
Thin layer chromatography 
Aluminium sheets Merck 60 F254 Silica gel, thickness 0.2 mm. 
Detection via UV light at 254 nm or through discolouration with ninhydrin in ethanol. 
 
Solvents 
Purification and drying according to accepted general procedures.
[65,66]
  
If not otherwise stated, commercially available solvent of the highest purity were used.  
 
4.4.1.4 Hair Substantitivity 
The substance to be tested (1 mg) was dissolved in ethanol:water (70:30, 50 ml) and 
allowed to stir at room temperature using a magnetic stirrer. Commercially available,[67] 
washed, sterile human hair (1.00 g, 0.4 - 0.7 cm pieces) was added to the solution and 
allowed to stir vigorously for one hour. The hair was filtered and washed three times with 
fresh solvent. The hair sample was dried overnight at 40 °C and 200 mbar, yielding 1.00 g 
of treated hair. 
 
The treated hair (0.5 g) was added to a solution of NaOH (1 M, 4 ml) and allowed to stir at 
65 °C for 2 hours, forming a brown suspension. The reaction mixture was neutralised with 
HCl (2M, 2 ml) after which methanol (3 ml) and THF (1 ml) were added and the mixture 
allowed to stir for a further hour.  
 
A sample (5 mg) of only the substance to be tested (no hair) was subjected to the same 
conditions to control the stability of the substance. The suspension was centrifuged 
(4000 rpm, 10 min) and the mother liquor decanted. The mother liquor was then filtered 
(0.2 µm polypropylene filter) to yield a clear light brown solution. A sample of only hair 
(no substance) was subjected to the same conditions and used as a reference. The hair 
substantivity test was carried out using both bleached European and natural light-middle 
brown European hair. No difference was noted in hair substantivity due to hair type. 
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4.4.1.5 X-ray Crystallography 
4-Oxo-4H-chromene-2-carboxylic acid ethyl ester (2) 
Crystal Data: C12H10O4, Mr = 218.20, monoclinic, space group P 21/c, a = 4.7382 (6) Å, 
b = 9.7230 (9) Å, c = 22.457 (2) Å, α = 90°, β = 97.190 (14)°, γ = 90°, V = 1026.45 (19) 
Å3, Z = 4, Dx = 1.412 Mg/m3, λ (Mo-Kα) = 0.71073 Å, µ = 0.107 mm-1, F(000) = 456, 
T = 173 (1) K, graphite monochromator. A translucent, colourless needle with dimensions 
of 0.560 x 0.080 x 0.060 mm was used to measure 8075 reflections (1960 unique 
reflections, Rint = 0.0910) from 2.78° to 25.80° on a STOE-IPDS diffractometer with the 
rotation method. 
 
Structure refinement: The F2 value was refined using the full-matrix least-squares 
refinement method, with a goodness-of-fit of 0.704 for all reflections and 145 parameters. 
The final R-Index R 0.0410 (wR2 = 0.1012). ∆ρmin = -0.212 e Å-3, ∆ρmax = 0.210 e Å-3. 
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7-Methoxy-4-oxo-4H-chromene-2-carboxylic acid butylamide (13a) 
Crystal Data: C15H17NO4, Mr = 275.30, monoclinic, space group P 21/c, a = 7.7733 (8) Å, 
b = 18.000 (9) Å, c = 10.5369 (9) Å, α = 90°, β = 98.003 (11)°, γ = 90°, V = 1460.0 (3) Å3, 
Z = 4, Dx = 1.253 Mg/m3, λ (Mo-Kα) = 0.71073 Å, µ = 0.091 mm-1, F(000) = 584, T = 297 
(1) K, graphite monochromator. A translucent, colourless prism with dimensions of 0.300 
x 0.260 x 0.060 mm was used to measure 9603 reflections (2573 unique reflections, 
Rint = 0.0438) from 2.26° to 25.30° on a STOE-IPDS diffractometer with the rotation 
method. 
 
Structure refinement: The F2 value was refined using the full-matrix least-squares 
refinement method, with a goodness-of-fit of 0.800 for all reflections and 184 parameters. 
The final R-Index R 0.0497 (wR2 = 0.1153). ∆ρmin = -0.142 e Å-3, ∆ρmax = 0.255 e Å-3. 
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6-Methoxy-4-oxo-4H-chromene-2-carboxylic acid butylamide (13b) 
Crystal Data: C15H17NO4, Mr = 275.30, monoclinic, space group P 21/c, a = 4.7091 (5) Å, 
b = 26.573 (2) Å, c = 11.3445 (11) Å, α = 90°, β = 97.612 (12)°, γ = 90°, V = 1407.1 (2) 
Å3, Z = 4, Dx = 1.299 Mg/m3, λ (Mo-Kα) = 0.71073 Å, µ = 0.095 mm-1, F(000) = 584, 
T = 173 (1) K, graphite monochromator. A translucent, colourless stick with dimensions of 
0.360 x 0.120 x 0.060 mm was used to measure 11598 reflections (2718 unique reflections, 
Rint = 0.0524) from 1.97° to 25.93° on a STOE-IPDS diffractometer with the rotation 
method. 
 
Structure refinement: The F2 value was refined using the full-matrix least-squares 
refinement method, with a goodness-of-fit of 0.879 for all reflections and 211 parameters. 
The final R-Index R 0.0386 (wR2 = 0.0989). ∆ρmin = -0.133 e Å-3, ∆ρmax = 0.349 e Å-3. 
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5-Methoxy-4-oxo-4H-chromene-2-carboxylic acid butylamide (13c) 
Crystal Data: C15H17NO4, Mr = 275.30, monoclinic, space group P 21/c, a = 4.7288 (5) Å, 
b = 23.526 (2) Å, c = 12.5669 (11) Å, α = 90°, β = 94.998 (11)°, γ = 90°, V = 1392.8 (2) 
Å3, Z = 4, Dx = 1.313 Mg/m3, λ (Mo-Kα) = 0.71073 Å, µ = 0.096 mm-1, F(000) = 584, 
T = 173 (1) K, graphite monochromator. A translucent, colourless stick with dimensions of 
0.320 x 0.080 x 0.080 mm was used to measure 12888 reflections (2680 unique reflections, 
Rint = 0.0362) from 2.38° to 25.90° on a STOE-IPDS diffractometer with the rotation 
method. 
 
Structure refinement: The F2 value was refined using the full-matrix least-squares 
refinement method, with a goodness-of-fit of 0.857 for all reflections and 184 parameters. 
The final R-Index R 0.0356 (wR2 = 0.0762). ∆ρmin = -0.132 e Å-3, ∆ρmax = 0.201 e Å-3.  
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4.4.2 Synthesis of New Compounds 
4-Oxo-4H-chromene-2-carboxylic acid ethyl ester (2)[68] 
O
O
O
O1
2
34
5
6
10
7
8
9
 
Sodium (1.49 g, 65 mmol) was dissolved in absolute ethanol (100 ml). Diethyloxalate 
(5.12 g, 35 mmol) and 2-hydroxyacetophenone (2.04 g, 15 mmol) were dissolved in 
absolute ethanol (10 ml) and added to the sodium ethanolate solution. The solution was 
allowed to reflux for 1 hour. Concentrated HCl was added dropwise until the reaction was 
acidic and a white precipitate formed. The white precipitate was filtered and the yellow 
solution concentrated to a slurry. The slurry was extracted with ethyl acetate, dried over 
Na2SO4 and evaporated to give a light yellow solid. The solid was recrystalised from 
methanol/diisopropylether (4:1) to yield white needles (3.20 g, 14.6 mmol, 98 %). 
 
MP: 63 °C; IR (KBr): ν~  (cm-1) = 3447, 3067, 2985, 2938, 1734, 1647, 1466, 758; 
1H-NMR (600 MHz, CDCl3): δ [ppm] = 1.43 (t, J = 7.1 Hz, 3 H, CH3), 4.46 (q, J = 7.1 Hz, 
2 H, CH2), 7.11 (s, 1 H, H-3), 7.44 (ddd, J = 1.2 Hz, 7.1 Hz, 8.0 Hz, 1 H, H-6), 7.61 (ddd, J 
= 0.4 Hz, 1.2 Hz, 8.5 Hz, 1 H, H-8), 7.74 (ddd, J = 1.7 Hz, 7.1 Hz, 8.5 Hz, 1 H, H-7), 8.20 
(ddd, J = 0.4 Hz, 1.7 Hz, 8.0 Hz, 1 H, H-5); 13C-NMR (150 MHz, CDCl3): δ [ppm] = 14.1 
(+, CH3), 63.0 (-, CH2), 114.8 (+, C-3), 118.8 (+, C-8), 124.4 (Cquat, C-9), 125.7 (+, C-5), 
125.9 (+, C-6), 134.7 (+, C-7), 152.2 (Cquat, C-2), 156.0 (Cquat, C-10), 160.6 (Cquat, C=O), 
178.4 (Cquat, C-4); MS (ESI-MS, EtOH/MeOH + 10 mmol/l NH4OAc) m/z (%): 219 (100) 
[MH]+; Elemental Analysis: C12H10O4 Calc: C 66.05; H 4.62; Found: C 66.07; H 4.72 
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4-Oxo-4H-chromene-2-carboxylic acid butylamide (3a) 
O
O
N
O
H
 
Ethyl-4-oxo-4H-chromene-2-carboxylate (655 mg, 3 mmol) was dissolved in the 
butylamine (658 mg, 9 mmol) allowed to stir at 50 °C for 10 minutes. The solvent was 
evaporated leaving a yellow solid. Glacial acetic acid (5 ml) was added and allowed to stir 
at 70 °C for 10 minutes. The mixture was added to ice water and a white precipitate formed 
which was filtered, washed with water and dried. The white solid was recrystalised from 
ethyl acetate to yield white needles (630 mg, 2.6 mmol, 86 %). 
 
MP: 130 °C; IR (KBr): ν~  (cm-1) = 3319, 3079, 2954, 2868, 1685, 1642, 1387, 755; 
UV/VIS (MeOH): λmax [nm] (log ε) = 202 (4.37), 236 (4.29), 305 (3.85); 1H-NMR 
(300 MHz, DMSO): δ [ppm] = 0.91 (t, J = 7.2 Hz, 3 H, CH3), 1.34 (qd, J = 7.2 Hz, 14.1 
Hz, 2 H, CH2), 1.54 (XX, J = 7.2 Hz, 2 H, CH2), 3.30 (q, J = 7.2 Hz, 2 H, CH2), 6.82 (s, 
1 H, H-3), 7.53 (ddd, J = 1.0 Hz, 7.1 Hz, 8.0 Hz, 1 H, H-6), 7.73 (dd, J = 1.0 Hz, 8.5 Hz, 
1 H, H-8), 7.89 (ddd, J = 1.7 Hz, 7.1 Hz, 8.5 Hz, 1 H, H-7), 8.05 (dd, 1.7 Hz, 8.0 Hz, 1 H, 
H-5), 9.10 (t, J = 5.6 Hz, 1 H, N-H); 13C-NMR (75 MHz, DMSO): δ [ppm] = 13.6 (+, 
CH3), 19.5 (-, CH2), 30.8 (-, CH2), 38.8 (-, CH2), 110.2 (-, C-3), 118.7 (+, C-8), 123.5 
(Cquat, C-9), 124.8 (+, C-5), 125.9 (+, C-6), 134.9 (+, C-7), 155.0 (Cquat, C-2), 155.7 (Cquat, 
C-10), 158.7 (Cquat, C=O), 177.2 (Cquat, C-4); MS (CI-MS, NH3) m/z (%): 263.1 (100) 
[M+NH3]+, 246.1 (26) [MH]+; Elemental Analysis: C14H15NO3 Calc: C 68.56; H 6.16; 
N 5.71; Found: C 68.58; H 6.04; N 5.61 
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4-Oxo-4H-chromene-2-carboxylic acid octylamide (3b) 
O
O
N
O
H
 
Ethyl-4-oxo-4H-chromene-2-carboxylate (655 mg, 3 mmol) and octylamine (1163 mg, 
9 mmol) were dissolved in dichloromethane (5 ml) and allowed to reflux for 10 minutes. 
The solvent was evaporated leaving a light yellow solid. Glacial acetic acid (5 ml) was 
added and allowed to stir at 70 °C for 10 minutes. The mixture was added to ice water and 
extracted with ethyl acetate. The organic layer was dried over Na2SO4 and evaporated to 
give a white solid. The solid was recrystalised from ethyl acetate to yield white needles 
(826 mg, 2.7 mmol, 91 %). 
 
MP: 131 °C; IR (KBr): ν~  (cm-1) = 3314, 2927, 2849, 1684, 1646, 1529, 1392, 751; 
UV/VIS (MeOH): λmax [nm] (log ε) = 202 (4.36), 236 (4.29), 305 (3.84); 1H-NMR 
(300 MHz, CDCl3): δ [ppm] = 0.85 - 0.91 (m, 3 H, CH3), 1.24 - 1.46 (m, 10 H, 5 x CH2), 
1.61 - 1.72 (m, 2 H, CH2), 3.49 (tq, J = 6.2 Hz, 7.2 Hz, 2 H, CH2), 6.91 (s, 1H, N-H), 7.16 
(s, 1 H, H-3), 7.45 (ddd, J = 1.0 Hz, 7.2 Hz, 8.1 Hz, 1 H, H-6), 7.52 (dd, J = 0.5 Hz, 8.5 Hz, 
1 H, H-8), 7.73 (ddd, J = 1.7 Hz, 7.2 Hz, 8.5 Hz, 1 H, H-7), 8.22 (dd, J = 1.7 Hz, 8.0 Hz, 
1 H, H-5); 13C-NMR (75 MHz, CDCl3): δ [ppm] = 14.1 (+, CH3), 22.6 (-, CH2), 26.7 (-, 
CH2), 27.0 (-, CH2), 29.1 (-, CH2), 29.2 (-, CH2), 29.5 (-, CH2), 31.8 (-, CH2), 40.1 (-, 
CH2), 112.1 (+, C-3), 118.0 (+, C-8), 124.4 (Cquat, C-9), 126.0 (+, C-5), 126.2 (+, C-6), 
134.5 (+, C-7), 154.8 (Cquat, C-2), 155.3 (Cquat, C-10), 159.2 (Cquat, C=O), 178.2 (Cquat, C-4); 
MS (CI-MS, NH3) m/z (%): 319.1 (100) [M+NH3]+, 302.1 (40) [MH]+; Elemental 
Analysis: C18H23NO3 Calc: C 71.73; H 7.69, N 4.65; Found: C 71.62; H 7.58, N 4.43 
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4-Oxo-4H-chromene-2-carboxylic acid dodecylamide (3c) 
O
O
N
O
H
 
Ethyl-4-oxo-4H-chromene-2-carboxylate (1.96 g, 9 mmol) and dodecylamine (5.0 g, 
27 mmol) were dissolved in dichloromethane (10 ml) and allowed to reflux for 10 minutes. 
The solvent was evaporated giving a light yellow solid. Glacial acetic acid (10 ml) was 
added and allowed to stir at 70 °C for 10 minutes. The mixture was added to ice water and 
extracted with ethyl acetate. The organic layer was dried over Na2SO4 and evaporated to 
give a yellow solid. The solid was recrystalised from ethyl acetate to yield white needles 
(2.30 g, 6.4 mmol, 71 %). 
 
MP: 108 °C; IR (KBr): ν~  (cm-1) = 3319, 2959, 2932, 2850, 1982, 1642, 1522, 1387, 753; 
UV/VIS (MeOH): λmax [nm] (log ε) = 203 (4.37), 236 (4.29), 305 (3.83); 1H-NMR 
(300 MHz, DMSO): δ [ppm] = 0.83 (t, J = 6.7 Hz, 3 H, CH3), 1.16 - 1.33 (m, 18 H, 9 x 
CH2), 1.48 - 1.60 (m, 2 H, CH2), 3.28 (m, 2 H, CH2), 6.81 (s, 1H, H-3), 7.53 (ddd, J = 1.0 
Hz, 7.2 Hz, 8.0 Hz, 1 H, H-6), 7.73 (dd, J = 0.6 Hz, 8.5 Hz, 1 H, H-8), 7.89 (ddd, J = 1.7 
Hz, 7.2 Hz, 8.5 Hz, 1 H, H-7), 8.05 (dd, J = 1.7 Hz, 8.0 Hz, 1 H, H-5), 9.12 (t, J = 5.8 Hz, 
1 H, N-H); 13C-NMR (75 MHz, DMSO): δ [ppm] = 13.8 (+, CH3), 22.0 (-, CH2), 26.3 (-, 
CH2), 28.6 (-, CH2), 28.7 (-, CH2), 28.8 (-, CH2), 28.9 (-, CH2), 28.9 (-, CH2), 28.9 (-, 
CH2), 31.2 (-, CH2), 39.2 (-, CH2), 39.4 (-, CH2), 110.2 (+, C-3), 118.7 (+, C-8), 123.5 
(Cquat, C-9), 124.8 (+, C-5), 125.9 (+, C-6), 134.9 (+, C-7), 155.0 (Cquat, C-2), 155.7 (Cquat, 
C-10), 158.7 (Cquat, C=O), 177.2 (Cquat, C-4); MS (CI-MS, NH3) m/z (%): 375.2 (100) 
[M+NH3]+, 358.2 (56) [MH]+; Elemental Analysis: C22H31NO3 Calc: C 73.92; H 8.74; 
N 3.92; Found: C 73.75; H 8.75; N 3.74 
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4-Oxo-4H-chromene-2-carboxylic acid (3-dimethylamino-propyl)-amide (4) 
O
O
N
O
H
N
 
Ethyl-4-oxo-4H-chromene-2-carboxylate (655 mg, 3 mmol) and 3-dimethylamino-
propylamine (920 mg, 9 mmol) were dissolved in dichloromethane (5 ml) and allowed to 
reflux for 20 minutes. The solvent was evaporated, glacial acetic acid (5 ml) was added 
and the solution allowed to stir at 70 °C for 10 minutes. The mixture was added to ice 
water and extracted with ethyl acetate. The organic layer was dried over Na2SO4 and 
evaporated to give a yellow solid. The solid was recrystalised from ethyl acetate to yield 
white needles (691 mg, 2.5 mmol, 84 %). 
 
MP: 125 °C; IR (KBr): ν~  (cm-1) = 3289, 2976, 2946, 2805, 1686, 1640, 1534, 1460, 
1392, 759; UV/VIS (MeOH): λmax [nm] (log ε) = 203 (4.37), 236 (4.29), 305 (3.84); 
1H-NMR (300 MHz, DMSO): δ [ppm] = 1.69 (p, J = 6.9 Hz, 2 H, CH2), 2.15 (s, 6 H, 2 x 
CH3), 2.28 (t, J = 6.9 Hz, 2 H, CH2), 3.33 (dd, J = 7.2 Hz, 12.7 Hz, 2 H, CH2), 6.82 (s, 1 H, 
H-3), 7.53 (ddd, J = 1.0 Hz, 7.2 Hz, 8.0 Hz, 1 H, H-6), 7.71 (dd, J = 0.7 Hz, 8.5 Hz, 1 H, 
H-8), 7.89 (ddd, J = 1.7 Hz, 7.2 Hz, 8.5 Hz, 1 H, H-7), 8.05 (dd, J = 1.7 Hz, 8.0 Hz, 1 H, 
H-5), 9.25 (t, J = 5.5 Hz, 1 H, N-H) ; 13C-NMR (75 MHz, DMSO): δ [ppm] = 26.4 (-, 
CH2), 38.0 (-, CH2), 45.1 (+, 2 x CH3), 56.9 (-, CH2), 110.2 (+, C-3), 118.6 (+, C-8), 123.5 
(Cquat, C-9), 124.9 (+, C-5), 125.9 (+, C-6), 134.9 (+, C-7), 155.0 (Cquat, C-2), 155.6 (Cquat, 
C-10), 158.7 (Cquat, C=O), 177.2 (Cquat, C-4); MS (PI-EIMS) m/z (%): 58.1 (100) 
[Me2N=CH2]+, 274.1 (11) [M]+•; Elemental Analysis: C15H18N2O3 Calc: C 65.68; H 6.61; 
N 10.21; Found: C 65.63; H 6.41; N 10.08 
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Trimethyl-{3-[(4-oxo-4H-chromene-2-carbonyl)-amino]-propyl}-ammonium 
iodide (5) 
O
O
N
O
H
N
+ I
 
Iodomethane (260 mg, 1.83 mmol) was dissolved in chloroform (5 ml) and added to a 
solution of 4-Oxo-4H-chromene-2-carboxylic acid (3-dimethylamino-propyl)-amide 
(500 mg, 1.82 mmol) in chloroform (5 ml). The solution was allowed to stir at RT for 
30 min and then at reflux for 15 min upon which a precipitate formed. The yellow 
precipitate was filtered and washed with chloroform yielding a light yellow solid (578 mg, 
1.39 mmol, 76 %). 
 
MP: 240 °C+; IR (KBr): ν~  (cm-1) = 3404, 3022, 2956, 1673, 1643, 1458, 740; UV/VIS 
(CH3CN): λmax [nm] (log ε) = 204 (4.62), 246 (4.43), 304 (3.83); 1H-NMR (300 MHz, 
DMSO): δ [ppm] = 1.95 - 2.06 (m, 2 H, CH2), 3.07 (s, 9 H, 3 x CH3), 3.34 - 3.44 (m, 6 H, 
2 x CH2), 6.86 (s, 1 H, H-3), 7.55 (ddd, J = 1.0 Hz, 7.2 Hz, 8.0 Hz, 1 H, H-6), 7.75 (d, J = 
8.5 Hz, 1 H, H-8), 7.92 (ddd, J = 1.7 Hz, 7.2 Hz, 8.5 Hz, 1 H, H-7), 8.06 (dd, J = 1.7 Hz, 
8.0 Hz, 1 H, H-5), 9.25 (t, J = 5.9 Hz, 1 H, N-H) ; 13C-NMR (75 MHz, DMSO): δ [ppm] = 
22.6 (-, CH2), 36.3 (-, CH2), 52.1 (+, CH3), 52.2 (+, CH3), 52.2 (+, CH3), 63.2 (-, CH2), 
110.5 (+, C-3), 118.6 (+, C-8), 123.5 (Cquat, C-9), 124.9 (+, C-5), 126.0 (+, C-6), 135.0 (+, 
C-7), 155.0 (Cquat, C-2), 155.4 (Cquat, C-10), 159.2 (Cquat, C=O), 177.2 (Cquat, C-4); MS 
(ESI, H2O/AcN) m/z (%): 289.0 (100) [K]+; Elemental Analysis: C16H21N2O3I Calc: 
C 46.17; H 5.08; N 6.73; Found: C 45.79; H 4.70; N 6.51 
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7-Hydroxy-4-oxo-4H-chromene-2-carboxylic acid ethyl ester (7)[69] 
O
O
O
OH
O
 
Sodium (1.84 g, 80 mmol) was dissolved in absolute ethanol (100 ml). Diethyloxalate 
(7.31 g, 50 mmol) and 2,4-dihydroxyacetophenone (2.28 g, 15 mmol) were dissolved in 
absolute ethanol (10 ml) and added to the sodium ethanolate solution. The solution was 
allowed to reflux for 1 hour. Concentrated HCl was added dropwise until the reaction was 
acidic and a white precipitate formed. The white precipitate was filtered off and the 
yellow/brown filtrate concentrated to a slurry. The slurry was extracted with ethyl acetate, 
dried over Na2SO4 and evaporated to give a light orange solid. The solid was recrystalised 
from methanol/diisopropylether (3:1) to yield white needles (2.78 g, 12 mmol, 79 %). 
 
MP: 210 - 211 °C; IR (KBr): ν~  (cm-1) = 3521, 3109, 1742, 1640, 1601, 1570, 1456, 1253, 
829; UV/VIS (MeOH): λmax [nm] (log ε) = 211 (4.44), 239 (4.24), 313 (3.96); 1H-NMR 
(600 MHz, DMSO): δ [ppm] = 1.34 (t, J = 7.1 Hz, 3 H, CH3), 4.37 (q, J = 7.1 Hz, 2 H, 
CH2), 6.82 (s, 1 H, H-3), 6.90 (d, J = 2.2 Hz, 1 H, H-8), 6.96 (dd, J = 2.2 Hz, 8.7 Hz, 1 H, 
H-6), 7.89 (d, J = 8.7 Hz, 1 H, H-5), 11.02 (s, 1 H, OH); 13C-NMR (150 MHz, DMSO): 
δ [ppm] = 13.8 (+, CH3), 62.5 (-, CH2), 102.4 (+, C-8), 113.6 (+, C-3), 115.8 (+, C-6), 
116.6 (Cquat, C-9), 126.7 (+, C-5), 151.5 (Cquat, C-2), 157.1 (Cquat, C-10), 159.9 (Cquat, C=O), 
163.5 (Cquat, C-7), 176.1 (Cquat, C-4); MS (EI-MS, 70 eV) m/z (%): 234.1 (100) [M]+•; 
HRMS (C12H10O5)+• Calc: 234.0528; Found: 234.0528 ± 0.76 ppm; Elemental Analysis: 
C12H10O5 Calc: C 61.54; H 4.30; Found: C 60.97; H 4.21 
 
 
7-Hydroxy-4-oxo-4H-chromene-2-carboxylic acid butylamide (8a) 
O
O
N
O
HOH
 
Ethyl-7-hydroxy-4-oxo-4H-chromene-2-carboxylate (585 mg, 2.5 mmol) and butylamine 
(512 mg, 7 mmol) were dissolved in dichloromethane (10 ml) and allowed to reflux for 
10 minutes. The solvent was evaporated upon which a light yellow solid formed. Glacial 
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acetic acid (10 ml) was added and allowed to stir at 70 °C for 10 minutes. The mixture was 
added to ice water. The precipitate was filtered off, washed with water and dried. The solid 
was recrystalised from ethyl acetate/diisopropylether (4:1) to yield a light brown solid (573 
mg, 2.2 mmol, 88 %). 
 
MP: 240 °C+; IR (KBr): ν~  (cm-1) = 3340, 3195, 3081, 2960, 2875, 1639, 1618, 1394, 
829; UV/VIS (MeOH): λmax [nm] (log ε) = 211 (4.41), 238 (4.31), 307 (3.98); 1H-NMR 
(300 MHz, DMSO): δ [ppm] = 0.90 (t, J = 7.2 Hz, 3 h, CH3), 1.32 (qd, J = 7.2 Hz, 14.2 Hz, 
2 H, CH2), 1.47 - 1.58 (m, 2 H, CH2), 3.28 (dd, J = 6.9 Hz, 13.2 Hz, 2 H, CH2), 6.69 (s, 1 
H, H-3), 6.94 (dd, J = 2.3 Hz, 8.7 Hz, 1 H, H-6), 6.99 (d, J = 2.2, 1 H, H-8), 7.88 (d, J = 8.7 
Hz, 1 H, H-5), 9.06 (t, J = 5.8 Hz, N-H), 10.98 (s, 1 H, OH); 13C-NMR (75 MHz, DMSO): 
δ [ppm] = 13.6 (+, CH3), 19.5 (-, CH2), 30.9 (-, CH2), 38.8 (-, CH2), 102.6 (+, C-8), 110.1 
(+, C-3), 115.6 (+, C-6), 116.4 (Cquat, C-9), 126.6 (+, C-5), 155.1 (Cquat, C-2), 156.9 (Cquat, 
C-10), 158.8 (Cquat, C=O), 163.1 (Cquat, C-7), 176.3 (Cquat, C-4); MS (CI-MS, NH3) 
m/z (%): 262.2 (100) [MH]+; Elemental Analysis: C14H15NO4 Calc: C 64.36; H 5.79; 
N 5.36; Found: C 64.12; H 5.48; N 5.11 
 
 
7-Hydroxy-4-oxo-4H-chromene-2-carboxylic acid octylamide (8b) 
O
O
N
O
HOH
 
Ethyl-7-hydroxy-4-oxo-4H-chromene-2-carboxylate (585 mg, 2.5 mmol) and octylamine 
(905 mg, 7 mmol) were dissolved in dichloromethane (10 ml) and allowed to reflux for 
10 minutes. The solvent was evaporated upon which a brown solid formed. Glacial acetic 
acid (10 ml) was added and allowed to stir at 70 °C for 10 minutes. The mixture was added 
to ice water yielding a precipitate, which was filtered off, washed with water and dried. 
The solid was recrystalised from ethyl acetate to yield a white solid (642 mg, 2.0 mmol, 
81 %). 
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MP: 215 °C; IR (KBr): ν~  (cm-1) = 3256, 3155, 2947, 2919, 2853, 1634, 1598, 1530, 
1388, 1242, 838; UV/VIS (MeOH): λmax [nm] (log ε) = 210 (4.44), 238 (4.33), 308 (3.99); 
1H-NMR (600 MHz, DMSO): δ [ppm] = 0.84 (t, J = 6.7 Hz, 3 H, CH3), 1.20 - 1.31 (m, 
10 H, 5 x CH2), 1.50 - 1.56 (m, 2 H, CH2), 3.27 (dd, J = 6.7 Hz, 13.4 Hz, 2 H, CH2), 6.69 
(s, 1 H, H-3), 6.94 (dd, J = 1.9 Hz, J = 8.7 Hz, 1 H, H-6), 6.99 (d, J = 1.9 Hz, 1 H, H-8), 
7.88 (d, J = 8.7 Hz, 1 H, H-5), 9.03 (t, J = 5.5 Hz, 1 H, N-H), 10.96 (s, 1 H, OH); 13C-
NMR (150 MHz, DMSO): δ [ppm] = 13.8 (+, CH3), 22.0 (-, CH2), 26.3 (-, CH2), 28.5 (-, 
CH2), 28.6 (-, CH2), 28.7 (-, CH2), 31.1 (-, CH2), 39.1 (-, CH2), 102.6 (+, C-8), 110.1 (+, C-
3), 115.6 (+, C-6), 116.4 (Cquat, C-9), 126.6 (+, C-5), 155.1 (Cquat, C-2), 156.9 (Cquat, C-10), 
158.8 (Cquat, C=O), 163.1 (Cquat, C-7), 176.2 (Cquat, C-4); MS (ESI, DCM/MeOH + 
10 mmol/l NH4Ac) m/z (%): 318.1 (100) [MH]+; Elemental Analysis: C18H23NO4 Calc: 
C 68.12; H 7.30; N 4.41; Found: C 67.85; H 7.30; N 4.24 
 
 
7-Hydroxy-4-oxo-4H-chromene-2-carboxylic acid (3-dimethylamino-propyl)-
amide (9) 
O
O
N
O
N
HOH
 
Ethyl-7-hydroxy-4-oxo-4H-chromene-2-carboxylate (1.17 g, 5 mmol) and 
3-dimethylaminopropylamine (1.53 g, 15 mmol) were dissolved in dichloromethane 
(10 ml) and allowed to reflux for 1 hour. The solvent was evaporated, glacial acetic acid 
(10 ml) was added and allowed to stir at 70 °C for 10 minutes. The mixture was added to 
ice water and extracted with ethyl acetate. The aqueous layer was neutralised with sodium 
hydrogen carbonate and extracted with ethyl acetate. The aqueous layer was made basic 
with sodium carbonate and extracted with ethyl acetate. The aqueous layer was made 
acidic with concentrated HCl and then evaporated to dryness giving a yellow solid. The 
yellow solid was added to methanol and a white solid crystallised out, which was filtered 
off. The yellow filtrate was evaporated to dryness and repeatedly dissolved in methanol 
until no further white solid crystallised. The yellow mother liquor was evaporated to 
dryness yielding a yellow solid, which was dissolved in boiling ethanol, filtered and 
evaporated to dryness yielding a yellow solid (1.37 g, 4.7 mmol, 94 %). 
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MP: 240 °C+; IR (KBr): ν~  (cm-1) =3455, 3273, 3064, 2999, 1683, 1650, 1619, 1548, 
1468, 1272, 786; UV/VIS (MeOH): λmax [nm] (log ε) = 210 (3.92), 237 (3.80), 307 (3.46); 
1H-NMR (300 MHz, DMSO): δ [ppm] = 2.00 (t, J = 7.2 Hz, 2 H, CH2), 2.72 (s, 6 H, 2 x 
CH3), 2.89 (t, J = 7.2 Hz, 2 H, CH2), 3.02 - 3.18 (m, 2 H, CH2), 6.72 (s, 1 H, H-3), 7.00 
(dd, J = 2.2 Hz, 8.8 Hz, 1 H, H-6), 7.16 (d, J = 2.2 Hz, 1 H, H-5), 7.86 (d, J = 8.8 Hz, 1 H, 
H-8), 9.40 (t, J = 5.9 Hz, 1 H, N-H), 11.36 (s, 1 H, OH); 13C-NMR (75 MHz, DMSO): 
δ [ppm] = 21.8 (-, CH2), 36.0 (-, CH2), 41.8 (+, 2 x N-CH3), 53.3 (-, CH2), 102.7 (+, C-8), 
110.2 (+, C-3), 115.8 (+, C-6), 116.3 (Cquat, C-9), 126.5 (+, C-5), 154.8 (Cquat, C-2), 156.9 
(Cquat, C-10), 159.2 (Cquat, C=O), 163.4 (Cquat, C-7), 176.3 (Cquat, C-4); MS (ESI, 
DCM/MeOH + 10 mmol/l NH4Ac) m/z (%): 291.1 (100) [MH]+; HRMS (C15H18N2O4)+• 
Calc: 290.1266; Found: 290.1266 ± 0.7 ppm 
 
 
{3-[(7-Hydroxy-4-oxo-4H-chromene-2-carbonyl)-amino]-propyl}-trimethyl-
ammonium iodide (10) 
O
O
N
O
N
+
HOH
I
 
7-Hydroxy-4-oxo-4H-chromene-2-carboxylic acid (3-dimethylamino-propyl)-amide 
(436 mg, 1.5 mmol) was added to acetonitrile (30 ml) containing sodium carbonate 
(415 mg, 5 mmol). Iodomethane (227 mg, 1.6 mmol) was added to the suspension and 
allowed to stir at RT overnight. The reaction mixture was evaporated to dryness and 
resuspended in methanol. A white precipitate was filtered off and the resulting yellow 
mother liquor evaporated to dryness yielding a light yellow solid (439 mg, 1 mmol, 68 %). 
 
MP: 240 °C+; IR (KBr): ν~  (cm-1) = 3445, 3266, 3064, 2979, 1681, 1645, 1252, 832; 
1H-NMR (300 MHz, DMSO): δ [ppm] = 1.90 - 2.02 (m, 2 H, CH2), 3.07 (s, 9 H, 3 x CH3), 
3.27 - 3.40 (m, 4 H, 2 x CH2), 6.66 (s, 1 H, H-3), 6.80 (d, J = 2.2 Hz, 1 H, H-8), 6.83 (dd, 
J = 2.2 Hz, 8.6 Hz, 1 H, H-6), 7.79 (d, J = 8.6 Hz, 1 H, H-5), 9.15 (t, J = 5.9 Hz, 1 H, N-H); 
13C-NMR (75 MHz, DMSO): δ [ppm] = 22.7 (-, CH2), 36.2 (-, CH2), 52.1 (+, 3 x N-CH3), 
63.2 (-, CH2), 102.3 (+, C-8), 110.2 (+, C-3), 114.5 (Cquat, C-9), 117.2 (+, C-6), 126.2 (+, 
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C-5), 154.3 (Cquat, C-2), 157.4 (Cquat, C-10), 159.4 (Cquat, C=O), 167.1 (Cquat, C-7), 175.9 
(Cquat, C-4); MS (ESI, H2O/AcN) m/z (%): 305.0 (100) [M]+; HRMS (C16H21N2O4)+ Calc: 
305.1501; Found: 305.1500 ± 1.23 ppm 
 
 
7-Methoxy-4-oxo-4H-chromene-2-carboxylic acid ethyl ester (12a)[68] 
O
O
O
O
O
 
Sodium (1.49 g, 65 mmol) was dissolved in absolute ethanol (100 ml). Diethyloxalate 
(5.12 g, 35 mmol) and 2-hydroxy-4-methoxyacetophenone (2.49 g, 15 mmol) were 
dissolved in absolute ethanol (10 ml) and added to the sodium ethanolate solution. The 
solution was allowed to reflux for 1 hour. Concentrated HCl was added dropwise until the 
reaction was acidic and a white precipitate formed. The white precipitate was filtered and 
the yellow solution concentrated to a slurry. The slurry was extracted with ethyl acetate, 
dried over Na2SO4 and evaporated to give a light yellow solid. The solid was recrystalised 
from methanol/diisopropylether (4:1) to yield a yellow solid (3.65 g, 14.7 mmol, 98 %). 
 
MP: 109 °C; IR (KBr): ν~  (cm-1) = 3459, 3110, 2997, 2856, 1742, 1664, 1628, 1442, 
1258, 838; UV/VIS (MeOH): λmax [nm] (log ε) = 212 (4.44), 238 (4.29), 310 (4.01); 
1H-NMR (300 MHz, DMSO): δ [ppm] = 1.34 (t, J = 7.1 Hz, 3 H, CH3), 3.91 (s, 3 H, 
O-CH3), 4.38 (q, J = 7.1 Hz, 2 H, CH2), 6.85 (s, 1 H, H-3), 7.07 (dd, J = 2.4 Hz, 8.9 Hz, 
1 H, H-6), 7.19 (d, J = 2.4 Hz, 1 H, H-8), 7.91 (d, J = 8.9 Hz, 1 H, H-5); 13C-NMR 
(75 MHz, DMSO): δ [ppm] = 13.8 (+, CH3), 56.2 (+, O-CH3), 62.5 (-, CH2), 100.8 (+, C-
8), 113.8 (+, C-3), 115.6 (+, C-6), 117.5 (Cquat, C-9), 126.7 (+, C-5), 151.5 (Cquat, C-2), 
157.1 (Cquat, C-10), 159.9 (Cquat, C=O), 163.5 (Cquat, C-7), 176.1 (Cquat, C-4); MS (EI-MS, 
70 eV) m/z (%): 248.1 (100) [M]+•; Elemental Analysis: C13H12O5 Calc: C 62.9; H 4.87; 
Found: C 62.67; H 4.67 
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7-Methoxy-4-oxo-4H-chromene-2-carboxylic acid butylamide (13a) 
O
O
O
O
N
H
 
Ethyl-7-methoxy-4-oxo-4H-chromene-2-carboxylate (590 mg, 2.4 mmol) and butylamine 
(512 mg, 7 mmol) were dissolved in dichloromethane (10 ml) and allowed to reflux for 
10 minutes. The solvent was evaporated yielding a light yellow solid. Glacial acetic acid 
(10 ml) was added and allowed to stir at 70 °C for 10 minutes. The mixture was poured 
into ice water, the precipitate was filtered off, washed with water and dried. The solid was 
recrystalised from dichloromethane/diisopropylether (1:1) to yield white needles (562 mg, 
2.0 mmol, 86 %). 
 
MP: 130 °C; IR (KBr): ν~  (cm-1) = 3349, 2959, 2869, 1655, 1610, 1357, 843; UV/VIS 
(MeOH): λmax [nm] (log ε) = 212 (4.42), 236 (4.35), 255 (sh 4.10), 304 (4.04); 1H-NMR 
(300 MHz, CDCl3): δ [ppm] = 0.97 (t, J = 7.3 Hz, 3 H, CH3), 1.43 (qd, J = 7.3 Hz, 14.4 Hz, 
2 H, CH2), 1.64 (td, J = 7.3 Hz, 14.9 Hz, 2 H, CH2), 3.48 (dd, J = 6.9 Hz, 13.4 Hz, 2 H, 
CH2), 3.91 (s, 3 H, O-CH3), 6.89 (d, J = 2.3 Hz, 1 H, H-8), 6.99 (dd, J = 1.9 Hz, 8.9 Hz, 
1 H, H-6), 7.09 (s, 1 H, H-3), 8.10 (d, J = 8.9 Hz, 1 H, H-5); 13C-NMR (75 MHz, CDCl3): 
δ [ppm] = 13.8 (+, CH3), 20.1 (-, CH2), 31.5 (-, CH2), 39.8 (-, CH2), 56.0 (+, O-CH3), 
100.4 (+, C-8), 112.2 (+, C-3), 115.0 (+, C-6), 118.2 (Cquat, C-9), 127.4 (+, C-5), 154.6 
(Cquat, C-2), 157.0 (Cquat, C-10), 159.3 (Cquat, C=O), 164.7 (Cquat, C-7), 177.5 (Cquat, C-4); 
MS (CI-MS, NH3) m/z (%): 276.2 (100) [MH]+; Elemental Analysis: C15H17NO4 Calc: 
C 65.44; H 6.22; N 5.09; Found: C 65.43; H 5.82; N 4.91 
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7-Methoxy-4-oxo-4H-chromene-2-carboxylic acid (3-dimethylamino-propyl)-
amide (14a) 
O
O
N
O
H
N
O
 
Ethyl-7-methoxy-4-oxo-4H-chromene-2-carboxylate (620 mg, 2.5 mmol) and 
3-dimethylaminopropylamine (766 mg, 7.5 mmol) were dissolved in dichloromethane 
(10 ml) and the reaction mixture was refluxed for 1 hour. The solvent was evaporated, 
glacial acetic acid (10 ml) was added and the solution allowed to stir at 70 °C for 
10 minutes. The mixture was added to ice water and extracted with ethyl acetate. The 
aqueous layer was neutralised with sodium hydrogen carbonate and extracted with ethyl 
acetate. The aqueous layer was made basic with sodium carbonate and extracted with ethyl 
acetate. The organic layer was dried over Na2SO4 and evaporated to give a yellow solid 
(654 mg, 2.1 mmol, 86 %). 
 
MP: 127 - 128 °C; IR (KBr): ν~  (cm-1) = 3440, 3257, 3032, 2950, 1667, 1630, 1442, 845; 
1H-NMR (300 MHz, CDCl3): δ [ppm] = 1.79 (td, J = 5.9 Hz, 11.8 Hz, 2 H, CH2), 2.36 (s, 
6 H, 2 x CH3), 2.51 - 2.58 (m, 2 H, CH2), 3.58 (td, J = 5.2 Hz, 5.9 Hz, 2 H, CH2), 3.91 (s, 
3 H, O-CH3), 6.80 (d, J = 2.3 Hz, 1 H, H-5), 6.99 (dd, J = 2.3 Hz, 8,9 Hz, H-6), 7.05 (s, 
1 H, H-3), 8.11 (d, J = 8.9 Hz, 1 H, H-8), 9.28 (s, 1 H, N-H); 13C-NMR (75 MHz, CDCl3): 
δ [ppm] = 24.8 (-, CH2), 40.6 (-, CH2), 45.6 (+, 2 x N-CH3), 55.8 (+, O-CH3), 59.2 (-, 
CH2), 100.5 (+, C-8), 111.8 (+, C-3), 114.5 (+, C-6), 118.3 (Cquat, C-9), 127.5 (+, C-5), 
155.1 (Cquat, C-2), 157.1 (Cquat, C-10), 159.2 (Cquat, C=O), 164.6 (Cquat, C-7), 177.7 (Cquat, 
C-4); MS (ESI, H2O/AcN) m/z (%): 305.0 (100) [MH]+; HRMS (C16H20N2O4)+• Calc: 
304.1423; Found: 304.1421 ± 0.44 ppm 
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{3-[(7-Methoxy-4-oxo-4H-chromene-2-carbonyl)-amino]-propyl}-trimethyl-
ammonium iodide (15a) 
O
O
N
O
H
N
+
O
I
 
7-Methoxy-4-oxo-4H-chromene-2-carboxylic acid (3-dimethylamino-propyl)-amide 
(456 mg, 1.5 mmol) was dissolved in chloroform (10 ml), iodomethane (284 mg, 2 mmol) 
added and the reaction mixture was allowed to stir at RT for 1 hour. The solution was 
heated to reflux for 10 min, the formed precipitate filtered off and washed with chloroform. 
The precipitate was dried yielding a white solid (575 mg, 1.3 mmol, 86 %). 
 
MP: 208 °C (decomposition); IR (KBr): ν~  (cm-1) = 3490, 3411, 3257, 3012, 2954, 1676, 
1633, 1604, 1442, 848; UV/VIS (CH3CN): λmax [nm] (log ε) = 210 (4.47), 242 (4.32), 304 
(3.80); 1H-NMR (600 MHz, DMSO): δ [ppm] = 1.97 - 2.03 (m, 2 H, CH2), 3.07 (s, 9 H, 
3 x CH3), 3.35 - 3.39 (m, 2 H, CH2), 3.36 - 3.41 (m, 2 H, CH2), 3.93 (s, 3 H, O-CH3), 6.78 
(s, 1 H, H-3), 7.13 (dd, J = 2.4 Hz, 8.9 Hz, H-6), 7.18 (d, J = 2.4 Hz, 1 H, H-8), 7.97 (d, 
J = 8.9 Hz, 1 H, H-5), 9.19 (s, 1 H, N-H); 13C-NMR (150 MHz, DMSO): δ [ppm] = 22.7 (-
, CH2), 36.3 (-, CH2), 52.2 (+, 3 x N-CH3), 56.1 (+, O-CH3), 63.3 (-, CH2), 100.8 (+, C-8), 
110.6 (+, C-3), 115.3 (+, C-6), 117.5 (Cquat, C-9), 126.5 (+, C-5), 155.1 (Cquat, C-2), 156.9 
(Cquat, C-10), 159.3 (Cquat, C=O), 164.3 (Cquat, C-7), 176.4 (Cquat, C-4); MS (ESI, H2O/AcN) 
m/z (%): 319.0 (100) [M]+; HRMS (C17H23N2O4)+ Calc: 319.1657; Found: 319.1661 ± 
1.16 ppm 
 
 
6-Methoxy-4-oxo-4H-chromene-2-carboxylic acid ethyl ester (12b) 
O
O
O
O
O
 
Sodium (1.49 g, 65 mmol) was dissolved in absolute ethanol (100 ml). Diethyloxalate 
(5.12 g, 35 mmol) and 2-hydroxy-5-methoxyacetophenone (2.49 g, 15 mmol) were 
dissolved in absolute ethanol (10 ml) and added to the sodium ethanolate solution. The 
solution was allowed to reflux for 1 hour. Concentrated HCl was added dropwise until the 
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reaction was acidic and a white precipitate formed. The white precipitate was filtered off 
and the yellow solution was concentrated to a slurry. The slurry was extracted with ethyl 
acetate, dried over Na2SO4 and evaporated to give a light yellow solid. The solid was 
recrystalised from methanol/diisopropylether (3:1) to yield a yellow solid (3.66 g, 
14.8 mmol, 98 %). 
 
MP: 98 °C; IR (KBr): ν~  (cm-1) = 3455, 3114, 3078, 2984, 2844, 1740, 1657, 1610, 1488, 
1288, 839; UV/VIS (MeOH): λmax [nm] (log ε) = 206 (4.45), 238 (4.22), 253 (4.31), 343 
(3.77); 1H-NMR (600 MHz, CDCl3): δ [ppm] = 1.42 (t, J = 7.1 Hz, 3 H, CH3), 3.89 (s, 
3 H, O-CH3), 4.45 (q, J = 7.1 Hz, 2 H, CH2), 7.10 (s, 1 H, H-3), 7.32 (dd, J = 3.2 Hz, 9.2 
Hz, 1 H, H-7), 7.53 (dd, J = 0.4 Hz, 3.2 Hz, 1 H, H-5), 7.54 (dd, J = 0.4 Hz, 9.2 Hz, 1 H, 
H-8); 13C-NMR (150 MHz, CDCl3): δ [ppm] = 14.1 (+, CH3), 56.0 (+, O-CH3), 62.9 (-, 
CH2), 104.6 (+, C-5), 113.8 (+, C-3), 120.2 (+, C-8), 125.0 (+, C-7), 125.2 (Cquat, C-9), 
150.8 (Cquat, C-10), 152.0 (Cquat, C-2), 157.5 (Cquat, C-6), 160.6 (Cquat, C=O), 178.3 (Cquat, 
C-4); MS (PI-EIMS, 70 eV) m/z (%): 248.0 (100) [M]+•; Elemental Analysis: C13H12O5 
Calc: C 62.90; H 4.87; Found: C 62.67; H 4.66 
 
 
6-Methoxy-4-oxo-4H-chromene-2-carboxylic acid butylamide (13b) 
O
O
O
N
O
H
 
Ethyl-6-methoxy-4-oxo-4H-chromene-2-carboxylate (590 mg, 2.4 mmol) and butylamine 
(512 mg, 7 mmol) were dissolved in dichloromethane (10 ml) and the reaction mixture was 
refluxed for 10 minutes. The solvent was evaporated upon which a light yellow solid 
formed. Glacial acetic acid (10 ml) was added and allowed to stir at 70 °C for 10 minutes. 
The mixture was added to ice water, the precipitate was filtered off, washed with water and 
dried. The solid was recrystalised from dichloromethane/diisopropylether (1:3) to yield 
white needles (572 mg, 2.1 mmol, 87 %). 
 
MP: 146 °C; IR (KBr): ν~  (cm-1) = 3305, 3091, 2956, 2869, 1639, 1610, 1359, 833; 
UV/VIS (MeOH): λmax [nm] (log ε) = 205 (4.43), 230 (4.25), 252 (4.36), 338 (3.75); 
1H-NMR (300 MHz, CDCl3): δ [ppm] = 0.98 (t, J = 7.3 Hz, 3 H, CH3), 1.43 (qd, J = 7.3 
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Hz, 14.3 Hz, 2 H, CH2), 1.65 (td, J = 7.3 Hz, 14.9 Hz, 2 H, CH2), 3.49 (dd, J = 7.1 Hz, 13.3 
Hz, 2 H, CH2), 3.90 (s, 3 H, O-CH3), 7.15 (s, 1 H, H-3), 7.31 (dd, J = 3.1 Hz, 9.2 Hz, 1 H, 
H-7), 7.45 (d, J = 9.2 Hz, 1 H, H-8), 7.56 (d, J = 3.0 Hz, 1 H, H-5); 13C-NMR (75 MHz, 
CDCl3): δ [ppm] = 13.8 (+, CH3), 20.1 (-, CH2), 31.5 (-, CH2), 39.8 (-, CH2), 56.0 (+, 
O-CH3), 105.1 (+, C-5), 111.2 (+, C-3), 119.4 (+, C-8), 124.6 (+, C-7), 125.1 (Cquat, C-9), 
150.0 (Cquat, C-10), 154.6 (Cquat, C-2), 157.5 (Cquat, C-6), 159.3 (Cquat, C=O), 178.1 (Cquat, 
C-4); MS (CI-MS, NH3) m/z (%): 276.2 (100) [MH]+; Elemental Analysis: C15H17NO4 
Calc: C 65.44; H 6.22; N 5.09; Found: C 65.33; H 5.92; N 4.80 
 
 
6-Methoxy-4-oxo-4H-chromene-2-carboxylic acid (3-dimethylamino-propyl)-
amide (14b) 
O
O
N
O
H
N
O
 
Ethyl-6-methoxy-4-oxo-4H-chromene-2-carboxylate (620 mg, 2.5 mmol) and 
3-dimethylaminopropylamine (766 mg, 7.5 mmol) were dissolved in dichloromethane 
(10 ml) and the reaction mixture was refluxed for 1 hour. The solvent was evaporated, 
glacial acetic acid (10 ml) was added and the solution allowed to stir at 70 °C for 
10 minutes. The mixture was added to ice water and extracted with ethyl acetate. The 
aqueous layer was neutralised with sodium hydrogen carbonate and extracted with ethyl 
acetate. The aqueous layer was made basic with sodium carbonate and extracted with ethyl 
acetate. The organic layer was dried over Na2SO4 and evaporated to give a yellow solid 
(615 mg, 2.1 mmol, 81 %). 
 
MP: 108-109 °C; IR (KBr): ν~  (cm-1) = 3434, 3305, 3041, 2945, 1680, 1641, 1385, 830; 
1H-NMR (300 MHz, DMSO): δ [ppm] = 1.68 (p, J = 6.9 Hz, 2 H, CH2), 2.15 (s, 6 H, 2 x 
CH3), 2.28 (t, J = 6.9 Hz, 2 H, CH2), 3.32 (dd, J = 6.9 Hz, 13.3 Hz, 2 H, CH2), 3.86 (s, 3 H, 
O-CH3), 6.79 (s, 1 H, H-3), 7.40 (d, J = 3.1 Hz, 1 H, H-5), 7.48 (dd, J = 3.1 Hz, 9.1 Hz, 1 
H, H-7), 7.66 (d, J = 9.1 Hz, 1 H, H-8), 9.23 (t, J = 5.6 Hz, 1 H, N-H); 13C-NMR (75 MHz, 
DMSO): δ [ppm] = 26.4 (-, CH2), 37.9 (-, CH2), 45.0 (+, 2 x CH3), 55.7 (+, O-CH3), 56.8 (-
, CH2), 104.5 (+, C-5), 109.3 (+, C-3), 120.2 (+, C-8), 124.1 (+, C-7), 124.3 (Cquat, C-9), 
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149.6 (Cquat, C-10), 155.4 (Cquat, C-2), 156.8 (Cquat, C-6), 158.7 (Cquat, C=O), 176.9 (Cquat, 
C-4); MS (CI-MS, NH3) m/z (%): 305.2 (100) [MH]+; HRMS (C16H20N2O4)+• Calc: 
304.1423; Found: 304.1425 ± 0.71 ppm 
 
 
{3-[(6-Methoxy-4-oxo-4H-chromene-2-carbonyl)-amino]-propyl}-trimethyl-
ammonium iodide (15b) 
O
O
N
O
H
N
+
O
I
 
6-Methoxy-4-oxo-4H-chromene-2-carboxylic acid (3-dimethylamino-propyl)-amide 
(456 mg, 1.5 mmol) was dissolved in chloroform (10 ml), iodomethane (284 mg, 2 mmol) 
was added and the reaction mixture was allowed to stir at RT for 1 hour. The solution was 
heated to reflux for 10 min, the formed precipitate filtered off and washed with chloroform. 
The precipitate was dried yielding a white solid (620 mg, 1.4 mmol, 93 %). 
 
MP: 240 °C +; IR (KBr): ν~  (cm-1) = 3422, 3298, 3031, 3013, 2945, 1680, 1651, 1615, 
1485, 828; UV/VIS (CH3CN): λmax [nm] (log ε) = 205 (4.42), 248 (4.34), 333 (3.54); 
1H-NMR (300 MHz, DMSO): δ [ppm] = 1.93 - 2.06 (m, 2 H, CH2), 3.07 (s, 9 H, 3 x CH3), 
3.30 - 3.41 (m, 4 H, 2 x CH2), 3.87 (s, 3 H, O-CH3), 6.83 (s, 1 H, H-3), 7.42 (d, J = 3.1 Hz, 
1 H, H-5), 7.51 (dd, J = 3.1 Hz, 9.2 Hz, 1 H, H-7), 7.70 (d, J = 9.2 Hz, 1 H, H-8), 9.24 (t, 
J = 5.9 Hz, 1 H, N-H); 13C-NMR (75 MHz, DMSO): δ [ppm] = 22.6 (-, CH2), 36.2 (-, 
CH2), 52.1 (+, 3 x CH3), 55.7 (+, O-CH3), 63.2 (-, CH2), 104.5 (+, C-5), 109.5 (+, C-3), 
120.3 (+, C-8), 124.2 (+, C-7), 124.3 (Cquat, C-9), 149.6 (Cquat, C-10), 155.1 (Cquat, C-2), 
156.8 (Cquat, C-6), 159.2 (Cquat, C=O), 176.9 (Cquat, C-4); MS (ESI, H2O/AcN) m/z (%): 
319.0 (100) [M]+; Elemental Analysis: C17H23N2O4I Calc: C 45.75; H 5.19; N 6.28; 
Found: C 45.40; H 5.14; N 6.51; HRMS (C17H23N2O4)+ Calc: 319.1658; Found: 319.1660 
± 0.76 ppm 
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5-Methoxy-4-oxo-4H-chromene-2-carboxylic acid ethyl ester (12c)[68] 
O
O
O
O
O
 
 
Sodium (1.49 g, 65 mmol) was dissolved in absolute ethanol (100 ml). Diethyloxalate 
(5.12 g, 35 mmol) and 2-hydroxy-6-methoxyacetophenone (2.49 g, 15 mmol) were 
dissolved in absolute ethanol (10 ml) and added to the sodium ethanolate solution. The 
solution was allowed to reflux for 1 hour. Concentrated HCl was added dropwise until the 
reaction was acidic and a white precipitate formed. The white precipitate was filtered off 
and the yellow solution concentrated to a slurry. The slurry was extracted with ethyl 
acetate, dried over Na2SO4 and evaporated to give a light yellow solid. The solid was 
recrystalised from methanol/diisopropylether (2:1) to yield a yellow solid (2.99 g, 
12.1 mmol, 80 %). 
 
MP: 124 °C; IR (KBr): ν~  (cm-1) = 3433, 3084, 2988, 2844, 1728, 1659, 1507, 1478, 
1269, 800; UV/VIS (MeOH): λmax [nm] (log ε) = 238 (4.22), 271 (4.00), 327 (3.64); 
1H-NMR (300 MHz, CDCl3): δ [ppm] = 1.40 (t, J = 7.1 Hz, 3 H, CH3), 3.97 (s, 3 H, 
O-CH3), 4.42 (q, J = 7.1 Hz, 2 H, CH2), 6.83 (d, J = 8.5 Hz, 1 H, H-6), 6.99 (s, 1 H, H-3), 
7.14 (dd, J = 0.9 Hz, 8.5 Hz, 1 H, H-8), 7.59 (t, J = 8.5 Hz, 1 H, H-7); 13C-NMR (75 MHz, 
CDCl3): δ [ppm] = 14.1 (+, CH3), 56.5 (+, O-CH3), 62.8 (-, CH2), 106.9 (+, C-6), 110.6 (+, 
C-8), 115.3 (Cquat, C-9), 116.5 (+, C-3), 134.7 (+, C-7), 150.3 (Cquat, C-2), 158.0 (Cquat, 
C-10), 159.8 (Cquat, C-5), 160.6 (Cquat, C=O), 178.0 (Cquat, C-4); MS (PI-EIMS, 70 eV) 
m/z (%): 248.0 (100) [M]+•; Elemental Analysis: C13H12O5 Calc: C 62.90; H 4.87; Found: 
C 62.84; H 4.75 
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5-Methoxy-4-oxo-4H-chromene-2-carboxylic acid butylamide (13c) 
O
O
O
N
O
H
 
Ethyl-5-methoxy-4-oxo-4H-chromene-2-carboxylate (590 mg, 2.4 mmol) and butylamine 
(512 mg, 7 mmol) were dissolved in dichloromethane (10 ml) and the reaction mixture was 
allowed to reflux for 10 minutes. The solvent was evaporated giving a light yellow solid. 
Glacial acetic acid (10 ml) was added, the solution was allowed to stir at 70 °C for 10 min, 
added to ice water, the precipitate filtered off, washed with water and dried. The solid was 
recrystalised from dichloromethane/diisopropylether (2/1) to yield white needles (607 mg, 
2.2 mmol, 93 %). 
 
MP: 128 °C; IR (KBr): ν~  (cm-1) = 3314, 3090, 2961, 1650, 1605, 1387, 794; UV/VIS 
(MeOH): λmax [nm] (log ε) = 238 (4.29), 260 (4.16), 323 (3.71); 1H-NMR (300 MHz, 
CDCl3): δ [ppm] = 0.96 (t, J = 7.3 Hz, 3 H, CH3), 1.35 - 1.47 (m, 2 H, CH2), 1.63 (td, J = 
7.3 Hz, 15.0 Hz, 2 H, CH2), 3.47 (dd, J = 6.8 Hz, 13.6 Hz, 2 H, CH2), 3.97 (s, 3 H, O-CH3), 
6.84 (d, J = 8.4 Hz, 1 H, H-6), 7.03 (s, 1 H, H-3), 7.05 (d, J = 8.4 Hz, 1 H, H-8), 7.60 (t, 
J = 8.4 Hz, 1 H, H-7); 13C-NMR (75 MHz, CDCl3): δ [ppm] = 13.8 (+, CH3), 20.1 (-, 
CH2), 31.5 (-, CH2), 39.7 (-, CH2), 56.6 (+, O-CH3), 107.0 (+, C-6), 109.8 (+, C-8), 113.7 
(+, C-3), 115.0 (Cquat, C-9), 134.5 (+, C-7), 152.8 (Cquat, C-2), 157.3 (Cquat, C-10), 159.2 
(Cquat, C-5), 160.1 (Cquat, C=O), 177.9 (Cquat, C-4); MS (CI-MS, NH3) m/z (%): 276.1 (100) 
[MH]+; Elemental Analysis: C15H17NO4 Calc: C 65.44; H 6.22; N 5.09; Found: C 65.40; 
H 6.00; N 4.96 
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5-Methoxy-4-oxo-4H-chromene-2-carboxylic acid (3-dimethylamino-propyl)-
amide (14c) 
O
O
N
O
H
N
O
 
Ethyl-5-methoxy-4-oxo-4H-chromene-2-carboxylate (620 mg, 2.5 mmol) and 
3-dimethylaminopropylamine (766 mg, 7.5 mmol) were dissolved in dichloromethane 
(10 ml) and the reaction mixture was refluxed for 1 hour. The solvent was evaporated, 
glacial acetic acid (10 ml) was added and the solution allowed to stir at 70 °C for 
10 minutes. The mixture was added to ice water and extracted with ethyl acetate. The 
aqueous layer was neutralised with sodium hydrogen carbonate and extracted with ethyl 
acetate. The aqueous layer was made basic with sodium carbonate and extracted with ethyl 
acetate. The organic layer was dried over Na2SO4 and evaporated to give a yellow solid 
(627 mg, 2.1 mmol, 83 %). 
 
MP: 87 - 88 °C; IR (KBr): ν~  (cm-1) = 3420, 3312, 3080, 2955, 1650, 1603, 798; 1H-NMR 
(300 MHz, DMSO): δ [ppm] = 1.67 (p, J = 6.9 Hz, 2 H, CH2), 2.15 (s, 6 H, 2 x CH3), 2.27 
(t, J = 6.9 Hz, 2 H, CH2), 3.31 (dd, J = 6.9 Hz, 13.3 Hz, 2 H, CH2), 3.86 (s, 3 H, O-CH3), 
6.61 (s, 1 H, H-3), 7.02 (d, J = 8.4 Hz, 1 H, H-6), 7.20 (dd, J = 0.7 Hz, 8.4 Hz, 1 H, H-8), 
7.75 (t, J = 8.4 Hz, 1 H, H-7), 9.17 (t, J = 5.6 Hz, 1 H, N-H); 13C-NMR (75 MHz, DMSO): 
δ [ppm] = 26.4 (-, CH2), 37.9 (-, CH2), 45.0 (+, 2 x CH3), 56.0 (+, O-CH3), 56.8 (-, CH2), 
107.4 (+, C-6), 109.9 (+, C-8), 111.8 (+, C-3), 114.0 (Cquat, C-9), 134.9 (+, C-7), 153.3 
(Cquat, C-2), 156.9 (Cquat, C-10), 158.7 (Cquat, C-5), 159.1 (Cquat, C=O), 176.4 (Cquat, C-4); 
MS (CI-MS, NH3) m/z (%): 305.2 (100) [MH]+; HRMS (C16H20N2O4)+• Calc: 304.1424; 
Found: 304.1425 ± 1.1 ppm 
 
 
180 
{3-[(5-Methoxy-4-oxo-4H-chromene-2-carbonyl)-amino]-propyl}-trimethyl-
ammonium iodide (15c) 
O
O
N
O
H
N
+O I
 
5-Methoxy-4-oxo-4H-chromene-2-carboxylic acid (3-dimethylamino-propyl)-amide 
(456 mg, 1.5 mmol) was dissolved in chloroform (10 ml), iodomethane (284 mg, 2 mmol) 
was added and the reaction mixture was allowed to stir at RT for 1 hour. The solution was 
heated to reflux for 10 min, the formed precipitate filtered off and washed with chloroform. 
The precipitate was dried yielding a white solid (625 mg, 1.4 mmol, 93 %). 
 
MP: 240 °C +; IR (KBr): ν~  (cm-1) = 3433, 3244, 3018, 2940, 1683, 1650, 1602, 1475, 
802; UV/VIS (CH3CN): λmax [nm] (log ε) = 242 (4.25), 319 (3.53); 1H-NMR (300 MHz, 
DMSO): δ [ppm] = 1.92 - 2.04 (m, 2 H, CH2), 3.06 (s, 9 H, 3 x CH3), 3.30 - 3.41 (m, 4 H, 
2 x CH2), 3.87 (s, 3 H, O-CH3), 6.65 (s, 1 H, H-3), 7.04 (d, J = 8.4 Hz, 1 H, H-6), 7.23 (dd, 
J = 0.7 Hz, 8.4 Hz, 1 H, H-8), 7.77 (t, J = 8.4 Hz, 1 H, H-7), 9.17 (t, J = 5.9 Hz, 1 H, N-H); 
13C-NMR (75 MHz, DMSO): δ [ppm] = 22.6 (-, CH2), 36.2 (-, CH2), 52.1 (+, 3 x CH3), 
56.1 (+, O-CH3), 63.2 (-, CH2), 107.5 (+, C-6), 109.9 (+, C-8), 112.0 (+, C-3), 114.0 (Cquat, 
C-9), 135.0 (+, C-7), 153.1 (Cquat, C-2), 156.9 (Cquat, C-10), 159.1 (Cquat, C-5), 159.2 (Cquat, 
C=O), 176.3 (Cquat, C-4); MS ESI, H2O/AcN) m/z (%): 319.0 (100) [M]+; HRMS 
(C17H23N2O4)+ Calc: 319.1658; Found: 319.1660 ± 1.02 ppm 
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